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Abstract
Sub-Saharan Africa’s (SSA) disease landscape is heavily burden with com-
municable and non-communicable diseases. Recently, the policy-makers’
decision-making process in the region has been influenced by the sustain-
able development goals (SDGs) that aim at reducing the mortality rates
from communicable and non-communicable diseases. Therefore, efforts are
being made to introduce more health interventions that can reduce the
prevalence of diseases in a cost-effective way.
Recently, health technologies have advanced to mHealth solutions that focus
on self-management and person-centred care. mHealth systems are depen-
dent on mobile technology namely mobile phones and smart phones. The
expansion of mobile technology into the market has brought about the de-
velopment of wearable devices. Wearable devices are mobile electronics that
can be worn extensively on the body as an accessory or embedded in cloth-
ing. These devices make it possible to collect, record and analyse data from
the user in a faster and more accurate manner. The main challenge in the
region currently is devising a strategy that integrates wearable technology
into SSA health system.
The aim of this study is to develop an approach that can be used to de-
termine the potential of wearable technology in SSA based on the disease
landscape. The disease landscape will be analysed using the data from the
World Health Organization database for the year 2015. The data collected
will then be used to select the diseases that heavily burden the region in
terms of daily-adjusted life years (DALYs) and fatality. On the other hand
a structured review will be used to determine the wearable technology and
iv
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its key enabling technologies. The physiological signs are used to cross-
reference the wearable sensors to the selected diseases in this study. A
2-step prioritisation exercise is then used to determine the wearable sensors
and diseases that are impactful and should receive priority in the region.
The stakeholder perspective analysis will be used to determine the entities
involved in the application and their anticipated perception and reception
of wearable technology in healthcare.
After the prioritisation exercise, the findings indicated that the wearable
sensors that will most likely have potential in SSA are photoplethysmog-
raphy (PPG) sensor, thermistor, pulse oximeter and biosensors, based on
the various application areas during disease management. The conditions
that require continuous monitoring are ischaemic heart diseases, stroke and
premature birth complications and will most likely be impacted by the in-
troduction of wearable technology through reduction of DALYs. From the
stakeholder perspective analysis, it was gathered that patients and medi-
cal facilities will most likely be resistant to the introduction of wearable
technology. The main reasons for the resistance identified were the costs
associated with the introduction of wearable technology and the confiden-
tial of their medical records.
Based on these findings, further research can be conducted to develop wear-
able devices that are tailor-made for the unique SSA disease landscape.
v
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Opsomming
Sub-Sahara-Afrika (SSA) se mediese landskap is swaar belas met oordraag-
bare en nie-oordraagbare siektes. Onlangs was die beleidsmakers se besluit-
nemingsproses in die streek be¨ınvloed deur die volhoubare ontwikkelings-
doelwitte wat daarop gemik is om sterftesyfers van oordraagbare en nie-
oordraagbare siektes te verminder. Daar word beoog om meer gesondheids
intervensies in te stel wat die voorkoms van siektes op ’n koste-effektiewe
manier te verminder.
Onlangs het gesondheidstegnologiee¨ gevorder na mHealth-oplossings wat op
selfbestuur en persoongesentreerde sorg fokus. mHealth-stelsels is afhank-
lik van mobiele tegnologie, naamlik selfone en slimfone. Die uitbreiding van
mobiele tegnologie in die mark het die ontwikkeling van draagbare toestelle
aangebring. Draagbare toestelle is mobiele elektronika wat omvattend op
die liggaam gedra kan word as ‘n bykomstigheid of in klere ingebed kan word.
Hierdie toestelle maak dit moontlik om inligting te versamel en analiseer van
die gebruiker op ‘n vinniger en meer akkurate manier. Draagbare toestelle
word hoofsaaklik vervaardig om nie-oordraagbare siektes aan te spreek wat
in gevolg die mees ontwikkelde lande swaar belas. In literatuur is daar tans
geen studie wat die potensieel van draagbare tegnologie in die SSA, wat
gefokus is massiewe siektes in in die gebied, bereken nie.
Die doel van hierdie studie is om ‘n benadering te ontwikkel wat gebruik
kan word om die potensiaal van draagbare tegnologie in SSA te kan bepaal.
Met behulp van die World Health Organisation (WHO) se databases vanaf
2015 sal die landskap se siektes ontleed word. Die versamelde data sal dan
gebruik word om die siektes te selekteer wat ‘n swaar las is in die streek in
terme van daaglike aangepaste lewensjare (DALYs) en noodlottigheid. Aan
vi
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die ander kant sal ’n gestruktureerde oorsig gebruik word om die draagbare
tegnologie en die sleutelbemagtige tegnologiee¨ waat met dit gepaard gaan
te bepaal.
Die fisiologiese tekens word gebruik om die draagbare sensors na die geselek-
teerde siektes in hierdie studie te verwys. ’n Twee-stap-prioriteitsoefening
word dan gebruik om die draagbare sensors en siektes wat ‘n hoe¨ impak
het, te bepaal sodat dit geprioritiseer word in die streek. Die perspektief-
analise van belanghebbendes sal gebruik word om die betrokke entiteite by
die toepassing en hul verwagte persepsie en ontvangs van draagbare teg-
nologie in gesondheidsorg te bepaal.
Na die prioriteitsoefening het die resultate aangedui dat die draagbare sen-
sors wat waarskynlik die grootste potensiaal in die SSA sal heˆ, gebaseer op
verskeie toepassings areas gedurende siektebestuur. is: ‘n Fotoplethysmo-
grafie (PPG) sensor, termistor, polsoksimeter en biosensors. Toestande wat
deurlopende monitering benodig , is iskemiese hartsiektes, beroertes en pre-
matuur geboorte komplikasies en sal waarskynlik be¨ınvloed word deur die
bekendstelling van draagbare tegnologie deur die vermindering van DALYs.
Uit die perspektief-analise van belanghebbendes was dit ontdek dat mediese
fakulteite en pasie¨nte heelwaarskynlik weerstand sal bied teen die bekend-
stelling van draagbare tegnologie. Die hoofredes vir die ge¨ıdentifiseerde
weerstand was die koste verbonde aan die bekendstelling van draagbare
tegnologie en die vertroulikheid van mediese rekords.
Op grond van hierdie bevindinge, kan verdere navorsing gedoen word om
draagbare toestelle te ontwikkel wat op maat gemaak is vir die unieke SSA-
siekte-landskap.
vii
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CHAPTER 1
INTRODUCTION
The purpose of this research inquiry is to determine the potential of wearable technol-
ogy for application to the sub-Saharan Africa (SSA) disease landscape. This chapter
serves as an introduction providing: (i) the background of the project; (ii) the prob-
lem statement along with research aim and objectives; (iii) the research design and
methodology; and finally (iv) the report’s structure.
1.1 Background
In 2000, the Millennium Development Goals (MDGs) were derived during the United
Nations’ Millennium Summit (United Nation General Assembly, 2000). These goals
were developed in order to improve the living conditions of poor people and to reduce
poverty. Of the eight goals that were derived four focused on the improvement of health
by 2015. These four goals included (United Nation General Assembly, 2000):
• MDG 1: eradicate extreme hunger and poverty;
• MDG 4: reduce child mortality;
• MDG 5: improve maternal health; and
• MDG 6: combat Human Immunodeficiency Virus or Acquired Immunodeficiency
Syndrome (HIV/AIDS), malaria, tuberculosis (TB) and other major diseases.
1
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These goals have managed to reshape healthcare decision-making in developed and
developing countries. SSA has managed to achieve remarkable gains in achieving the
MDGs, including reducing child and maternal deaths and the prevalence of HIV/AIDS.
Specifically, child and maternal mortality were both reduced by approximately 54 per-
cent from 2000 to 2015, respectively. Furthermore, AIDS related deaths have decreased
from 1.8 million people in 2005 to 1.1 million people in 2013, as well and the cases of
newly infected people halved from 2005 to 2013 (World Health Organization (WHO),
2016). Despite these achievements, women have continued to die during pregnancy or
from childbirth-related complications (United Nations, 2015).
As a result, there was a need to create a people-centred development agenda. The
process was conducted through a series of global consultations between civil society
organisations, citizens, scientists, academics and the private sectors around the world.
They were all actively engaged in the process to develop Sustainable Developmental
Goals (SDGs) . The SDGs include 17 goals and 169 targets (United Nations, 2016).
The third SDG focuses on ”ensuring healthy lives and promoting well-being for all
at all ages” (United Nations, 2016). This goal has been considered to have a wider
range compared to MDGs that were limited to child and maternal mortality as well as
communicable diseases. The targets that were set for the third SDG expand on the
MDGs by adding non-communicable diseases (NCDs) and other aspects such as:
1. Reduce the global maternal mortality ratio to below 70 per 100 000.
2. Reduce neonatal mortality to below 12 per 1 000 and under five mortality ratio
to 25 per 1 000.
3. End the pandemics of AIDS, tuberculosis, malaria, and neglected tropical diseases
and combat hepatitis, water-borne diseases and other communicable diseases.
4. Reduce by one-third premature mortality from NCDs.
5. Strengthen the prevention and treatment of substance abuse.
6. Halve the number of global deaths and injuries from road traffic accidents by
2020.
2
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7. Ensure universal access to sexual and reproductive health-care services.
8. Achieve universal health coverage.
9. Reduce the number of deaths and illnesses from hazardous chemicals and air,
water and soil pollution and contamination.
MDGs helped in mobilising the international community, leaders, politicians, civil
society and sectoral ministries as well as departments to focus on achieving these time-
bound and measurable goals. In turn, SDGs not only act as a continuation of the
MDGs but will also aim at improving global health with the additional targets (Kumar
et al., 2016).
Consequently, SDGs and MDGs have played a vital role in the development of new
health interventions to help improve health. Health interventions can be classified into
two broad categories, namely (Lukowicz et al., 2004):
(i) preventive interventions: those that prevent disease from occurring and reduce
the incidence(new cases) of diseases; and
(ii) therapeutic interventions: those that treat, mitigate, or postpone the effects of
disease, once it is under-way and thus reduce the case fatality rate or reduce
disability or morbidity associated with a disease.
In real life situations, some health interventions can be classified as both preventive
and therapeutic interventions.
For example, preventive interventions that are currently being used to prevent the
spread of diseases include: vaccines, nutritional interventions, maternal and neonatal
interventions, education and behavioural change and drugs for the prevention of dis-
ease. On the other hand, therapeutic interventions that are currently being applied
in SSA include: treatment of infectious disease, surgical and radical treatment, diag-
nostics to guide therapy and control of chronic diseases. SSA faces the challenge of
developing new technologies that can aid in eradicating the major diseases including
non-communicable diseases.
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The World Health Assembly has set a target of a 25 percent reduction of preventable
deaths from NCDs by 2025 through the use of person-centred care with improved out-
reach and self-management to effectively manage risk factors and multi-morbidity (Atun
et al., 2013). The use of advanced technology is one way that has been suggested to
achieve this goal. The advanced technologies that focus on person-centred care and self
management are classified under mHealth. mHealth is a health domain that focuses
on mobile and sophisticated technologies such as sensors, mobile phones, smart phones
and miniaturised electronics (Lukowicz et al., 2004).
Some of the roles of mHealth in public health include:
• promotion of patient-centred care at lower cost delivered in the patient’s natural
environment;
• enhanced efficiency in clinical decision-making;
• increased effectiveness of chronic disease management; and
• increased awareness by the user, in turn promotion of healthy lifestyle and self-
care.
An important aspect of this research is the investigation of the opportunities to
leverage the work that has already been done in the development of wearable tech-
nology by considering whether existing solutions can, for example, be applied in an
impactful way in SSA with some minor adjustments (either to the wearable device it-
self or to the condition which the device targets). Therefore, innovators in Sub-Saharan
Africa must develop solutions that can add value for the region’s disease landscape while
also considering resource availability and the intended users of wearable technology.
1.2 Research problem statement
In SSA, the disease landscape is mainly dominated by infectious diseases but non-
communicable diseases are also on the rise. Due to the nature of the available funds,
the majority of the current health interventions that are being introduced in SSA aim
at reducing the spread of infectious diseases. One of the main funding agencies in
4
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Africa is The Global Fund which supports projects concerned with AIDS, tuberculosis
and malaria (De Maeseneer et al., 2008). However, SDGs have a target that aims
at reducing the premature mortality from NCDs. Therefore, there is a growing need
amongst national health departments to start developing new health interventions,
aimed at reducing NCDs, that are accessible and affordable to the whole population.
This research seeks at determining the potential of wearable technology in the SSA
disease landscape.
1.2.1 Research aim and objectives
The aim of this research is to investigate the potential application of wearable technol-
ogy to prominent diseases in the SSA region and to make recommendations on such
applications that should be prioritised for further development. The research objectives
are as follows:
(i) Review the SSA disease landscape with the goal of summarising significant current
and anticipated future health challenges and identifying the prioritised set of
diseases that will be considered during the remainder of the research.
(ii) Review the wearable technology landscape in an effort to generate a comprehen-
sive overview of commercially available technologies and technologies that are in
advanced stages of development and are expected to become commercially avail-
able in the medium term.
(iii) Identify opportunities for the application of the wearable technologies identified
in (ii) to the prioritised healthcare challenges identified in (i).
(iv) Define criteria for prioritising the development of wearable technology for appli-
cation to specific healthcare challenges.
(v) Apply the criteria defined in (iv) to the range of opportunities identified in (iii) so
as to recommend a short list of wearable technology applications to be prioritised
for further development.
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1.2.2 Research scope
The research’s main purpose will be utilised to identify the wearable devices that can
be utilised in SSA within the short to medium term. The goal is to use the informa-
tion so that biomedical engineers can design wearable devices that will be impactful
to the SSA health systems when addressing the unique healthcare challenges in SSA.
The infrastructure associated with the introduction of wearable technology will only be
looked at from the availability of wearable sensors. The other key enabling technolo-
gies associated with information and communication technologies (ICTs) as well data
analysis will not be looked at in detail as this is out of the scope of this study.
With the time constraint the disease landscape will be studied as a region not at
country level. All the countries are affected by the same kind of diseases what will
differ is the prevalence and incidence rates.
1.2.3 Research design and methodology
This study comprises qualitative research conducted to document the current SSA dis-
ease landscape and the metrics (such as disease severity and disability-adjusted life
years (DALYs)) that can be used to determine disease impact either on an individual
or population level. The quantitative data for the diseases was collected from the WHO
databases and the latest data is from the year 2015.
A structured review is conducted to determine the characteristics of the wearable
technology so as to have a comprehensive overview of the wearable technology land-
scape. The study comprises information about the characteristics of wearable devices
that have been developed and are currently commercially available. The information
about the wearable devices was gathered from manufacturer’s websites and research ar-
ticles. The wearable devices were then assessed to determine the technology maturity
of each device using the technology readiness levels (TRL) assessment scale coupled
with the S-Curve.
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To determine the opportunities for applications in SSA structured interviews with
subject matter experts (SMEs) were conducted to determine the physiological signs
and the intended user(s). The data from the interviews was utilised to cross-reference
the wearable sensors to diseases and determine the shareholders that will utilise the
technology.
In order to prioritise the wearable sensors a set of criteria was defined through the
use of previous studies that were conducted in SSA. Heat maps were utilised to identify
the wearable sensors that have the highest priority in SSA for the diseases considered for
this study. In this study the stakeholder analysis was performed through a qualitative
analysis of literature. Figure 1.1 provides the schematic representation of the research
methodology followed.
Figure 1.1: Schematic representation of the research methodology
1.3 Structure of the report
This study is arranged in a such a manner that guides the reader through the research
process, beginning with a comprehensive overview of the SSA disease landscape and
the wearable technology landscape. Then conduct a prioritisation approach in order to
7
Stellenbosch University  https://scholar.sun.ac.za
1.3 Structure of the report
identify the wearable sensors and diseases that require priority. Finally make recom-
mendations based on the findings.
Chapter 2 provides a comprehensive overview of the SSA disease landscape by de-
termining the impact of diseases on a population and at individual patient level. In
this chapter the disease burden estimates used were the disability-adjusted life years
(DALYs) metric and the age-specific deaths for the year 2015.
Chapter 3 gives a comprehensive overview of the current wearable technology land-
scape by (i) broadly describing wearable technology; (ii) providing the different factors
that play vital roles in the usability, functionality and adoptability of wearable devices;
and (iii) describing technology maturity of the wearable devices.
Chapter 4 seeks to determine the opportunities between the identified wearable
technology and healthcare challenges. This chapter gives a background of the inter-
view process carried out in research and provides a motivation as to why structured
interviews were conducted for this part of the study. The summary of the feedback from
the interviews as well the cross-reference between the wearable sensors and the diseases.
Chapter 5 defines the selected set of criteria for prioritisation of diseases and wear-
able sensor technology through literature review. The criteria were categorised under
core criteria such as economics, knowledge of need and intervention outcomes. The
availability of data will be discussed in detail and the defined set of criteria will be
short-listed. The methods to determine the composite score during priority-setting will
be discussed as well.
Chapter 6 summarises the findings and discusses the results of the prioritised wear-
able sensors. In addition to the prioritisation approach, a stakeholder analysis was
performed in order to determine the expected reception of the technology and influence
of the identified stakeholders on the adoption of wearable technology. Chapter 7 is the
final chapter of the study, containing conclusions drawn from the study and proffering
recommendations.
8
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1.4 Conclusion
This chapter introduces the research problem briefly, providing the rationale of the
study along with the research methodology and the structure of the report. In the
following chapter, the current SSA disease landscape is described in more detail by
introducing methods of quantifying disease burden, communicable diseases and non
communicable diseases. The current disease landscape in SSA is also described and
explained using data from World Health Organisation (WHO) databases.
9
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CHAPTER 2
SUB-SAHARAN AFRICA DISEASE
LANDSCAPE
This chapter comprises background information of the health status of the different
WHO regions and highlights the uniqueness of the SSA disease landscape, for instance
by considering the quantification of disease burden by looking at communicable diseases
and non-communicable diseases. The quantification methods that were considered
were mortality rates and disability-adjusted life years (DALYs) as well as the cost-
effectiveness concept. Then, Section 2.2 analyses the current SSA diseases based on
the latest data from the World Health Organization (WHO) databases for the year
2015.
2.1 Background
In the last two decades, the global health landscape has transformed. This is evi-
denced by the improvements of the following health indicators namely the global life
expectancy, world population and child mortality. The global life expectancy has in-
creased from 66.4 in 2000 to 71.5 in 2015 (World Health Organization (WHO), 2017),
and in many places the older population is growing. The number of people in the world
has increased from 6.1 billion in 2000 to 7.4 billion in 2016 mainly because of improved
healthcare (Worldometers, 2017). Child mortality has decreased from approximately
10
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12.8 million in 1990 to 6.2 million in 2015 due to improved healthcare (The World
Bank, 2016).
Globally, the leading causes of death and disability have shifted from communica-
ble diseases (CDs) (also known as infectious diseases) in children to non-communicable
diseases (NCDs)1 in adults. Of 56.4 million global deaths in estimated 2015, 70 percent
of these resulted from NCDs. On the contrary, in SSA communicable diseases are still
dominant contributing to approximately 60 percent of the total deaths in the region
(World Health Organization, 2016b).
Appendix A provides the details of the top leading causes of mortality in all the
different regions in the world. As shown in Appendix A, East Asia and Pacific (Table
A.1), Europe and Central Asia (Table A.2), Latin America and Caribbean (Table A.3),
Middle East and North Africa (Table A.4), North America (Table A.5) and South Asia
(Table A.6) are mainly dominated by non-communicable diseases.
The non-communicable diseases that dominate these regions include stroke, is-
chaemic heart disease, chronic obstructive pulmonary disease, Alzheimer’s disease, lung
cancer and diabetes. In contrast, SSA (refer to Table 2.3) is mainly dominated by infec-
tious diseases such as HIV/AIDS, lower respiratory infections 2 and diarrhoeal diseases.
SSA has a unique disease landscape compared to the other regions and therefore re-
quires different health interventions that will specifically target its unique healthcare
challenges.
Previous studies have been performed in order to have a comprehensive overview
of the global disease landscape. The most popular study was the Global Burden of
Disease (GBD) study (Murray and Lopez, 1996). The first Global Burden of Disease
(GBD) study, was carried out by Chris Murray at Harvard University and Alan Lopez
at the World Health Organization (WHO), in collaboration with a global network of
over 100 scientists (Murray and Lopez, 1996). This study provided comprehensive,
1Non-communicable disease is a medical condition or disease that is by definition non-infectious
and non-transmissible among people (Dalal et al., 2011)
2Lower respiratory infections which affect the airways and lungs. These infections include: bron-
chitis, pneumonia and influenza. (NHS Choices, 2015; Simoes et al., 2006)
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valid, reliable and comparable information of maximum relevance to decision-making
concerning the global disease landscape (Mathers et al., 2007).
This study assessed the burden of disease consistently across diseases, risk factors
and regions. Also this provided information on the distribution and determinants of
health-related states or events (including diseases) that affect a population (Friis, 2009;
World Health Organization, 2016a).
The GBD study estimated mortality, incidence, prevalence and disability weights
for over 130 diseases by age, sex and world region (Murray and Lopez, 1996). The
study introduced a new metric, the disability-adjusted life years (DALYs), which sum-
marised the loss of health due to mortality and morbidity combined. Because of this
metric the GBD study has faced some criticism (Anand and Hanson, 1997; Barendregt,
2003; Oliver, 2005; Williams, 1999). Particularly, because of the social choices around
age-weights and severity scores for disabilities and relatively little information around
the large uncertainty in the basic descriptive epidemiology 1, especially in developing
countries (Mathers et al., 2007). In order to get an understanding of how these weights
are applied in the DALY metric, Section 2.1.1 will provide a more detailed explanation.
The GBD approach has been widely adopted by countries and health development
agencies as the standard for health accounting (Murray, 1994). Below is a list of the
countries that have previously adopted the study (Mathers et al., 2007):
• Mexico
• Mauritius
• The Netherlands
• Australia
• Brazil
• Malaysia
• Turkey
• South Africa
• Zimbabwe
• Thailand
• United States
• Canada
The GBD study has improved over the years because of the improved availability of
data. In the 1990 GBD study, the main source of data was the WHO database but in
1Descriptive epidemiology provides a way of organising and analysing data in order to understand
variations in disease frequency geographically and over time, and how disease (or health) varies among
people based on a host of personal characteristics (person, place, and time) (Evans et al., 2005).
12
Stellenbosch University  https://scholar.sun.ac.za
2.1 Background
recent years information has been gathered from national disease registers, epidemio-
logical studies, health surveys and health facility data(Kassebaum et al., 2016; Murray,
1994, 2015b; Murray and Lopez, 1996). Therefore, more reliable information has be-
come readily available to assist in making more informed estimates for the disability
weights used in the DALY metric (Mathers et al., 2007).
On the other hand, the World Bank’s Development Report, ’Investing in Health’,
introduced a framework for planning and allocation of resources for healthcare (World
Bank, 1993). This framework was designed to identify the diseases with the highest
burden using the GBD study. In this framework, the burden of disease was merged
with the cost-effectiveness of healthcare interventions. This was used to provide an
idea of the lowest possible cost that could reduce the disease burden most for resource
allocation and prioritisation (Murray et al., 1994).
2.1.1 Quantifying disease burden using DALYs
The DALY metric was first introduced in the 1990 GBD study to enable conditioned
and country-based comparison of disease burden and facilitate healthcare decision-
making (Murray, 1994). The DALY metric is used to measure the burden of diseases
in a population. The metric is also used to determine the health gap between an
ideal health situation where everyone lives to an old age and the actual population
health. Furthermore, DALYs provide an indication of the loss of a patients healthy
years through living with an illness and years that are lost due to premature death
compared with the ideal life expectancy (Barendregt, 2003; Oliver, 2005; Williams,
1999). The DALY metric is calculated by adding the years lived with disability (YLD)
and years of life lost because of premature death (YLL) (Barendregt, 2003; Donev
et al.).
2.1.1.1 Years lived with disability (YLD)
Diseases cause not only deaths but also varying time periods with morbidity and dis-
ability. The time period in years that is lived in states of poor health or disability
due to each disease is another dimension of the DALY measure (Donev et al.; Murray,
1994). Disability is measured by considering the length in years and in severity by
13
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using a measure called YLD.
YLD is based on the incidence of a particular disease and disability weight in a
given time period. The disability weight provides information on the severity of dis-
ease using a scale of zero to one for each disabling condition (also known as disabling
sequelae). These weights were determined by a panel of health experts with the knowl-
edge about disease conditions. Most diseases or conditions possess different disability
sequelae (Mathers et al., 2007).
To illustrate how the disability weights are applied, see Table 2.1, which shows how
malaria has different disability sequelae. For each disability sequelae corresponding
values of YLDs are provided. The disabling conditions for malaria include: episodes,
anaemia and neurological sequelae. According to the information in the table, the high-
est disability weight of malaria is experienced when there are episodes of chills, fever
and sweating. At this point the patient will be hospitalised (Murray and Lopez, 1996).
Anaemia in malaria is the lowest sequelae because this occurs when the patient
has repeated attacks of malaria. Malaria causes the depletion of red blood cells and a
decrease in red blood cell production, resulting in anaemia. This condition can be mild
or severe depending on the sufferer of malaria (Phillips and Pasvol, 1992). The YLD
metric is then derived from multiplying the disability weight with the average duration
the person suffers from the disability from each disease.
The neurological sequelae are a common cause of cerebral malaria. The clinical hall-
mark of cerebral malaria is the presence of coma. Most survivors of cerebral malaria
make a full recovery. However, neurological sequelae such as hemiplegia, speech prob-
lems, cortical blindness and epilepsy occur in 3 to 31 percent where the affected person
has to live with disabilities (Oluwayemi et al., 2013).
14
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Table 2.1: GBD cause categories, disabling sequelae and average disability weights for
Malaria (Reproduced from: Mathers et al. (2007))
Cause Case Definition
Disability Weight
Average Range
Malaria Infectious disease caused by
protozoa of the genus Plasmod-
ium
0,191 0,172-
0,211
Episodes Attacks of chills, fever and sweating
because of Plasmodium infection
0,471 0,443-0,471
Anaemia Defined using WHO criteria for mild
to very severe anaemia
0,012 0,012-0,013
Neurological
sequelae
Include hemiplegia, aphasia, ataxia
and cortical blindness
0,35 0.33-0.36
2.1.1.2 Years of life lost (YLL)
YLL metric takes into account the number of deaths at a certain age multiplied by a
global standard life expectancy which is a function of that age. In this estimate the
different age groups are given different values based on the human capital capabilities,
usually referred to as age weights. A number of studies suggest that the years lived by
a young adult have more value compared to those of a young child or an older person
(Boutayeb, 2006; Murray and Lopez, 1996). This is where the age weight faces criticism
because of how unethical it is to place a value on human life (Anand and Hanson, 1997).
The age weights are obtained from a scale where the value of a year lost rises steeply
from zero at birth to a maximum at 25 years of age and then decreases progressively
at older ages. From Figure 2.1 it is clear that the relative value of a life year for
children under 10 and people more older than about 55 years of age is less than 1.
Therefore, when priority-setting, interventions targeting these age groups receive less
priority (Donev et al.).
15
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Figure 2.1: Relative values of a year of life. (Reproduced from: The World Bank
(1993))
The reasons why DALYs are widely used for the epidemiological studies in devel-
oping countries are as follows (Murray and Lopez, 1996):
• Aid in the setting of health services priorities;
• Aid in identifying disadvantaged groups and targeting of health interventions;
and
• Provide a comparable measure of output for intervention, programme and sector
evaluation and planning.
This metric will be used in this study to indicate the SSA disease burden because
of its capability in showing mortality and morbidity.
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2.1.2 Cost-effectiveness analysis
Cost-effectiveness analysis (CEA) has been used as a tool used to evaluate the health-
care system to provide an economic perspective when addressing resource allocation
issues especially in areas with limited resources. The advantage of CEA is that it
makes it possible to compare different health interventions in terms of relative cost and
health gains (such as DALYs) (Hutubessy et al., 2003). This section aims at providing
the methodology used to calculate cost-effectiveness in healthcare based on the study
performed by Hansen and Chapman (2008).
2.1.2.1 Costs used for the cost-effectiveness analysis
The costing process can comprise the identification, measurement and valuation of
resources required to provide a health service. When performing an economic evaluation
the costs considered can be categorised into direct cost and indirect costs. The direct
costs that are usually accounted for when performing CEA include (Paganini et al.,
2018):
1. medical services such as consultations with a general practitioner or nurses;
2. hospital costs associated with in-patients and out-patients;
3. medication costs associated with the drugs taken during the duration of the illness
4. intervention cost refers to the cost to them at which national intervention agencies
are obliged to purchase any amount of a commodity, regardless of the level of
market prices; and
5. travel costs that are incurred during treatment.
When costing in healthcare, indirect cost refers to the productivity loss that is faced
as a result of absenteeism at work caused by either illness, presenteeism or premature
death (Luppa et al., 2007). In the case of a technology-based intervention, the costs
associated with integrating the technology in the health system can be considered as
well. When the above costs are calculated they provide a unit cost for an individual
health intervention (Hansen and Chapman, 2008).
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Regarding the total cost of an intervention at population level this can be calcu-
lated using the unit cost for an individual health intervention (Hansen and Chapman,
2008). The number of treatments for each disease was determined by incidence and the
health seeking behaviour of the population. The incidence of diseases can be drawn
from the WHO databases which provide age and gender (sex) specific incident rates
for the population (World Health Organization (WHO), 2016). In order to get the
proportions of cases by diseases likely to seek treatment, this can be determined from
consulting healthcare providers or by using the 80 percent assumption used in most
studies. Therefore, the total number of treatments by age and sex can be estimated for
each disease under consideration.
Equation 2.1.1 shows how the total costs of a treatment health intervention is
multiplied by the unit cost for an individual intervention (Hansen and Chapman, 2008):
Cj = U j
∑
a
∑
s
IjasH
j
as (2.1.1)
where Cj is the population level costs of intervention j, U j indicates the unit costs
of treatment health intervention j. In addition,Ias is the absolute, annual number of
incident cases of a health problem (which may be treated by intervention j ) in popu-
lation group of age a and sex s, while Hjas is the proportion of incident cases seeking
medical attention in the same population group.
On the other hand, for chronic conditions a different formula is used to estimate
the total cost of an intervention at a population level. In these cases, the specific
cost figures estimated for a given length of time were recalculated to match the life
expectancies at various ages at the beginning of the diseases as indicated in Equation
2.1.2 below (Hansen and Chapman, 2008):
Cj = U j
∑
a
∑
s
IjasH
j
as
T (as)∑
t=1
[(1 + r)−(t−1)Ajt ] (2.1.2)
where Ajt is the annual costs at time t for health intervention j for a chronic condi-
tion while T(as) indicates the life expectancy of an individual belonging to population
group of age a and sex s. Future costs are discounted using a real discount rate r of
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three percent (Hansen and Chapman, 2008).
Regarding preventive interventions the incurred costs are regarded at district and
provincial health offices and typically also at the level of health providers such as health
centres and hospitals. Then, cost of components for preventive interventions followed
the general form (see Equation 2.1.3) (Hansen and Chapman, 2008):
Cj = Dj + P j + U j
∑
a
∑
s
M jasN
j
as (2.1.3)
where Dj and P j represent the overall costs related to preventive intervention j
at the district and the particular district’s share of the provincial office, respectively.
In addition, U j denotes the unit costs of preventive activities at health centres and
hospital outpatient departments. Finally, M jas is the absolute number of individuals in
population group of age a and sex s targeted for intervention j and N jas denoting the
percentage actually covered (Hansen and Chapman, 2008).
2.1.2.2 Estimation of effectiveness of interventions at population level
Effectiveness is based on real-world experience and gives a better idea of whether the
technology would work or has worked in the past. If data on effectiveness of a health
intervention is unavailable efficacy can be considered because evidence of the latter is
more readily available through systematic reviews, randomized trials, etc. (Mathew,
2017). Effectiveness of health interventions in a real-world setting depends on a wide
range of factors such as efficacy of individual drugs, diagnostic accuracy, appropriate-
ness of the treatment prescribed and patient compliance.
Mathematically the effectiveness is the reduction in the burden of disease (known
as DALYs averted) as a result of intervention. Following the GBD methodology, the
burden of disease for an individual of sex s dying prematurely at age a, BODas, and
with life expectancy T(as) (or suffering from a disease episode starting at age a with
length T(as)) could be calculated from the formula (Hansen and Chapman, 2008):
BODas =
∫ a+T (as)
t=a
WKte−βte−r(t−a)dt (2.1.4)
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where W is a quality adjustment factor (disability weight) representing different
levels of health. The component Kte−βt is an age weighting curve of an inverted u-
shape so that the relative value of life years in young adulthood is higher than at
other ages while e−r(t−a) is the discount factor using discount rate r is three percent.
Life expectancies T(as) therefore depend on both age and sex. The benefit in terms
of DALYs gained from a successful intervention j for a person of age a and sex s is
calculated in the following way (Hansen and Chapman, 2008):
∆BODjas = BODas −BODjas (2.1.5)
where ∆BODjas is the burden of disease after a successful intervention.
The benefits at population level in terms of DALYs averted of a specific curative
health intervention j were subsequently calculated as (Hansen and Chapman, 2008):
DALY sj = EjBjF jGj
∑
a
∑
s
IjasH
j
as∆BOD
j
as (2.1.6)
whereEj , Bj , F j and Gj are efficacy of the drug prescribed, diagnostic accuracy, cor-
rect treatment and patient compliance respectively for curative intervention j measured
as percentages. Expressed in words, this equation estimates the number of individuals
cured through treatment j by excluding ineffective services from the total number of
individuals seeking treatment and translating the resulting health benefits into DALYs
averted.
The number of DALYs averted at population level for a given preventive intervention
j was calculated as:
DALY sj = EjRj
∑
a
∑
s
Ijas∆BOD
j
as (2.1.7)
where Ej is the efficacy of the intervention under ideal circumstances and Rj is any
necessary downward adjustment j (less than perfect coverage) of efficacy while Ijas is
the incidence of disease in different age and sex groups.
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2.1.2.3 Calculation of cost-effectiveness ratios
Having estimated the total costs and effectiveness of various health interventions, the
cost-effectiveness ratio for intervention j, CERj , was found as:
CERj =
Cj
DALY sj
(2.1.8)
where costs were estimated using equation 2.1.1, 2.1.2 or 2.1.3 and effects were
estimated using 2.1.6 or 2.1.7.
2.1.3 Communicable diseases
Communicable diseases are illnesses that arise as a result of specific infectious agents
that are transmitted from an infected human, animal or inanimate reservoir to sus-
ceptible host. An illness results from the presence and growth of pathogenic biological
agents in an individual host organism (Mboera et al., 2014). Communicable disease are
infectious or contagious diseases, parasitic diseases, infections transmitted by a vector
(the zoonoses) and all the transmissible diseases. A brief explanation of zoonoses is
provided in Section 2.1.3.2.
Communicable diseases can be either in the endemic or epidemic form (Van den
Berg and Viljoen, 1999) . An endemic is constantly present in a geographical area or
population group (Webber, 2016). An example of an endemic disease is malaria, an
infectious disease that is constantly present in tropical regions because of the conducive
condition for the mosquito life cycle. An epidemic is the introduction of a new infection
or the presence of an illness in excess of normal expectancy(Webber, 2016). In some
instances, this can be seasonal such as with influenza. In other instances, this results
when the number of susceptible people is sufficient for a new epidemic to take place,
for example measles.
2.1.3.1 Mode of transmission
Webber (2016) suggested that the best way to know about diseases is being able to
group them based on their modes of transmission. In many instances, some diseases
may share the same mode of transmission therefore can be treated in the same way.
The agents that transmit the communicable diseases can be organisms (such as virus,
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prion, bacteria, rickettsia, protozoa, helminth, fungus or arthropods), or a physical or
chemical agent (toxin or poison). Communicable diseases are transmitted through the
three ways listed below (Ayim, 2011):
• direct contact transmission;
• mechanical transmission; and
• biological transmission.
Direct contract transmission is the instantaneous transfer of the infectious agent
from a reservoir to a susceptible host by direct contact or droplet spread. Direct
contact can either occur with an infected animal, human or plants through touching,
kissing, skin contact, and sexual intercourse (Ayim, 2011; Van den Berg and Viljoen,
1999; Webber, 2016). Vibrio cholerae bacterium is transmitted through water contam-
inated by a person infected with cholera.
Droplet spread of infectious agents entails aerosols, coughing, sneezing or even talk-
ing to a contaminated person. Typically, TB is spread when an infected person coughs,
sneezes or spits Mycobacterium tuberculosis. The Mycobacterium is released into the
air and breathed in by an unaffected human (Ayim, 2011).
Mechanical and biological transmission is aided by a vector. In brief, a vector is an
organism that carries an infection by transferring pathogens from one host to another.
Mechanical transmission occurs when the agent does not multiply or undergo any phys-
iological changes in the vector. For example flies pick up micro-organisms from human
or animal excretions and deposit them on food (World Health Organization, 2005).
In contrast to mechanical transmission, biological transmission occurs when the
agent multiplies or undergoes part of its life cycle inside a vector before transmission to
a susceptible host (Ayim, 2011). For instance, malaria is transmitted to a susceptible
host by a female Anopheles mosquito. The process is explained in more detail in
Section 2.2.2.1. Understanding the transmission of a communicable disease allows the
development of effective preventive measures. The Centre for Disease Control used this
strategy to control the malaria, Ebola and HIV epidemics (Toole, 1997).
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2.1.3.2 Factors that cause communicable diseases
In reality, most of the infectious diseases that are being passed on originate from ani-
mals; these are zoonotic in nature. A number of publications suggest that between 65
and 80 percent of CDs are transmitted from animals (Jones et al., 2008; Mboera et al.,
2014). The zoonoses that have posed health threats in sub-Saharan Africa are avian
influenza, bovine tuberculosis, rabies, Ebola, anthrax, plague and bovine brucellosis
(Toole, 1997).
The spread of CDs is influenced by other factors such as socio-economic, ecological
factors and environmental factors. These factors are discussed below:
Socio-economic factors: In order for an infection to prevail socio-economic factors
play a vital role. The factors that can be considered are: education, resources and
economics as well as communities and movements (Webber, 2016).
Education can be used to stop the spread of infections. Education plays a vital role
in preventing the spread of some diseases because people will be knowledgeable and
aware of the best practices for better living conditions. Education is a complex process
which involves teaching people and making sure the people understand how to modify
their lives. Webber (2016) suggested that it is not only the tropical climates that con-
tributes to much of the spread of infectious disease but this is added to by poverty and
lack of education. In developed countries communicable diseases have been eradicated
because of the improvement in health education (European Centre for Disease Preven-
tion and Control (ECDC), 2014). As education improved people began to understand
the need for good water and proper sanitation, personal hygiene and cleanliness (Van
den Berg and Viljoen, 1999).
The lack of resources leads to poverty, which reduces the ability to combat disease.
In this context, resources refer to everything that people have to carry out for their
livelihood. Resources are required to enable the preventive, palliative and curative
methods or raise the standards that have come to be demanded by education. Diseases
are best prevented by education on how to overcome them, but resources are required
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to achieve this (Webber, 2016).
Some of the essential resources that are needed for a better livelihood are:
• Food is required to build up body processes and prevent malnutrition;
• Clean and safe water supply; and
• Housing in good conditions.
Resources, education and disease are linked directly. The type of houses that a
community occupies plays an essential role in the type of diseases they are exposed
to. In South America, the Reduviidae bugs that transmit Chagas’ disease live in the
mud walls of houses, so replacing these with more permanent materials can prevent the
disease (Beard et al., 2002).
Recently, the attraction to cites has resulted in large demographic changes. In the
past, the majority of the population lived in rural areas but now urban areas have be-
come the commonest place of residence in tropical countries (Dalal et al., 2011; Mayosi
et al., 2009). Because of urbanisation (unplanned and under-planned urbanisation)
and migration to urban areas for employment, people settle in slums where they have
poor living conditions. The water sources provided in such communities make them
susceptible to diarrhoeal diseases(Webber, 2016).
Recently, issues have arisen as a result of globalisation and dietary changes, leading
to the emergence of fast food chains in developing countries. Fast food poses a health
risk and contributes to the emergence of non-communicable diseases (Pang and Guin-
don, 2004).
Ecological changes and environmental factors : Ecological changes and envi-
ronmental factors usually occur when people are exposed to vectors that they were
not in contact with but were already in existence such as zoonotic or arthropod-borne
infections (Morse, 1995). Global warming has led to an increase in the global tem-
perature resulting in climatic changes. Climate change has brought about increase in
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tropical cyclones making the affected populations susceptible to diseases (Ayim, 2011;
Van den Berg and Viljoen, 1999; World Health Organization, 2005). These diseases
include diarrhoeal diseases and leptospirosis which thrive in watery environments.
The increase in the average temperature has also led to the spread of infectious
diseases such as malaria. In most cases, these high temperatures are favourable for
mosquitoes to thrive in and multiply especially in tropical areas in SSA (Kirigia and
Barry, 2008). Recently, the southern part of Africa has been experiencing more droughts
because of climate change (Ko et al., 2016). This has resulted in the scarcity of food
in some areas leading to malnutrition. Malnutrition usually affects children under the
age of five by making their immune system weaker and susceptible to diseases such as
lower respiratory infections, kwashiorkor and marasmus (Webber, 2016).
These are the other environmental factors that can contribute to the spread of
infectious disease (Webber, 2016):
(i) agricultural activities that attract rodents that are associated with the spread of
the plague;
(ii) deforestation and reforestation may cause the spread Lyme disease; and
(iii) dams can lead to the spread of malaria by providing breeding places for mosquitoes.
It is estimated that 40 percent of the disease burden in SSA is environmentally
determined (Barrat et al., 2014). As a result, complex health problems such as CDs
are difficult to solve without an understanding of these factors.
2.1.4 Non-communicable diseases
A non-communicable disease is a medical condition or disease that is by definition non-
infectious and non-transmissible among people (Dalal et al., 2011). The main types of
NCDs are cardiovascular diseases 1, chronic lung diseases, cancer and diabetes. Most
NCDs are linked and strongly associated with four preventable risk factors namely:
i) tobacco use, ii) physical inactivity, iii) unhealthy diet and iv) the harmful use of
1Cardiovascular diseases include Rheumatic heart disease, Ischaemic heart disease, Stroke, Hyper-
tensive heart disease and Cardiomyopathy and myocarditis
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alcohol. These behavioural risk factors lead to four key physiological changes listed
below (World Health Organization, 2010):
(i) high blood pressure;
(ii) overweight or obesity;
(iii) hyperglycaemia (high blood sugar levels); and
(iv) hyperlipidaemia (excess fat level)
According to the World Health Organization (WHO) (2014a), tobacco is not only
the most prominent cause of cancer but also cardiovascular diseases and chronic respi-
ratory disease. It has been estimated that in the twentieth century 100 million people
died worldwide from tobacco-associated diseases (Boutayeb, 2006). Despite the risk
associated with smoking, there are 1.2 billion smokers in the world and 80 percent live
in developing countries. The number of smokers in developing countries increases by
3.4 percent per annum (World Health Organization (WHO), 2014a). It is estimated
that 6 million deaths recorded in 2015 recorded were linked to smoking and 10 percent
of those were from passive smoking (Kassebaum et al., 2016).
Obesity and dietary habits represent potential risk factors for cardiovascular dis-
eases, type 2 diabetes, and some types of cancers, especially in the absence of physical
activity. Approximately 3.2 million deaths are linked to physical inactivity every year
(World Health Organization, 2010). Recent studies reported by the World Health Or-
ganization (2016b) suggest that the intake of fruit and vegetables is recommended and
helps reduce the risk of coronary disease, stroke and high blood pressure. However, in
developing countries the Western diet is taking over, leading to the reduction in the
consumption of fruit and vegetables (Bourne et al., 2002; World Health Organization
(WHO), 2014a).
Alcohol consumption is a risk factor associated with 2 million deaths in the world
ever year (World Health Organization (WHO), 2014a). It is mainly associated with
liver disease and oesophageal cancer. The increase in alcohol consumption in developing
countries will contribute other hazards caused by violence and road accidents to the
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burden of disease (Crampin et al., 2016). Table 2.2 gives a summary of the main risk
factors and their associated diseases.
Table 2.2: Diseases that are linked to the four main risk factors
Risk Factors Diseases Linked to Risk
Factors
Comments
Tobacco oral cancer, hypertension,
heart diseases, lung cancer,
chronic respiratory disease,
cardiovascular diseases and
also communicable diseases
such as tuberculosis and lower
respiratory infections
6 million deaths and of
this 10 percent from second
hand smoking. There are
different forms of smoking
smokeless (unburnt forms)
and smoking. (Stevens,
2009)
Insufficient
physical activ-
ity
ischaemic heart disease, dia-
betes, breast and colon cancer,
stroke, hypertension, and de-
pression
3.2 million deaths reported
annually (World Health Or-
ganization, 2010). People
who are not sufficiently ac-
tive have a high 20 - 30
percent increased risk of
all cause mortality. Au-
tomation of work is taking
away the physical aspect.
(Crampin et al., 2016)
Harmful use of
alcohol
cancers , cardiovascular dis-
eases, liver cirrhosis, ischaemic
heart disease, cerebrovascular
disease
2.3 million deaths annu-
ally (World Health Organi-
zation (WHO), 2014a)
Unhealthy diet gastrointestinal cancer, is-
chaemic heart disease, stroke
insufficient intake of fruits
and vegetables (Cordain
et al., 2005)
2.2 Disease landscape in sub-Saharan Africa
The SSA disease landscape can best be described as double-burdened because of the
prevalence of CDs and NCDs. Over the past decade, there has been a gradual increase
of the mortality and morbidity caused by NCDs in SSA, unlike in the past where
the disease landscape was dominated by infectious diseases (Boutayeb, 2006). The
challenge that faces SSA health systems is the limited resources which forces them to
prioritise communicable disease more than NCDs. As a result most of the resources are
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allocated to controlling the spread of infectious diseases and epidemics (Anyangwe and
Mtonga, 2007). In this section the disease landscape will be determined by considering
the burden of disease.
2.2.1 Top causes of death in SSA for the year 2015
Of the 9.5 million deaths in SSA in 2015, more than half (55 percent) were due to the
top 10 causes (see Table 2.3). Lower respiratory infections, HIV/AIDS and diarrhoeal
diseases are the region’s biggest killers, accounting for a combined 2.5 million deaths
in 2015. These diseases have remained the leading causes of death for the past 15 years.
Stroke claimed 459 thousand lives in 2015, while ischaemic heart disease caused 453
thousand deaths. Tuberculosis killed 446 thousand in 2015. Deaths due to malaria
recorded in 2015 were 409 thousand deaths. Pre-term birth complications caused 355
thousand deaths and birth asphyxia and birth trauma claimed 338 thousand babies
lives. Road injuries claimed 273 thousand in 2015. These diseases affect different age
groups in the population. This gives an idea of the target group when coming up with
interventions for different age groups.
In SSA, children under five have the highest mortality from communicable diseases
such as lower respiratory infections, malaria and diarrhoeal diseases. About 70 percent
of these conditions could be treated with access to simple, affordable interventions.
Over half of all under-five child deaths occur partly due to poor or delayed seeking
of treatment, leaving children in developing countries 10 times more likely to die than
children in developed countries (Lloyd and de Witt, 2013; Palmer and Gershbein, 2012).
Between the ages of 5 to 14 years mortality is due to severe malnutrition, HIV/AIDS,
diarrhoeal diseases, meningitis and acute lower respiratory infections. In literature the
majority of these diseases affect children that live in rural areas because of the poor
health care services and socio-economic factors (Dedefo et al., 2016).
Among young adults in SSA fatality results mainly from these communicable dis-
eases, namely HIV/AIDS, diarrhoeal diseases, lower respiratory diseases, meningitis,
tuberculosis and malaria. The females in this age group are susceptible to maternal
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deaths. The top causes of maternal mortality include: pathogenic causes, obstetric
haemorrhage, puerperal sepsis, pregnancy induced hypertension, obstructed labour,
ruptured uterus and complication from unsafe abortions(Rogo et al., 2006). A study
in Eritrea found that 16 percent of maternal deaths occurred during pregnancy, 48
percent of those during childbirth, and 36 percent post-partum (Ghebrehiwot, 2004).
Non-communicable diseases that affect the population in this age group are: ischaemic
heart disease and liver cirrhosis. These NCDs are as a result of risk factors such as un-
healthy diet, harmful use of alcohol and smoking (World Health Organization (WHO),
2014a).
From the age of 30 to 49 years more people die from NCDs than the people below
30. The top NCDs that cause fatality include: liver, breast and cervical cancer, dia-
betes and stroke. The same diseases affect the elderly population. According to WHO,
the life expectancy of sub-Saharan Africa has risen from 50.6 to 60.0 (World Health
Organization (WHO), 2017). This indicates that the demographics in SSA are shift-
ing and the elderly population is increasing. However, the elderly are mainly affected
by conditions such as: cancer, diabetes, ischaemic heart disease, stroke and chronic
obstructive pulmonary disease, all of which are chronic conditions (World Health Or-
ganization (WHO), 2016).
Table 2.3: Top 10 Causes of Death and disease burden in Sub-Saharan Africa 2015
(Adapted from: World Health Organization (WHO) (2016))
Rank Causes of death Deaths thou-
sands (000)
Diseases DALYs
(000s)
1 Lower respiratory infec-
tions
1 040 Lower respiratory infec-
tions
64 750
2 HIV/AIDS 765 HIV/AIDS 45 870
3 Diarrhoeal diseases 671 Diarrhoeal disease 44 483
4 Stroke 459 Malaria 35 615
5 Ischaemic heart disease 453 Preterm birth complica-
tions
31 798
6 Tuberculosis 446 Birth asphyxia and
birth trauma
30 367
7 Malaria 409 Congenital anomalies 19 846
Continued on next page
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Table 2.3 – Continued from previous page
Rank Causes of death Deaths thou-
sands (000)
Cause DALYs
(000s)
8 Preterm birth complica-
tions
355 Tuberculosis 18 543
9 Birth asphyxia and
birth trauma
338 Road injury 16 463
10 Road injury 273 Neonatal sepsis and in-
fections
15 984
2.2.1.1 Cause-specific DALYs in 2015
The total DALYs in SSA recorded in 2015 were 629 million. The top ten causes (in
Table 2.3 ) accounted for 51 percent of the total DALYs in the region. Lower respira-
tory infections, HIV/AIDS and diarrhoeal diseases cause the highest disease burden in
the region, accounting for 25 percent of the total DALYs.
Pre-term birth complications, birth asphyxia and congenital anomalies all combined
accounted for 98 million DALYs in children under the age of five. The child mortality
is believed to have been reduced by cost effective interventions such as resuscitation
of the new born baby, breastfeeding, kangaroo mother care 1 and prevention of hy-
pothermia in resource limited settings (Darmstadt et al., 2004). Congenital anomalies
refer to structural defects, chromosomal anomalies, inborn errors of metabolism and
hereditary disease present at birth (Lloyd and de Witt, 2013). Congenital anomalies
can contribute to long-term disabilities that is why it causes three percent DALYs.
The morbidity due to malaria accounted for 36 million DALYs and tuberculosis
19 million DALYs. The survivors from a stroke are usually paralysed, have trouble
speaking or understanding speech and trouble seeing(Mayo Clinic).
The neonatal (babies that are 0 - 28 days old) DALYs accounted for about 82 mil-
lion DALYs in the year 2015 and this gradually increased to 145 million for children
under the age of five. The number of deaths for the population between the ages of 5
1 Kangaroo mother care is a method of care for pre-term infants. The method involves infants being
carried, usually by the mother, with skin-to-skin contact especially for low-birth-weight and pre-term
infants (World Health Organization (WHO) and Dept. of Reproductive Health and Research, 2017)
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to 14 years steeply decreases to about 45 million DALYs. Then there is a ten percent
decrease of the DALYs rates in the 15- to 29-year age group to 40 million DALYs. The
DALYs rate increases slightly for the young adult population between 30 to 49 years
of age to about 50 million DALYs. Finally, for the elderly population above 50 the
DALYs dropped to 7.7 million.
Babies under the age of 28 days are burdened by neonatal conditions such as pre-
term birth complications, birth asphyxia and birth trauma, neonatal sepsis and infec-
tions. Children under the age of five have disabilities resulting from diarrhoeal dis-
eases, malaria, lower respiratory infections, childhood cluster diseases (such as whoop-
ing cough, diphtheria, measles and tetanus) and protein energy malnutrition (World
Health Organization (WHO), 2016). These children under the age of five have the
highest DALYs from the communicable diseases.
The population between the ages of 15 to 49 is affected by a different set of com-
municable diseases such as tuberculosis, HIV/AIDS, lower respiratory infections and
diarrhoeal diseases. In this age group the females are burdened because of maternal
conditions. The elderly population is susceptible to the conditions that affect the adult
population except for the disabilities caused by maternal complications (World Health
Organization (WHO), 2016).
For non-communicable diseases the trend shows a gradual increase from 0 to 49
years and then a decrease from then on. In the neonatal stage non-communicable dis-
eases have the lowest DALYs (7.6 million DALYs) recorded in 2015. Then the DALYs
increase slightly to 20 million DALYs for children under the age of five.The DALYs
recorded for children aged between 5 and 14 years they levels off at 20 million DALYs.
The NCDs reach a peak (37 million DALYs) for the ages between 30 to 49 years. Then
from the ages of 50 to over 70 the disease burden levels off at about 22 million DALYs.
The neonatal disabilities from NCDs are as a result of congenital anomalies. For
children under the age of five in addition to congenital anomalies there is sickle cell
anaemia, epilepsy and skin diseases. The children aged from 5 to 14 years are af-
fected by the same NCDs as the children under the age of five. The changes in the
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NCDs affecting the population between the age of 15 to 29 years include: sickle cell
anaemia, depressive disorder, alcohol use disorders, drug use disorders, anxiety disor-
ders, epilepsy, ischaemic heart disease, asthma, kidney diseases and cirrhosis of the
liver. Most of these are chronic conditions that affect the daily livelihood of the people.
The major concern in SSA is the fact that non-communicable diseases affect the active
age group (15 to 29) which affects the economy. The NCDs have started to take over
the SSA disease landscape because of the unhealthy diet, smoking, physical inactiv-
ity and alcohol abuse (World Health Organization (WHO), 2016). Furthermore, SSA
health systems lack the policies that can be used to prevent the prevalence of NCDs
(World Health Organization, 2010).
For elderly people, the burdens they are ridden with include: prostate, breast and
cervical cancer, hearing loss, ischaemic heart disease, chronic obstructive pulmonary
disease, diabetes, Alzheimer disease and other dementias, and stroke. Most of the el-
derly population are burdened by chronic conditions. These chronic conditions need
constant monitoring and treatments are extremely expensive. Such costs can force fami-
lies into catastrophic spending and impoverishment (World Health Organization, 2010).
From the data presented in Table 2.3 SSA is still heavily burdened by communicable
diseases. This explains why the health systems focus mainly on CDs at the expense of
NCDs.
2.2.2 Disease physiological signs
In this section the top 10 diseases will be briefly described to get an understanding of
each diseases and how they can be monitored through physiological signs.
Lower respiratory infections are common for causing disease burden in infants
especially pneumonia. Rodriguez et al. (2015) made a severity score for the parameters
that can be used to clinically assess lower respiratory infections. The parameters that
were considered for the monitoring of lower respiratory infections were respiratory rate,
heart rate and oxygen saturation. Furthermore, the GP-Update suggested more phys-
iological signs such as temperature, respiratory rate and blood pressure (GP-Update
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Red Whale, 2016).
HIV infection harms the immune system by destroying the white blood cells that
fight against infections. This leaves the body vulnerable to contracting serious infections
and certain cancers. HIV infection advances in three significant stages:
• During the initial stage the signs of HIV infection that may be evident are swollen
glands and flu-like symptoms which eventually disappear after two to four weeks.
• Then Stage 2 may last for 10 years or so, with no more apparent symptoms.
• Lastly Stage 3 is when the immune system is severely damaged that it can no
longer fight off serious infections and diseases, also known as ”opportunistic in-
fections”.
The three stages are then followed by AIDS. However not everyone with HIV develops
AIDS. Currently the only way to diagnose HIV infection is through a blood test. The
disease can be monitored by checking the level of the CD4 count in the blood. The
infected person takes antiretrovriral medication after being tested positive.
Diarrhoeal diseases are characterised by loose and watery stools that occur more
frequently than usual. The severity of the disease varies from the frequency of defeca-
tion of the loose stool. According to Crombie et al. (2013), the physiological signs that
can be utilised to assess diarrhoea include temperature, body fluid levels, electrolyte
composition, blood pressure, heart rate and heart electrical activity (especially in the
case of tachycardia 1).
1Tachycardia is a condition when the heart beats too fast leading to the failure of proper blood
circulation to all parts of the body. (GP-Update Red Whale, 2016)
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Stroke is an acute condition that affects people that are hypertensive. There is need
to monitor these patients continuously to prevent the occurrence of a stroke. The rec-
ommended vital signs that can be used to monitor high risk patients are blood pressure,
body temperature, blood oxygen saturation, and blood glucose levels (Wong and Read,
2008). After the stroke heart electrical activity, blood pressure, body temperature,
pulse oximetry, blood glucose and brain activity can be monitored to improve the pa-
tient’s health during treatment and rehabilitation (Moheet and Katzan).
Ischaemic heart diseases are monitored using the heart rate, respiratory rate,
blood pressure, oxygen saturation, heart electrical activity, heart sounds and urine
composition. At the moment there are devices that can be used to change the lifestyle
of a patient at high risk by monitoring the activities and sleep quality (Ministry of
Health and Quality of Life, 2000; National Heart Lung and Blood Institute, 2017).
Tuberculosis is an communicable disease caused by Mycobacterium tuberculosis. For
tuberculosis the vital signs that can be monitored are the heart rate, blood pressure,
temperature and respiratory rate (International Union Against Tuberculosis and Lung
Disease). In some instances the cough frequency in the first three months of contraction
of the disease can be used to screen TB patients (Bregani et al., 2013). The sputum
is analysed to detect the presence of tuberculosis when the patient shows some of the
signs and symptoms.
Malaria results from being bitten by an infected Anopheles mosquito. The infected
Anopheles carries a Plasmodium parasite which is released into the bloodstream. These
parasites infect the red blood cells and begin to multiply and cause the red blood cells
to burst open. There are different forms of malaria such as:
• swelling of the blood vessels of the brain, or cerebral malaria;
• accumulation of fluid in the lungs that causes breathing problems or pulmonary
oedema;
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• organ failure of the kidneys, liver or spleen;
• anaemia due to the destruction of red blood cells; and
• low blood sugar.
Malaria is diagnosed through a blood test and can only be prevented by not allow-
ing the intrusion of the malaria parasite into the body. The signs and symptoms of
malaria are non-specific, therefore a proper diagnosis has to be carried to confirm the
results.
Congenital anomalies are known as ”birth defects.” These are defined as structural
or functional anomalies that occur during the intrauterine life and can be identified pre-
natally, at birth or sometimes may only be detected later in infancy. These conditions
can be caused by genetic factors, environmental factors and infections. This condition
can be corrected through paediatric surgery and early treatment can be administered to
children with functional problems such as recessive blood disorders, sickle cell disorders
and reduced function of the thyroid.
Pre-term birth complications arise from immature organ systems that are not yet
prepared to support life in the external environment. These complications can lead to
the risk of contracting acute neonatal illnesses which are dependent on the length of the
gestation period and reflect the fragility and immaturity of the brain, lungs, immune
system, kidneys, skin, eyes and gastrointestinal system (Behrman and Butler, 2007).
Infants born prematurely (’preemies”) have the highest likelihood of dying during the
first 28 days (neonatal) and infancy (first year). Therefore, the mortality rate increases
proportionally with decreasing gestation age or birth weight. Preemies in the intensive
care unit require that their respiratory rate, blood pressure, heart rate, brain activity,
temperature, haemoglobin levels and blood sugar levels be monitored continuously as
well as after they are discharged from hospital (Hofmeyr et al., 2014).
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Birth asphyxia is a condition arises when a baby is deprived of oxygen before, during
or just after birth. This condition can be caused by the following complications during
birth (World Health Organization):
• mother’s blood possessing insufficient oxygen levels;
• placenta separating from the uterus too soon;
• long delivery process;
• high or low blood pressure in the mother; and
• baby’s blood cells cannot carry enough oxygen.
These conditions can be assessed or monitored by taking note of the following phys-
iological signs: temperature, heart rate, capillary refill time (perfusion), colour, oxygen
saturation, respiration rate, brain activity, haemoglobin levels and blood glucose levels
(World Health Organization). It is important that the heart rate, heart electrical ac-
tivity and the oxygen saturation of the pregnant woman are monitored before giving
birth to prevent and detect complications that can cause pre-term birth complications
(Mahmudul, 2013).
Neonatal sepsis is a blood infection. This infection can be caused by bacteria such
as Escherichia coli, Listeria and some strains of streptococcus (Lee, 2016). The infec-
tion can be characterised by body temperature changes, breathing problems, diarrhoea,
low blood sugar, slow or fast heart rate and yellow skin, as well as the whites of the
eyes (jaundice). The physiological signs that can be measured to assess neonatal sepsis
are heart rate variability, respiratory rate and oxygen saturation (Griffin et al., 2007).
In order to get more understanding, the leading causes of mortality and morbidity
are described in detail in Appendix A Table A.7. This table provides information on
the causes, signs or symptoms, preventive measures and treatments of a disease.
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2.2.3 Other challenges that affect health in SSA
SSA has widespread poverty, marginalisation and displacement. Poverty and health
form a vicious cycle which can be broken by encouraging economic development through
improving healthcare (Kengne et al., 2013). Furthermore, the environmental factors
and degradation are not sufficiently addressed even though they influence the trans-
mission of most infectious diseases as stated in Section 2.1.1. The region also faces
shortfalls in agriculture, low literacy, on going conflicts and lack of safe water, ade-
quate sanitation, electrification and infrastructure. All of these are drivers of the SSA
disease burden (Akintola et al., 2015).
The health interventions that are developed often do not match the scale of the
problem. The other challenge that most people are facing in SSA is insufficient empow-
erment to improve their health and inadequate involvement by the health departments
in their respective countries. According to Anyangwe and Mtonga (2007) the improve-
ment of health systems plays an important role in improving the health of sub-Saharan
Africa. There is also an issue with equity of health services where the people who are
heavily burdened by diseases do not have access to them.
In SSA the extent of extreme poverty has been reduced from 57 percent in 1990 to 43
percent in 2012 (Kengne and Mayosi, 2014). However, the reduction of poverty and the
development of countries leads to a shift from primary infections such as diarrhoea and
pneumonia to non-communicable such as cardiovascular diseases and cancers (Bourne
et al., 2002). This shift results from:
i Improvements in medical care, which mean that children can not easily die from
preventable and curable diseases such as diarrhoea.
ii The ageing population, because NCDs affect older adults at the highest rates. (De-
mographic transition)
iii Public health interventions such as vaccinations and the provision of clean water and
sanitation, which reduce the incidence of infectious diseases, as stated by Stevens
(2009).
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Non-communicable diseases in SSA are on the rise in rural communities and are
also affecting poor people living in urban settings, resulting in an increase in chronic
disease care (World Health Organization, 2010). As stated by Bourne et al. (2002)
the reason why South Africa is facing a transition from CDs to NCDs is because of
the shifts in dietary intake. In urban settings the fat intake by people has increased
from 16.4 to 26.2 percent of total energy whereas carbohydrate intake has decreased
from 69.3 to 61.7 percent in the past 50 years (Cordain et al., 2005). This has resulted
in having a population that is at high risk of suffering from non-communicable diseases.
Kengne and Mayosi (2014) stated that the transition from communicable to non-
communicable diseases in SSA is increasing at a faster rate than it did in high-income
countries.This rapid transition poses challenges to the health systems in the region as
they struggle to adapt at a sufficient pace to provide the resources required for chronic
care, typically associated with NCDs. The transition has been evidenced by the increase
of deaths from diabetes, chronic kidney disease and cancer especially of the prostate
and cervix, and by the increasing proportion of disability-adjusted life years (DALYs)
attributed to neuropsychiatric disorders such as anxiety, neurotic complaints and mood
disorders (Mayosi et al., 2009).
Studies have shown that non-communicable diseases accounted for 14 percent of
the total deaths in SSA. The mortality rate of the adults under 60 was 29 percent
compared to 13 percent in high-income countries (Unwin et al., 2001). Data estimates
have proven that the probability of death from NCDs prevalence is higher in SSA than
in developed countries (Mayosi et al., 2009; Unwin et al., 2001). This has raised alarms
in SSA and from 2009 approximately 89 percent of SSA countries are paying attention
to NCDs by setting divisions in Ministries of Health that focus on action plans and
functional programs (Kengne and Mayosi, 2014). In 2014, WHO performed surveys
and found that only about 26 percent of the countries had a functional programme or
an action plan (World Health Organization (WHO), 2014a).
It is of importance that policies be implemented to encourage better lifestyle and
to control the rapid increase of NCDs, despite the fact that most SSA countries do
not prioritise this (Hughes et al., 2012). In 2007, $21.8 billion was allocated by the
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Global Fund for assistance in health and only three percent of that was dedicated to
NCDs (Nugent and Feigl, 2010). Monitoring of NCDs should be encouraged because it
was observed that these diseases have a negative impact on health systems because of
increasing demand and escalating health care costs.Therefore, SSA countries need to
improve their surveillance and monitoring of NCDs by implementation of population-
wide interventions.
2.2.4 Selected diseases for this study
The diseases that will be used for the rest of the study where found to be the diseases
that heavily burden (50 percent of the total DALYs in the region) and cause the highest
mortality in SSA (55 percent of the total deaths in the region). The list of the diseases
that will be considered further for this study are:
1. Lower respiratory infections
2. HIV/AIDS
3. Diarrhoeal diseases
4. Stroke
5. Ischaemic heart disease
6. Tuberculosis
7. Malaria
8. Congenital anomalies
9. Pre-term birth complications
10. Birth asphyxia and other infections
11. Neonatal sepsis
2.3 Conclusion: Sub-Sahara Africa Disease Landscape
This chapter broadly explored the DALY metric, the cost-effectiveness of health inter-
ventions, communicable diseases and non-communicable diseases. It also provided an
overview of the SSA disease landscape based on the data recorded by the World Health
Organisation for 2015. In Chapter 2 the top 10 causes of death and disease burden
(in terms of DALY), according to the World Health Organization (WHO) (2016), were
discussed in detail to give an idea of how they affect the SSA population. This infor-
mation will be used to identify the diseases that should be prioritised and can benefit
from new health intervention such as wearable technology.
39
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 3
WEARABLE TECHNOLOGY
LANDSCAPE
This chapter aims at providing the necessary knowledge and background pertaining to
the status quo of the wearable technology landscape in healthcare. The overview of
the wearable technology landscape includes the characteristics of the devices and the
application areas. The technology maturity of the wearable devices will be assessed
in detail. A portion of the research contained in this chapter was presented at the
International Association for the Management of Technology’s annual conference held
in Vienna, Austria, in May 2017.
3.1 Background
Wearable technology (wearables) can be broadly defined as mobile electronic devices
that can be worn extensively as an accessory or embedded in the user’s clothing (Lam
Po Tang, 2007; Mahoney and Mahoney, 2010; McCann and Bryson, 2009; Sultan, 2015).
Stedmon (2016) provides the following description of wearable devices:
(...) this technology aims to bring computing power closer to the user so
that, ultimately, they form one and the same system: physically and func-
tionally. However, these are more than just portable computing systems,
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they offer the potential for fully integrated interfaces which aim to synthe-
sise the user and task, through seamless interface technology, to new levels
of operational capability.
The concept of wearable technology aims to bring computer power closer to the user
with the intention of forming one and the same system, physically and functionally
(Stedmon, 2016).
Claude Shannon and Edward Thorp at Massachusetts Institute of Technology (MIT)
developed the first wearable computer in June 1961. This device predicted where the
ball would end up on the roulette wheel (Thorp, 1998). Since this breakthrough, wear-
able devices have become more advanced and usable because of the development of
mobile devices, sensor technology, battery technology as well as microelectronics. As a
result, the increase of adoption as well as compliance of the user to wearable devices has
led to the development of more devices. The devices that have been developed over the
years include Mann’s wearcam (Mann, 1997), Philips-Levi’s industrial clothing design
ICD + Jacket (Sheriff, 2000), smart tattoos (Heo and Takeuchi, 2013), Google Glass
(Iltifat, 2014) and Pebble (Pebble, 2016).
Over the past decade, mobile technology has become a popular communication
platform and it is expected to become even more so in the future. This is according
to research conducted by the Connected Life Initiative sponsored by Groupe Speciale
Mobile Association (GSMA). The Initiative established that in 2011, there were 6 bil-
lion mobile devices in use and estimated that by 2020, this figure will have increased to
12 billion (Connected Life Initiative, 2013). This increase in mobile devices usage has
played an important role in the development of wearable devices (Patel et al., 2012).
Bass et al. (1997) predicted that with the decreasing size and increasing power of most
of the modern computer components, it was a matter of time before computers could
be worn on the body.
The miniaturisation of sensors and electronic circuits based on the use of microelec-
tronics has also played a key role in the development of wearable systems. In the past,
one of the hurdles of adopting sensing technology, especially for wearable applications,
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has been the size of the sensors and front-end electronics that were obstructive for
long-term monitoring applications (Patel et al., 2012). Recently in the field of micro-
electronics, researchers have developed miniature circuits entailing sensing capability,
front-end amplification, micro controller functions and radio transmission thereby mak-
ing wearable devices non-invasive (Patel et al., 2012).
3.1.1 Wearable technology characteristics
Despite the development of different wearable devices for different purposes, ranging
from industrial to personal applications, they all share some common characteristics
that allow for easy differentiation from other mobile devices. Rhodes (1997) proposed
the following list of the main characteristics that wearable devices typically possess:
• Sensors – miniaturised computers and transmission embedded on objects that
can be worn on the body. Sensors can be used for measuring temperature, heart
rate, and blood glucose level.
• Continuous operation – constant interaction with the human recording, collecting
and analysing data.
• Portable – easy to carry around and rechargeable batteries that allow several
hours or more of operation without access to an external charger or power source
• Hands-free use – include the use of head-up displays, direct voice output and
gesture recognition
• Proactive – the ability to convey data to its user even when it is not being actively
used. The tasks that wearables usually perform are collection, recording and
analysing.
The characteristics can be used by engineers to develop a design philosophy of wear-
ables Stedmon (2016). The main distinguishable feature of wearable devices is that they
are also designed to be usable at any time with the minimum amount of invasion of the
user’s primary task (Rhodes, 1997).
In this study these characteristics will be used as a guide to identify wearable devices
that have been developed specifically for healthcare applications.
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3.1.2 Types of wearable devices
A misconception is that wearable technology refers exclusively to wrist worn devices.
The International Data Corporation (2016) reported that 78.1 million wearable device
units were shipped in 2015 and that of those, 50.4 million units were smart watches.
In reality, wearable technology comes in many forms that can be broadly classified
as either portable or implantable devices as shown in 3.1 (Mann, 2014; Tehrani and
Andrew, 2014).
Figure 3.1: Types of wearable devices
These two categories of wearable devices will be discussed briefly in Section 3.1.2.1
and 3.1.2.2:
3.1.2.1 Portable devices
Portable devices are hand-held and can easily be carried around. These portable de-
vices can be further classified into three classes as shown in Figure 1: wrist-worn,
garment-integrated and body-worn (Patel et al., 2010) .
Wrist-worn devices available on the market include wristbands, smart watches and
jewellery. Some of the brands that are currently available for consumers include Fitbit,
Apple, Jawbone, Pebble, Samsung and Sony.
Garment-integrated devices are embedded into a garment and are designed for con-
stant wear. They only function when worn on the body (Barfield and Baird, 1998).
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These devices are smart garments that incorporate textile based sensing and smart
garment design (Dunne et al., 2005). Currently, the garments that are available on the
market include AiQ Smart Clothing (AiQ, 2016) and Athos Gear (Athos, 2017).
Body-worn devices are also designed to be constantly worn, but not in the form
of traditional clothing. Instead they are strapped on or otherwise affixed to the body.
Examples of the devices that have been developed include the BodyMedia SenseWear
armband (Bodine and Gemperle, 2003).
3.1.2.2 Implantable devices
Implantable devices are devices used to replace or act as a fraction or the whole of the
biological structure. Implantable devices have been developed for various applications
such as orthopaedics, pacemakers, cardiovascular stents, defibrillators, neural prosthet-
ics and drug delivery systems (Regar et al., 2001). Implantable devices are further
classified into cardiovascular implants, orthopaedic implants and drug implants (Khan
et al., 2014).
Cardiovascular implants are devices used for the treatment of heart diseases. These
implants are divided into three further categories that are pacemakers, cardiac stents
and related stents as well as structural cardiac implants (Khan et al., 2014). Pacing
devices are used for cardiac resynchronisation therapy. They also used as cardioverter-
defibrillators. A cardiac stent is a small, expandable tube that treats narrowed arteries
in the body and is inserted into the artery through an angioplasty procedure (Beck-
erman, 2016). Structural cardiac implants incorporate technological advances in heart
valves, ventricular assist devices and implantable monitors (Khan et al., 2014).
Orthopaedic implants are defined as medical devices used to replace or provide fix-
ation of bone or to replace articulating surfaces of a joint (Rouhi and Amani, 2013).
This category incorporates procedures such as knee replacements, hip replacements and
spinal implants (Khan et al., 2014).
Drug implants are utilised for drug delivery. These drug implants allow site specific
drug administration where the drug is needed the most (Arps, 2013). Examples in-
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clude histreline implants for palliative treatment of prostate cancer and uterine fibroids
(Hirsch et al., 2005).
3.2 Methodology: identifying wearable technology devices
In order to investigate the current wearable technology landscape a review was con-
ducted that was limited to devices that are currently on the market and underdevelop-
ment. On completion of the review, information regarding the various wearable devices,
based on the prominent categories from the structured review, was gathered by means
of internet sources such as web-pages and articles. The devices that were investigated
in detail are listed in Table B.7.
In this study, 62 wearable devices have been reviewed from internet sources exclud-
ing journals Appendix B Table B.7. The aim of this study is to review devices that are
currently commercially available and at the latter stages of development. The detailed
information on these devices is provided on the product’s company web pages. All the
devices that were reviewed were portable devices as described in Section 3.1.2.1. The
key enabling technologies of the wearables devices were identified and the applications.
3.3 Methodology: Identify wearable technology charac-
teristics
Because of the different wearable devices that are being produced they possess a wide
range of characteristics. In order to achieve the second research objective in Section
1.2.1 a structured literature review was performed in order to determine the different
features or characteristics that can be used to describe the wearable technology land-
scape.
A structured search of the electronic database, Scopus, was conducted to identify
the relevant articles in the wearable technology landscape. The search terms used were
related to the characteristics or features of wearable technology in healthcare. These
were the search terms used: ( health* AND technolog* AND wearable AND character-
istic* ) OR ( health* AND technolog* AND wearable AND feature* ) ). The relevant
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articles searched dated from 2006 to 2017 with no language restriction. Manual searches
were conducted on references to obtain additional relevant studies.
Figure 3.2: Schematic representation of the systematic review process
The first stage for checking the results of a search includes assessing the titles,
abstracts and keywords to determine whether each article meets the pre-determined
eligibility criteria. The pre-determined eligibility criteria included studies that consid-
ered:: i) characteristics of wearable devices, ii) applications of wearable devices and iii)
technologies incorporated in wearable devices. Table B.1 in Appendix B gives the stud-
ies that were reviewed and motivates the reasons for inclusion or exclusion. When the
screening process was completed, the full text of the selected citations considered for
the review were further assessed . The information gathered from the relevant articles
are presented in Table B.2, Table B.3, Table B.4, Table B.5 and Table B.6.
From the search terms 60 of the most cited articles were reviewed. After that, their
abstracts were assessed in order to determine which articles were relevant for the study.
From this exercise 25 articles were identified. As indicated in Figure 3.2 the full texts
of the 25 articles that were selected were reviewed for eligibility. Six of the articles were
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excluded because:
(i) articles unavailable;
(ii) repeated articles;
(iii) articles not in English; and
(iv) not relevant to the study.
After reviewing the 19 articles, four additional articles were extracted from the refer-
ence lists of all the included studies. From the 23 articles the prominent characteristics
or features that were identified were grouped together to form categories such as: i)
sensing technology, ii) information and communication technology, and iii) healthcare
services.
3.4 Key enabling technologies
The success of wearable technology relies entirely on several key enabling technologies.
Without these technologies, it would be impossible to achieve the usability, connec-
tivity and capabilities required for applications such as remote monitoring of chronic
conditions. Based on the structured review described in Section 3.3 the key enabling
technologies that are used in wearable systems typically include:
(i)z Sensing technology, and
(ii)z Information and Communication Technology
3.4.1 Sensing technology
From the findings of the structured review, the sensing technologies were subdivided
into i) hardware description, ii) physiological signals or vital signs and iii) diseases and
conditions monitored by wearable devices. These categories indicate the sensors and
their relevance in wearable technology.
Sensors are usually embedded in clothing or worn as an accessory on the body
(Lukowicz et al., 2004). They measure physiological signs such as: blood pressure,
47
Stellenbosch University  https://scholar.sun.ac.za
3.4 Key enabling technologies
body or skin temperature, respiration rate, oxygen saturation, heart rate, blood glu-
cose levels and body motion. These vital signs are used to determine the health status
of a patient and can be further analysed to identify the disease or condition affecting a
patient.
Wearable technology allows sensors that will be positioned on the user for pro-
longed periods. Wearables consist of multiple miniaturised, smart, non-invasive and
self-powered sensor devices that can be attached, or even implanted into, humans
to monitor their physiological, body motion and behavioural parameters (Alam and
Hamida, 2014; Banos et al., 2014; Khattak et al., 2011; Pantelopoulos and Bourbakis,
2010; Tao et al., 2012).
3.4.1.1 Sensor hardware
Micro-Electro-Mechanical Systems (MEMS) technology has enabled the development
of miniaturised inertial sensors that have been used in motor activity and other health
status monitoring systems. By using batch fabrication techniques, significant reduction
in the size and cost of sensors has been achieved (Patel et al., 2012). Microelectronics
has also been relied upon to integrate other components, such as microprocessors and
radio communication circuits, into a single integrated circuit thus resulting in System-
on-Chip implementations(Brand, 2006). A system-on-chip is ”a microchip with all the
necessary electronic circuits and parts for a given system, such as a wearable device,
on a single integrated circuit”(Flynn and Luk, 2011).
Micro-controller boards are used in wearable systems for data collection and are
usually based on wired transmission of biosignals from the sensors to the processing
board (Pantelopoulos and Bourbakis, 2010). In order for sensors to work effectively,
microcontrollers should incorporate the following vital capabilities (Niewolny, 2013):
(i) Low-power operation – this is essential because it allows the extension of bat-
tery life and keeps the device footprint small. Wearable devices should be able
to operate maintenance-free for long periods of time. Some devices are being
designed with the intention of having battery-free operation by means of energy
harvesting methods (through body heat or motion) through the utilisation of
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ultra-low-power DC-DC converters. Low power operation can be achieved by
improvements in battery technology, power scavenging techniques and low-power
transceivers (Pantelopoulos and Bourbakis, 2010).
(ii) Integrated precision-analogue capabilities – these make it possible for sensors to
achieve high accuracy at low costs.
(iii) Graphical user interfaces (GUIs) – GUIs improve the usability by allowing display
devices to convey vast amounts of information in clear detail and give easy access
to information.
From the structured review, the sensors in Table B.2 were summarised in Table 3.1
with their respective measurable.
Table 3.1: Sensors and their respective measurable
Type of Sensor Measurable Description of measured data
Skin or chest electrodes Electrocardiogram
(ECG)
Electrical activity of the heart
Arm cuff-based monitor or
Blood pressure sensor
Blood pressure Focuses on the force exerted by circulat-
ing blood on the walls of blood vessels,
especially the arteries.
Temperature probe or skin
patch or skin temperature
sensor or thermistors
Body or skin temper-
ature
A measure of the body’s capability to
generate and release heat
Piezoelectric or piezoresis-
tive sensor or pressure sen-
sor or Respiratory meter
Respiration rate Number of movements indicative of inspi-
ration and expiration per unit time
Pulse oximeter Oxygen saturation Indicates the oxygenation or the amount
of oxygen that is being ’carried’ in a pa-
tient’s blood.
Pulse oximeter or skin elec-
trodes
Heart rate Frequency of the cardiac cycle
Galvanic skin response or
Skin electrical conductivity,
Thermal conductivity sensor
Perspiration or skin
conductivity
Electrical conductance of the skin is as-
sociated with the activity of the sweat
glands
Phonocardiograph Heart sounds A record of heart sounds, produced
by a microphone (stethoscope) properly
placed on the chest.
Strip-base glucose meters Blood glucose Measurement of the amount of glucose in
blood.
Continued on next page
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Table 3.1 – Continued from previous page
Type of Sensor Measurable Description of measured data
Enzyme electrodes Blood glucose Use of glucose oxidase immobilised on a
gel to measure the concentration of glu-
cose in biological solutions and in the tis-
sues in vitro
Skin electrodes Electromyogram
(EMG)
Electrical activity of the skeletal muscles
Scalp placed electrodes Electroencephalogram
(EEG)
Measurement of electrical spontaneous
brain activity and other potentials
Accelerometer Body Movements Measurement of acceleration along its
sensitive axis
Gyroscope Angular velocity Measure of the radial motion
Magnetoresistive Static and dynamic
magnetic fields
Measurement of motion and posture of
the human segment in gait analysis by
measuring gait analysis
Flexible goniometer Angular measure-
ment of the human
joint
Measurement of the range of motion in
the range of motion in bending the arm
at the elbow, bending the knee, bending
at the waist.
Piezoelectric sensors Force Based on the piezoelectric effect which
generates electric charge when stressed
Electric field sensor Electric conductivity Proximity sensing that allows robots and
computers to detect, evaluate and work
with objects in their vicinity
Force sensors or force sensi-
tive resistors
Force Based on the variation of conductivity of
the sensor itself.
Capacitative sensors Body pressure Measured by the changes in capacitance
in the function of the applied force
Figure 3.3 illustrates different types of sensors that are found in wearable devices.
Sixteen different sensors were identified during the investigation. From the results, there
are four dominant sensors that are being used in wearable technology for healthcare:
• Accelerometers (used in 18 of the 62 reviewed devices). Accelerometers are pop-
ular because they measure and assess physical activity in tracking devices (Yang
and Hsu, 2010). Tracking devices are the most popular wearable devices that
have been developed to date (Crawford et al., 2015). Accelerometers can also
be used to detect the user’s respiratory and snoring characteristics that can be
utilised to diagnose sleep apnoea (Kawada et al., 2008);
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• Electrocardiographs electrodes (used in 15 of the 62 reviewed devices).ECG elec-
trodes records electrical signals generated by the heart and can be used to diagnose
heart attacks, ischaemia and abnormalities to the user’s heart (Maric et al., 2009)
;
• Photoplethysmography (PPG) (used in 12 of the 62 reviewed devices).PPG sen-
sors allow the user to measure their heart rate in real time using optical sensing
technology (Ozana et al., 2015). Usually, PPGs are found wrist worn fitness
trackers (FitBit, 2017; Jawbone, 2017); and
• Thermometers (used in 8 of the 62 reviewed devices). The thermometer is used
to measure the skin temperature of the user. Skin temperature fluctuations can
be used to determine the health status of the user. For example, an increase
of one or more degrees Celsius above the normal temperature could indicate the
presence of infectious diseases (Go¨rges et al., 2017).
Other sensors that have been utilised in wearable technology include global posi-
tioning system (GPS), respirometers, EEG (used to evaluate electrical activity in the
brain and diagnose conditions such as seizures, stroke and dementia), biosensors, glu-
cometers, pressure sensors as well as pedometers. The analysis also revealed that most
wearable devices have multiple sensors. They therefore, have the ability to record,
collect and analyse multiple vital signs.
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Figure 3.3: Sensors utilised in the 62 wearable devices included in this review
3.4.1.2 Wearable devices measurable
The measurement of these vital biosignals, leads to a collection of real-time gathered
physiological parameters which give an overall indication of the user’s health condition
at any given time. The data collected by wearable devices is important because it can
be used to determine the health status of the user. The data that can be collected
by wearable devices can be subdivided into: physiological data, behavioural data and
body motion data (Alam and Hamida, 2014; Banos et al., 2014; Patel et al., 2012).
Physiological data: According to the British Department of Health, the term phys-
iological measurement reflects on services that can be used to assess the function
of major organ systems (Department of Health, 2007). In wearable technology,
physiological data that can be assessed includes: blood pressure, heart rate, oxy-
gen saturation, glucose levels, electrocardiogram, skin or body temperature and
respiration rate. Some of the physiological data that are collected by wearable
devices are listed in Table 3.1.
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The devices that can collect physiological data can be designed to enable easy
integration into the clinical work-flows of healthcare professionals. The data mon-
itored is usually focused on clinical parameters related to a patient’s clinical con-
dition regarding chronic diseases such as cardiovascular diseases and diabetes
making remote monitoring possible.
Behavioural data: The data collected from wearable devices include information
about an individual’s activity, type of activity, walking or climbing stairs and
patterns of activity. The activity data can be used for early detection and better
understanding of patient conditions such as motor problems in Parkinson disease
(Butala et al., 2012; Patel et al., 2010; Salarian et al., 2007), patients with bipolar
disorder (Naslund et al., 2015), posture and gait problems (Pappas et al., 2004;
Shull et al., 2014) in the elderly population that can be used to assess risk for
falls and activity of the daily living assessment using related indicators.
The devices that are available at the moment provide valuable information re-
garding the individual’s behaviour and when linked to the GPS and self-reporting
tools on the wearables. They can help detect and alert early detection of some
risks (Patel et al., 2012). Some of the devices that are being developed can be
used for tracking patients with dementia and include an emergency button in case
of a fall detection (Mahoney and Mahoney, 2010).
Recently, the technologies developed can detect psychological stress and poor
sleep quality of a person may serve as indicators for predicting the onset of men-
tal health problems such as depression and/or anxiety (Swan, 2012).
Body motion data: Body motion data can be used to study human locomotion (Tao
et al., 2012). Locomotion is the study of the variety of movements or methods
that animals use to move from one place to another. Because of advances in
technology, the measuring of human movement has been made possible using
wearable devices. The data that is collected by wearable devices include (Alam
and Hamida, 2014):
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(i) body posture and orientation;
(ii) activity;
(iii) fall;
(iv) mobility;
(v) acceleration; and
(vi) limb movement.
These measurements can be used for gait analysis (Shull et al., 2014; Tao et al.,
2012), early fall detection (Patel et al., 2012; Tolkiehn et al., 2011b; Zhang and
Sawchuk, 2012) and early disease diagnosis (Shull et al., 2014).
As shown in Figure 3.4 the main vital signs that are measured by the 62 wearable
devices are heart rate (22 devices), skin temperature (10 devices), motion (10 devices)
and breathing rate (8 devices). These physiological signs can be used by clinicians to
determine the complications that a user could have developed during long-term moni-
toring (Lukowicz et al., 2004). Cardiovascular diseases are some of the complications
that can be monitored using the heart rate and heart electrical activity wearables.
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Figure 3.4: The different measurable measured by the 62 wearable devices included in
this study
3.4.1.3 Disease or condition monitored by wearables
Currently, there are various diseases that can be monitored, diagnosed or treated using
wearable devices. With the assistance of multi-physiological signs, mentioned previ-
ously, different diseases can be managed. These include:
• Cardiovascular disease is a heart disease that can be diagnosed using wearable
devices that can remotely monitor and analyse ECG patterns (Grange et al.,
2009; Maric et al., 2009). The diseases that are classified under cardiovascular
diseases include: angina, atherosclerosis, cardiac dysrhythmia, congestive heart
failure, coronary artery disease, heart attack and tachycardia (Chan et al., 2012).
• Diabetes mellitus is a disorder of glucose metabolism. Patients suffering from this
condition require continuous blood glucose level monitoring and correct adminis-
tration of insulin to prevent hypoglycaemic complications (Hettige and Cooper,
2017). A device can be designed to manage and monitor glucose levels and the
infusion of insulin (Gomez et al., 2008).
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• Respiratory diseases include diseases such as dyspnoea, sleep apnoea syndrome,
chronic obstructive pulmonary disease and asthma can be monitored for early
detection of symptoms or administration of treatments (Okubo et al., 2009).
ADAMM is a wearable device used for asthma symptom detection by monitoring
the cough, respiration rate, wheeze and heart rate (Health Care Originals, 2016).
Parkinson’s disease, renal diseases and stress are amongst other conditions that can
be monitored by wearable devices. Monitoring of diseases using wearable devices im-
proves healthcare in a cost-efficient manner and gives patients easy access to clinicians.
Figure 3.5 illustrates the different diseases that are monitored by the devices that
were reviewed in this study. The most prominent diseases or conditions that are mon-
itored by wearable devices are cardiovascular diseases. There are 29 wearable devices
which are used to monitor cardiovascular diseases. Metabolic syndromes (monitored
using 12 wearable devices) are a risk factor for cardiovascular diseases and diabetes.
Diabetes and infectious diseases are each monitored by 7 wearable devices.
Most of the devices that are currently on the market are used to either prevent,
treat or diagnose chronic conditions such as cardiovascular diseases, metabolic syn-
drome, diabetes, chronic pain, muscle disorder as well as respiratory conditions such as
asthma (Fafoutis et al., 2016). This observation is also supported by the results of this
review, displayed in Figure 3.5.
Some of the devices that have been included in this review of wearable technology
for healthcare applications are not designed to address specific diseases or conditions
and have therefore been excluded from Figure 3.5. Examples include devices that have
been designed to assist in rehabilitation (2 devices), posture and balance (3 devices),
and specialised care for disabled and elderly individuals (6 devices).
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Figure 3.5: Diseases and conditions utilised in the 62 wearable devices included in this
study
3.4.2 Information and communication technology (ICT)
The term ’information and communication technology’ (ICT) is generally used to refer
to all devices, networking components, applications and systems that combined allow
people and organisations (for example businesses, non-profit agencies, governments and
criminal enterprises) to interact in the digital world. Therefore based on this broad
definition, ICT was categorised as shown in Figure 3.6. The different categories were:
1. Data communication
• Communication Devices
• Data Transfer including wired and wireless connections
2. Data Handling
• Storage and computation
• Data analysis
• Data encryption and security
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The last category includes the healthcare services provided by manufacturers of
wearable devices through the stages of care and intended user.
Figure 3.6: Schematic representation of information and communication technology
Communication hardware and software in wearable technology play a vital role in
relaying data collected by sensors to a mobile phone or an access point (Patel et al.,
2012).
3.4.2.1 Data communication
This study introduces a brief description of the different communication software and
hardware found in wearable technology.
Communication Devices: Khattak et al. (2011) suggested that wearable devices
are designed in such a way that allows easy communication between them and mobile
devices such as PDA, smartphones or tablets. In other instances, the data is directly
transferred to laptops or computers as well (Butala et al., 2012). Research (Banos et al.,
2014) has shown that these communication devices can typically be used in wearable
technology to :
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(i) run an application that can be used as a data collector (Hu et al., 2008; Liu and
Xiao, 2011);
(ii) support a system for medical diagnosis and health alerts;
(iii) interface with user data inspection;
(iv) act as a gateway to forward the data to a remote storage device for further analysis;
(v) access data processing and analysis capabilities (Butala et al., 2012); and
(vi) transmit using data logging and sending commands (Patel et al., 2012).
Gateways are the information centres that collect sensor data, analyse it and then
transfer it to the cloud via wide area network (WAN) technologies (Niewolny, 2013).
Gateways can be designed to be applied in clinical or home settings. This is the plat-
form that is mainly utilised by wearable devices that require remote access of patients
that require remote monitoring in healthcare (Patel et al., 2010). For example, the data
transmitted from sensors can be sent to gateways such as mobile phones or personal
computers (PCs).
Figure 3.7 shows the communication devices that are used to relay information from
the wearable devices to servers. The gateways that were identified from the investi-
gation were smartphones (used by 39 of the devices), PCs or laptops (used by 18 of
the device), monitors (used by 12 of the devices) and smartwatches (used by 3 of the
devices). 14 of the devices reviewed incorporated more than one gateway.
The incorporation of smartphones into wearable systems reduces cost because there
is no need to develop specific additional devices (Moro´n et al., 2014). Smartphones are
characterised by an integration of all the necessary technologies in an mHealth system.
These special capabilities smartphones have powerful processors, large memory capac-
ity, multiple network interfaces such as Bluetooth, Wi-Fi and mobile communication,
relatively low cost, etc. (Patrick et al., 2008).
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Figure 3.7: Communication devices utilised in the 62 wearable devices included in this
study
Data Transfer The transmission of measured data in a wearable system needs to be
performed for two different purposes:
(i) for communicating the collected physiological signals from the sensors to the sys-
tem’s central node; and
(ii) for sending the aggregated measurements from the wearable system to a remote
medical station or to a physician’s smart phone.
In wearable technology, short-range transmission can be handled either by wires or
by multiple wireless links such as body area network (BAN) or body sensor network
(BSN). Long-range communication between the wearable device and a remote station
is made possible by wireless technologies that can serve that goal. Examples are:
(i) Sensor network systems
Because of the development of wireless connections, wired systems are gradually
being replaced in sensor technology. The viability of wireless connection in sen-
sor network systems was proved and tested by Chae et al. (2012). Two different
wireless sensor networks that relay the information collected by the sensor to the
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device are BAN or BSN and personal area network (PAN). BAN is worn or im-
planted on the body of the user and this network comprises wearable sensors and
a personal digital assistant (PDA) as a wearable device (Chan et al., 2012).
BAN can then connect to a PAN, providing a connection to the other devices the
user will have in their immediate environment. The short range connections that
are mostly employed in BANs are IEEE 802.15.1(Bluetooth), Bluetooth Low En-
ergy (BLE) and 802.15.4 (Zigbee) (Alam and Hamida, 2014; Pantelopoulos and
Bourbakis, 2010). Examples of the other devices the user can typically have are:
smartphones, a pocket PC and environment sensors (Pantelopoulos and Bour-
bakis, 2010).
(ii) Wireless networking
Wireless networking removes the physical restrictions caused by traditional wired
solutions such as Ethernet and USB (Nsoesie et al., 2015). Technologies that
are currently being used are wireless local area network (WLAN), global system
for mobile communications (GSM), universal mobile telecommunications system
(UMTS) and worldwide interoperability for microwave access (WiMAX). There
are also Broadband cellular networks such as (GSM, General Packet Radio Ser-
vice (GPRS), 3G or 4G, LTE, etc.). The popular wireless standards include Blue-
tooth® and Bluetooth Low Energy (BLE) for personal area networks (PAN)
and Wi-Fi® and Bluetooth for local area networks (LAN) in clinics or hospitals
(Niewolny, 2013; Patel et al., 2012). Use is also made of mobile network GSM
and GPS for wireless networking (Niewolny, 2013).
Table 3.2: Long range transmission
Transmission
Type
Description
WLAN Wireless network communication over short distances using radio
or infrared signals instead of traditional network cabling. A WLAN
is a type of local area network (LAN).
GSM Mobile communications
Continued on next page
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Table 3.2 – Continued from previous page
Transmission
Type
Description
GPRS Packet oriented mobile data service on the 2G and 3G cellular
communication system’s global system for mobile communications
(GSM).
UMTS A third-generation (3G) broadband, packet-based transmission of
text, digitised voice, video, and multimedia at data rates up to
2 megabits per second (Mbps). UMTS offers a consistent set of
services to mobile computer and phone users, no matter where they
are located in the world.
WiMAX A wireless industry coalition dedicated to the advancement of IEEE
802.16 standards for broadband wireless access (BWA) networks.
4G or 3G mobile
communication
As ’ultra-broadband’ access for mobile devices
Long term evolu-
tion (LTE)
Wireless broadband technology designed to support roaming Inter-
net access via cell phones and handheld devices.
Wi-Fi Technology for wireless local area networking with devices based on
the IEEE 802.11 standards.
Table 3.3: Short range transmission
Transmission
Type
Description
Bluetooth Wireless technology standard for exchanging data over short
distances from fixed and mobile devices, and building personal
area networks.
Bluetooth Low En-
ergy
The power version of Bluetooth that was built for the Internet
of Things (IoT).
Zigbee An IEEE 802.15.4-based specification for a suite of high-level
communication protocols used to create personal area networks
with small, low-power digital radios, such as for home automa-
tion, medical device data collection, and other low-power low-
bandwidth needs, designed for small-scale projects which need
wireless connection.
Infra-red Is the use of wireless technology in devices or systems that
convey data through infrared (IR) radiation. Infrared is elec-
tromagnetic energy at a wavelength or wavelengths somewhat
longer than those of red light.
Continued on next page
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Table 3.3 – Continued from previous page
Transmission
Type
Description
Medical Implant
Communication
Service
Low-power, short-range (2 m), high-data-rate, 401–406 MHz
(the core band is 402–405 MHz) communication network that
has been accepted worldwide for transmitting data to support
the diagnostic or therapeutic functions associated with medical
implant devices.
Ultra wideband A radio technology that can use a very low energy level for
short-range, high-bandwidth communications over a large por-
tion of the radio spectrum.
Currently, most wearable devices use Bluetooth Low Energy (BLE) which allows
the transfer of large amounts of data. One of the limitations of using BLE is the limited
range it covers. This is because the device needs to be tethered to a mobile phone at
a close range. Some wearable devices, such as Google glass, use Wi-Fi which is easy
to access when in a Wi-Fi hotspot. Otherwise, Google glass uses mobile connection
when the user is not in a Wi-Fi hotspot (Iltifat, 2014). There are also devices that are
designed to operate using BLE and Wi-Fi connections, for instance an Apple iWatch.
Figure 3.8 illustrates the network connections that are used to transfer data from
the device to the gateways. The data can be relayed using USB connections, Wi-Fi,
mobile connections (GSM), GPS, Ethernet and Bluetooth. As shown in Figure 3.8,
most of the wearable devices have wireless connections: 29 wearable devices use Wi-Fi
connections, 28 use Bluetooth connection, 10 use mobile connections and seven devices
utilise GPS connections.
Devices that use Bluetooth require the receiving device to be in close proximity
(approximately 5 to 30 metres). FitBit Charge2 and Jawbone UP are examples of
devices that utilise Bluetooth to transfer data from the sensor to a smartphone (Lee
et al., 2016; Soultanopoulos et al., 2016). Wi-Fi connections range from 32 to 95
metres and are the preferred choice for remote monitoring systems (Maric et al., 2009;
Patel et al., 2012). Therefore, the type of connectivity required is dependent on the
application area of the device in healthcare.
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Figure 3.8: Data transfer methods utilised in the 62 wearable devices included in this
study
3.4.2.2 Data handling
Storage and computation: The data collected by wearable devices is transferred to
several systems such as smartphones, computers and servers or cloud services (de Arriba-
Perez et al., 2016). These systems can be divided into two different categories, namely
(Pantelopoulos and Bourbakis, 2010):
• Proprietary systems – these can be found as wearable devices, applications for
smartphones and computers and servers or cloud services. They are provided and
maintained by vendors of wearables to collect users’ data to perform analytics
and to provide data and analytic results to the users and to authorised third
parties (de Arriba-Perez et al., 2016). Proprietary systems usually provide a
Representational State Transfer Application Programming Interface (REST API)
for data collection. This REST API allows third parties to gain access to users’
data collected by a proprietary system (de Arriba-Perez et al., 2016). Examples
of devices that have proprietary systems are the Jawbone UP Move and the
Microsoft Band.
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• Third-party systems – include services, applications (apps) for smartphones and
wearables, and computer programs that can be developed as well as maintained
by external entities to provide specific functionalities. An example of a device
with a third party system is a Galaxy Gear which allows external entities to
collect data from the sHealth application (de Arriba-Perez et al., 2016). Third
party applications that utilise existing platforms such as Strava which enable the
connectivity of people of from different parts of the world and can share their
information about their fitness lifestyle (Strava).
The data collected can be transferred and stored on the cloud. Al-Qurishi et al.
(2015) suggested that the advantage of cloud-based systems is their capability to in-
crease access to healthcare services in rural areas. Furthermore, the user’s data can be
easily updated in the databases without requiring that the patient install any software
on their personal monitoring device. These advantages make the system maintenance
quick and cost effective.
In the operation of wearable technology there are different mobile operating systems
that they are compatible with. These systems combine the different features a wearable
device or a smartphone can possess. The common features in mobile operating systems
are cameras, Bluetooth, GPS and Wi-Fi.
The mobile operating systems that are utilised in the wearable devices for health-
care applications are shown in Figure 3.9. The Apple iOS mobile operating system is
compatible with 26 of the 62 wearable devices reviewed, Android with 21 of the devices,
Windows with 16 of the devices and the OSX operating system with 4 of the devices.
Furthermore, 15 of the wearable devices are compatible with both Android and iOS
systems.
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Figure 3.9: Mobile operating systems utilised in the 62 wearable devices included in
this study
Data Analysis Techniques: From the structured review a number of data analysis
techniques were identified. The techniques that were identified include:
1. nearest neighbour (Chan et al., 2009).
2. signal processing (Chan et al., 2009; Hu et al., 2008; Lukowicz et al., 2004; Patel
et al., 2012; Tao et al., 2012).
3. integrated analysis support for making decisions and diagnosis.
4. decision support system (Pantelopoulos and Bourbakis, 2010).
5. extraction and classification techniques (Banos et al., 2014; Egbogah and Fapo-
juwo, 2011; Hu et al., 2008).
6. image processing (Hu et al., 2008).
7. pattern recognition (Hu et al., 2008; Khattak et al., 2011; Patel et al., 2012;
Segerst˚ahl and Oinas-Kukkonen, 2011).
Recently, wearable devices have advanced from simple reasoning readings (such as cal-
culating sleep hours or steps per day) to the higher level of data processing, in order
to give much more information that is valuable to end users. In wearable technology,
the main application for data analysis is remote monitoring of a patient using tech-
niques such as prediction and anomaly detection. Also in clinical settings, the data
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mining task focuses on diagnosis (Baig and Gholamhosseini, 2013; Stacey and McGre-
gor, 2007). Data analysis supports real-time decision making that can be useful to the
intended user(s) (Patel et al., 2012). An example of a data analysis technique typically
used for remote monitoring is data mining (de Arriba-Perez et al., 2016) .
Data mining (also known as knowledge discovery) is the process of discovering
interesting knowledge such as patterns, associations, changes, anomalies and significant
structures from large amounts of data stored in the database or other information
repositories. It is a multi-disciplinary field, borrowing and enhancing ideas from diverse
areas such as machine learning, signal and image processing, image understanding1 and
pattern recognition (Han et al., 2012). For example, machine learning can be used to
detect soft falls based on pattern recognition (Genoud et al., 2016).
Data encryption and security Wearable technologies are expected to deal with
essential private information such as personal healthcare data. These devices can
subsequently be connected to global information networks for their access anytime,
anywhere.
The security requirements for wearable technology that were gathered from the
structured review include (Riazul Islam et al., 2015):
1. Confidentiality – This ensures the inaccessibility of medical information for unau-
thorised users.
2. Integrity – Ensures that received medical data are not altered in transit by an
adversary. In addition to that, the integrity of stored data and content should
not be compromised.
3. Authentication – This enables the wearable device to ensure the identity of the
user with which it is communicating.
4. Availability – This ensures the survivability of wearable technology services (ei-
ther local or global/cloud services) to authorised parties when needed even under
denial-of-service attacks.
1Image understanding is the task-oriented reconstruction and interpretation of a real world scenario
by means of images.
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5. Data freshness – This ensures that each data set that is collected by a wearable
device is recent and makes sure that no adversary replays old messages.
6. Authorisation – This ensures that only authorised nodes can access network ser-
vices and resources.
7. Fault tolerance – A security scheme should continue to provide respective security
services even in the presence of a fault, for instance a software glitch, a device
compromise and a device failure.
8. Self-healing – A wearable device in a system may fail or run out of energy. Then
remaining or collaborating devices should enable a minimum level of security.
9. Encryption – This ensures the conversion of information or data into a code,
especially to prevent unauthorised access (Pantelopoulos and Bourbakis, 2010).
3.5 Wearable technology in healthcare
Over the past several decades, the impact of mHealth systems in improving access to
primary, secondary and tertiary healthcare services has been demonstrated (Connected
Life Initiative 2013). Its importance is mainly noticed in the management of chronically
ill and elderly people who require continuous monitoring of human vital signs (Awad
et al., 2017). The South African Department of Health define mHealth as:
“Mobile computing, medical sensor and communication technologies used for the
delivery of health related services in the support of medical and public health” National
Department of Health (2015).
In 2003 mHealth was first introduced, in response to the expansion of mobile com-
munication technology (Istepanian, 2011). The growth in mobile applications designed
to monitor or improve users’ health and well-being allowed the expansion in m-health.
An important feature of m-health is the person-centred nature and ubiquity enabled by
mobile phone technology and connection to the Internet (as a Personal Area Network
(PAN)) (Bashshur et al., 2011).
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The only health domain that focuses on mobility technology and sophisticated tech-
nologies that involve transmission, storage and receipt of voice, still images, data, and
video is mHealth (Bashshur et al., 2011). These sophisticated technologies include gen-
eral packet radio service (GPRS), third- and fourth-generation mobile telecommunica-
tions (3G and 4G systems), global positioning system (GPS) and Bluetooth technology
(World Health Organization, 2011).
The emergence of advanced technology in mHealth is important for two reasons
(Niewolny, 2013):
(i) Advancement in sensor and connectivity technology allows the design of devices
that collect, record and analyse data, thereby supporting increased access to
healthcare services. This enables the collection of patient data over time that
can be used to support preventive care, allow prompt diagnosis of acute com-
plications and promote understanding of how a specific therapy is impacting a
patient’s relevant parameters.
(ii) The ability of wearable devices to gather data on their own removes the limi-
tations of human-entered data by automatically obtaining the data the doctors
need, at the time and in the format they need it. This reduces the risk of error.
The reduction of error results in increased efficiency, reduced costs and improved
quality in the healthcare industry.
Wearable devices are classified under devices used for mHealth. Wearable technol-
ogy use in mHealth has expanded; the total revenue is expected to grow from USD 3.2
billion in 2016 to 7.9 billion in 2021 (Mordor Intelligence, 2017). This technology can
be applied either for remote monitoring, clinical care or early intervention (Chowles,
2015; Swan, 2012).
Wearable technology systems comprise miniature sensors, wireless communication,
wired communication, processing units, multimedia devices, software as well as data
analysis as shown in Figure 3.10. As described in the previous section sensors are used
to measure physiological signs. The data measured is transferred using wireless and
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wired connections provided in the section above such as Wi-Fi, Bluetooth, GSM, Eth-
ernet, universal serial bus (USB) and cable wires (de Arriba-Perez et al., 2016).
The data communicated through these methods is transferred to a gateway such as
Personal Digital Assistant (PDA) or a microcontroller board. These central nodes turn
the data into information that can be displayed on a graphical user interface (GUI)
or transmitted as aggregated vital signs to a medical centre. Smart phones, personal
computer (PC), laptop and tablet are some of the communication hardware that is
used in a wearable system.
In a wearable system, as shown in Figure 3.10, the relayed information is used by
either the device user, clinicians or paramedics. The wearable systems designed for the
user or clinician vary in complexity. The one designed for the user focuses on personal
situations that need attention such as monitoring of physical activities. For instance,
the data communicated to the user by a FitBit Charge 2 is the heart rate, step count,
calories burned, active minutes or sleep quality (FitBit, 2017), whilst for clinicians,
the system is designed to allow them access to data while interacting with a patient,
performing a procedure or remote monitoring (Lukowicz et al., 2004). For instance,
Google glass can be used to gain access to patient data or direct advice from a remote
expert (Iltifat, 2014).
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Figure 3.10: Illustration of the wearable system that is utilised in healthcare during
remote monitoring or self-management(Source: de Arriba-Perez et al. (2016))
Therefore, the wearable system indicates the important aspects that make it func-
tional. It shows the key enabling technologies such as sensors, and communication
hardware and software and intended user(s) for the technology.
3.6 Healthcare services in wearable technology
Healthcare services are the most visible functions of the health system, both to the
users and the general public. A new form of healthcare service has been introduced by
mHealth, allowing people to take charge of their own health and gain easy access to
health practitioners. The stages of care that are provided by wearable devices include
preventive, wellness care, diagnosis, treatment and restorative or rehabilitative, based
on the information gathered from the structured review in Table B.6.
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3.6.1 Stages of care
In this section the stages of care are briefly described by providing how they function
and how they are applied using wearables.
3.6.1.1 Preventive
Preventive care aims at reducing the risk of developing an illness in individuals and
within a community. Wearable devices have played a role in the provision of patient-
generated data that improve preventive care strategies (Technology Advice, 2014). For
instance, FitBit devices are typically used to track fitness and daily activity level.
These tracking devices provide the user with information on their vital signs so that
they can prevent chronic conditions by improving their lifestyle (Roderick, 2016). In
other instances, wearable devices have been developed for remote monitoring of patients
with chronic conditions by clinicians to prevent heart attacks and strokes (Maric et al.,
2009; Meystre, 2005).
3.6.1.2 Wellness care
Wellness is an active process of becoming aware of and making choices towards a healthy
and fulfilling life. In addition to that, the World Health Organization define wellness
as:
“. . . a state of complete physical, mental, and social wellbeing, and not merely the
absence of disease or infirmity.”
Healthy people can benefit from wearable technology because of the ability to mon-
itor vital signs, daily activities and well-being (Niewolny, 2013). Currently on the
market there are devices designed to bring wellness to people including tracking de-
vices. Tracking devices such as FitBit Charge series (FitBit, 2017) and Jawbone UP
series (Jawbone, 2017) are also examples of devices used for wellness purposes.
3.6.1.3 Diagnosis and screening
Diagnosis is the process of determining which disease or condition explains a person’s
symptoms and signs. Currently, wearable devices are being designed to diagnose move-
ment disorders (Son et al., 2014) and constantly monitor patients that require special
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attention from clinicians using non-invasive devices. The Monica AN24 (foetal health
monitor) is a wearable device used to diagnose muscle and nerve disorder, coronary
heart diseases as well as heart failure (Monica Healthcare, 2016). Screening is the
checking of the body for cancer before any symptoms show (Centers for Disease Con-
trol and Prevention (CDC), 2016). For instance, iSono Health device is a wearable
device that can be used for the screening of breast cancer.
3.6.1.4 Treatment of diseases
Treatment is the medical care given to a patient for an illness or injury. Usually chronic
diseases need medical care (Yu et al., 2016). Examples of wearable devices that can
be used to treat different conditions include the Quell and implantable pills. Quell
can be worn on the leg and stimulates the sensory nerves for pain relief (Quell, 2016).
Implantable pills are used to dispense drugs into the system when required (Arps, 2013).
3.6.1.5 Rehabilitation
Rehabilitation is designed to restore an individual back to an optimal level of health.
This is to reduce the risk of permanent disability related to disease or illness (Patel
et al., 2012). Rewalk Personal 6.0 is used for clinical rehabilitation for people that have
suffered lower limb injuries.
Therefore, various conditions can be monitored using these healthcare services.
Currently, most of these devices are designed to track fitness and daily activity levels.
They are aimed at improving people’s lifestyle and eradicate cardiovascular diseases.
There are five different healthcare services that are provided by wearable devices.
As shown in Figure 3.11, 40 and 39 of the wearable devices that have been included in
this review are used for wellness and preventive purposes respectively; 14 of the devices
are used for treatment purposes; 7 for diagnosis and screening and 6 for rehabilitation.
As mentioned above, the devices that are used for wellness purposes motivate people
to follow a healthy lifestyle. These help prevent the user from developing chronic
conditions such as cardiovascular diseases, diabetes and obesity. The devices that are
used for treatment usually cater for chronic pain, diabetes as well as muscle disorders.
Three of the wearable devices reviewed used for screening mainly focus on breast cancer
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(Cyrcadia Health, 2016; iSono Health, 2016). An example of a device that has been
designed for rehabilitation purposes, is the Rewalk Personal 6.0, which assists the user
to regain their walking abilities.
Figure 3.11: Stages of care provided by the 62 wearable devices included in this study
3.6.2 Intended users of the wearable device
Chan et al. (2009, 2012); Shull et al. (2014) suggested that wearable devices are de-
signed to be utilised by elderly people, people with disabilities, people with chronic
conditions and hospital-based health professionals. The intended users are dependent
on the care provided. For instance, wearable devices for health and wellness care are
designed with the intention that the user or patient acquires information on their vital
signs such as heart rate.
Figure 3.12 shows the three different intended users of wearable devices, namely:
clinicians, user and paramedics. Figure 10 shows that 49 of the 62 devices are in-
tended for the patient or user, followed by 15 devices for the clinicians. The devices
that are intended for the user are usually for self-management, for clinicians for re-
mote monitoring and paramedics for access to medical records in case of emergency.
Currently, healthcare’s main focus regarding wearable technology is on fitness tracking
which gives the user information on vital signs such as heart rate, temperature and
motion (Technology Advice, 2014).
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Figure 3.12: Intended user of the 62 wearable devices included in this study
3.7 Technology maturity
In the structured review, Pantelopoulos and Bourbakis (2010) was the only researcher
who performed a technology maturity evaluation. He performed the evaluation in order
to identify the development level of the devices based on their potential and to provide
possible direction for further research in the fields that they show a lack of performance.
Based on the nature of this study, technology maturity is considered so as to highlight
the development levels and performance of the different devices in healthcare.
Technology maturity explains the growth of technology. Growth means change over
time (Nolte, 2008). Nolte (2008) suggests that technology maturity means that the un-
derstanding of technology has also improved. As the knowledge of technology expands
it makes it easier for the people to apply it to meet their needs. A technology reaches
maturity when people know almost everything about it and at that point technology
growth depreciates. The depiction of technology maturity can be shown by the s-curve
shown in Figure 3.13 (Christensen, 1992).
S-curves show different forms of technology as shown in Figure 3.13:
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• New technology is still in the early stages and the rate of progress in performance
is slow. This is because of the level of low levels of understanding, control and
rate of diffusion (Sahal, 1981).
• Improving technology is within the exponential developmental phase. The expo-
nential phase can be assessed using the universally accepted method of Technology
Readiness Level (TRL) scale.
• Mature technology is the stage when technology development ceases. This occurs
when all the knowledge about that technology has been exhausted (Nolte, 2008).
• Ageing technology — at this stage technology performance declines because new
technologies will be developed that are more efficient and/or cheaper (Nolte,
2008).
Figure 3.13: Technology maturity: S-Curve (Source: ?)
3.7.1 Maturity characteristics
One of the ways to characterise technology maturity is using dimensionality. Dimen-
sionality considers technology to be measurable using the different dimensions suggested
by Nolte (2008). In order to get the full picture of technology maturity involves looking
at and measuring technology from all possible viewpoints including:
76
Stellenbosch University  https://scholar.sun.ac.za
3.7 Technology maturity
• Programmatic maturity - used to determine the maturity of a program by focusing
on aspects that are programmatic in nature such as the documentation, customer
focus and budget
• Developer maturity – this is the consideration of the technology developer. The
dimensions for developer maturity are capability, production process and past
performance.
• Customer maturity - this considers the compliance of the customers towards a
new technology.
However, this paper will focus on technology maturity because this gives insight into
the wearable technology landscape. Below are the six dimensions that were developed
by Nolte (2008):
i Current state of technology development - This parameter gives an idea of the
current state of the technology. This uses the Technology Readiness Level (TRL)
scale that was developed by NASA.
ii Amount of development work remaining - This is a difficult indicator to use because
it requires an estimation of the amount of technology that still needs to be developed
for the device to be fully functional.
iii Difficulty of remaining work – This is a predictive dimension because there is a need
to measure the level of difficulty of the remaining work. Therefore, this dimension
raises uncertainty.
iv Predicted supportability of final product – Sub-divided into three different mea-
surements; reliability, availability and maintainability. Reliability is the probability
that the technology is fit for use at any given time. Availability is the probability
that the item will be fit when it is needed. Maintainability considers the ease with
which an item can be repaired after it breaks.
v Interoperability with existing systems or products – This measures how compatible
systems or components are, especially when they must exchange information or
interact with each other.
77
Stellenbosch University  https://scholar.sun.ac.za
3.7 Technology maturity
vi Manufacturing and producibility - This based on whether or not you can manufac-
ture a product that uses a particular technology.
In this research, the main focus will be on the first dimension which can be coupled
with the S-Curve and give the picture of the current wearable technologies that are
currently available in industry.
3.7.2 Technology readiness levels
Technology readiness levels are a type of measurement system used to assess the matu-
rity level of a particular technology in the improving phase of the S-curve as mentioned
in the previous section (Mai, 2015). The National Aeronautics and Space Admin-
istration (NASA) initiated the process in the 1980s to inform the development and
deployment of new systems for space technology (Mai, 2015). For instance, TRL has
been used to assess the technology maturity of advanced nuclear fuels and materials
(Carmack et al., 2017).
Each technology is evaluated against the parameters for each technology level and
is then rated based on the TRL scale. The scale ranges from TRL 1 (lowest) to TRL 9
(highest) as shown in Table 3.4. When the technology is at TRL 1, scientific research
begins and those results can be translated into future research and development. Then,
during TRL 2 the invention begins, practical application is identified but is speculative;
no experimental proof or detailed analysis is available to support the conjecture.
TRL 3 occurs once there is an active research and design. In this level, both ana-
lytical and laboratory studies are required to determine the appropriate context for the
technology application. In this level, a proof-of-concept model is constructed. After
this, the technology advances to TRL 4 when the proof-of-concept model is ready. In
this level multiple component pieces are tested with one another.
TRL 5 is a continuation of TRL 4. A technology that is at level 5 is identified
as a ’breadboard technology’ and must undergo more rigorous testing than technology
that is only at TRL 4. Simulations should be run in environments that are as close to
realistic as possible. After this, the technology advances to TRL 6 where it has a fully
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functional prototype or representation model.
A TRL 7 technology requires that the working model or prototype be demonstrated
in a space environment. Then, a TRL 8 technology has been tested and ’flight qualified’
and it is ready for implementation into an already existing technology. Finally, when
a technology is flight proven during a successful mission it is called TRL 9.
This TRL has not only been applied to measure technology maturity by NASA. For
example, Carmack et al. (2017) used the TRL to measure the technology maturity of
advanced nuclear fuels and developed a framework to follow.
Table 3.4: Technology readiness levels (Adapted from: U.S. Department of Energy
(2010))
TRL range Definitions Description
TRL 1 Basic principles observed
and reported
Scientific research is beginning and
then later translated into future re-
search and development. At this
level basic scientific principles are
being studied analytically and ex-
perimentally.
TRL 2 Concept and/or applica-
tion formulated
Practical applications are begin-
ning to be invented or identified.
Applications are still speculative
and there is no proof or detailed
analysis to support assumptions.
TRL 3 Concepts demonstrated an-
alytically or experimentally
At this level active research and
development is initiated. This in-
cludes analytical and laboratory-
based studies to physically validate
predictions of key elements of the
technology. These studies and ex-
periments should constitute ’proof-
of-concept’ validation of the appli-
cations or concepts formulated at
TRL 2.
Continued on next page
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Table 3.4 – Continued from previous page
TRL range Definitions Description
TRL 4 Key elements demon-
strated in laboratory
environment
The key elements must be inte-
grated to establish that the pieces
will work together. The valida-
tion should be consistent with the
requirements of potential applica-
tions but is relatively low-fidelity
when compared to a final product.
TRL 5 Key elements demon-
strated in relevant environ-
ments
Key elements increase significantly.
These elements are integrated with
realistic supporting elements so
that the technology can be tested
and demonstrated in simulated or
actual environments.
TRL 6 Representative of the deliv-
erable demonstrated in rel-
evant environments.
Represents a major step in a tech-
nology’s demonstrated readiness.
TRL 7 Final development version
of the deliverable demon-
strated in operational envi-
ronment
Development version of the deliv-
erable is near or at the planned
operational system. This repre-
sents a significant beyond TRL 6
and requires the demonstration of
an actual development version of
the deliverable within the next as-
sembly, and advanced technology
demonstrations of integrated sys-
tems such as flight testing.
TRL 8 Actual deliverable qualified
through test and demon-
stration
The technology has been proven to
work in its final form under ex-
pected conditions. This represents
the end of true system develop-
ment.
TRL 9 Operational use of deliver-
able
Application of the technology in its
final form and under mission con-
ditions such as those encountered
in operational test and evaluation.
This is the end of the last bug fix-
ing aspects of true system develop-
ment.
Figure 3.14 gives information on the technology maturity of the wearable devices
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using the TRL coupled with the S-curve that were reviewed in this study. A total of
57 of the 62 devices reviewed have passed the prototype phase which starts at TRL 6
(Mai, 2015). From the investigation, 15 of the devices are below TRL 8 because they
could be in the process of seeking approval from FDA or are undergoing clinical trials.
From the data gathered the technology maturity is determined by the advancement
of the technology. The devices that have reached maturity are mostly fitness trackers.
The advancement of wearables is as a result of the development of micro-electronics-
mechanics systems resulting in advancement of sensors for monitoring physiological
signs, recording and transferring reliable data collected.
Most wrist-bands devices that are used for fitness tracking have reached maturity
because they have been on the market for less than five years and the understanding
of the technology has improved. The developers of these devices keep on upgrading
them so that they avoid reaching the ageing phase of technology maturity. For exam-
ple FitBit has over the years evolved from FitBit Flex (released in 2013) to FitBit Alta
2 (released in March 2017).
The FitBit Flex had sensors such as 3-axis accelerometer and vibration motor.
Then the FitBit Alta 2 developed also includes photoplethysmography and 3-axis ac-
celoremeters. The company has been working on the improvement of their products
through the development of the devices software. According to the CEO of FitBit their
products have dominated the wearable technology landscape because of timing. Their
device was released at the right time when people were starting to realise the potential
of sensors for fitness tracking.
The challenges that are faced in the development of wearable devices are:
• Power consumption
• Data security
• Wearability
• Data integrity
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• Sensor technology
Figure 3.14: Technology maturity of the 62 wearable devices included in this study
The maturity of wearable devices is dependent on the intended users in Section
3.6.2.The stakeholders play a vital role because they are the ones that require their
needs to be met by the specific technology. For this technology to be utilised by peo-
ple, it should first gain acceptance from the intended users. The act of the user to
accept and use the device is affected by many factors. In the case of wearable comput-
ers, it should be able to perform two functions: first, as a computer and second, as a
garment or accessory, and these will both affect users’ preferences of the device. The
fulfilment of these preferences or requirements will then lead to acceptance.
The acceptance of a technology determines its rate of diffusion. The rate of diffusion
also determines the technology maturity. The issues that affect the acceptability of
wearable technology are:
• Users are attracted to devices that fulfil their fundamental needs such as moni-
toring sport activity and regulating body temperature which satisfy physiological
needs.
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• The acceptance of wearable technology is also affected by social aspects such as
personal privacy, social influences1 and culture2.
• The other aspect is the physical aspect which relates to the (i) physical comfort
and safety, (ii) aesthetics and appearance, and (iii) mobility.
• Demographic characteristics such as gender and age. In terms of the age elderly
are not accustomed to technology and experience difficulties with understanding
it. Research has shown that men are more receptive to smart shirts compared to
women. Then women are less accepting to technologies because they have low a
level of interest towards technologies.
• Previous technical experience with technologies affects how people accept tech-
nologies.
The other issue with the adoption of wearable devices is the certification and regu-
lations of medical devices. Certification and regulations are based on the classification
of the devices which is determined by the level of risk the device poses to the patient.
Most non-invasive wearable devices are classified as Class A devices because they have
low risk to the user (RSA, 1998). The devices that are invasive such as an OmniPod
which is used to monitor and regulate blood glucose levels have needle-like structures
that penetrate the skin as such are classified as Class B devices as they pose intermedi-
ate threat to the user. Therefore when producing wearable devices the designer should
ensure that the devices meet the standards that are required for the medical devices so
that the certification process does not take long.
Wearable technology is still going through the development and improvement stages
therefore the technologies are still emerging into the healthcare field especially for ad-
vanced applications. More research and development still needs to be carried out to
1Social influences are based on the human interaction and how people value the opinion and beliefs
of the people that surround them. People tend to shy away from wearable technology especially if the
society does not favour the technology.
2Culture has a significant effect on people’s behaviour, beliefs, and decisions. Thus, it is not sur-
prising that culture influences an individual’s acceptance and use of wearable technology. In evaluating
the acceptance of some features of smart clothing, Duval et al. hypothesised that the high acceptance
of artificial intelligence in Japan was affected by the users’ religion
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improve the efficiency of the wearable devices and ensure that the users do not abandon
their devices after a specific period of time. The wearable technology developers have
to ensure the data transfer process is efficient and secure in order to protect the privacy
of the users and the integrity of the healthcare providers.
Wearable technology developers should also pay close attention to the intended user
as the new device will affect their day-to-day lives as they have to carry the device at
all times. Therefore, in order for people to accept the device the developers need to
ensure that the technology will benefit the users without infringing their daily lives and
be user friendly.
3.8 Conclusion: Wearable technology landscape
A better understanding of the current wearable technology landscape can be achieved
by investigating the key characteristics that make it functional. In order to achieve the
main objective of this paper, it was important to perform a comprehensive review to
help identify the important aspects that will give an understanding of the landscape.
From the review, the following key aspects were identified: sensors and data collection
software, communication software and hardware, data analysis, diseases monitored, in-
tended user(s), physiological signs measured as well as the technology maturity using
S-curve and TRL assessment. Past work in literature focused on wearable technology
in specific applications such as remote monitoring (Maric et al., 2009; Patel et al., 2010,
2012). The current study focuses on all the wearable devices that are being used in
healthcare for other applications such as clinical care and early prevention so as to get
a broader picture of the landscape.
This study revealed that the main wearable sensors that are currently found in
the wearable technology landscape are accelerometers, ECGs, heart rate monitors and
thermometers. These are mainly incorporated in fitness trackers and activity monitors.
The data gathered by the sensors is transferred to the servers through a gateway. From
the investigation, the most popular gateway in a wearable system is a smartphone. The
smartphones that are commonly used in wearable systems are either compatible with
android, iOS mobile operating systems or both. Most wearable systems use network
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connections such as Wi-Fi and Bluetooth to transfer data from the wearable device to
the servers.
The most prominent physiological signs that can be measured using wearable de-
vices are heart rate, temperature, motion as well as breathing rate. The main medical
conditions that are usually monitored are cardiovascular diseases, metabolic syndrome,
diabetes and infectious diseases. These diseases can be monitored using the tempera-
ture, heart rate, motion and blood glucose levels. From the investigation, most of the
wearable devices are being designed for the user to monitor their own health especially
for wellness and preventive purposes.
Technology maturity was determined using the S-curve and TRL scale. Most of
the devices are that were reviewed showed that the devices that are on the market
are reaching maturity already especially fitness trackers. The devices that are used for
advanced healthcare such as Google contact lenses are still at the prototype phase (at
TRL 6).
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CROSS-REFERENCE THE DISEASES
TO THE WEARABLE DEVICES
This chapter contains the results of a qualitative analysis, through interviews, that was
conducted in order to collect medical knowledge about prominent diseases that affect
the sub-Saharan African region (refer to Section 2.3) from clinical subject matter ex-
perts (SMEs). During the interviews, SMEs provided information on the physiological
signs that are used to clinically monitor these diseases. They were asked to consider
the potential application of wearable technology to each disease and to provide infor-
mation on the stage(s) of care where the measured data may be useful and also which
stakeholders may find such data useful and/or benefit from it. The feedback gathered
from the interviewers will be gathered and discussed in detail.
4.1 Interviews with experts
This section focuses on providing the background information of interviews and the
different types that are available. Interviewing is a primary way of collecting qualitative
data. According to Mouton (2001), the following are the advantages of conducting
interviews:
• Flexibility and adaptability.
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• The interviewer has control over the responses and can ensure all the questions
are answered by the interviewee. The interviewer can provide clarity to the in-
terviewee if there are questions that are misunderstood.
• Anonymity is provided so that the interviewee gives unbiased responses.
• There is a high response rate to face-to-face interviews compared to providing
responses via email or telephone interviews.
Mouton (2001) also highlights an important disadvantage of interviews, namely that
they are subject to bias.
The three common types of interview techniques used for data collection include:
(i) structured; (ii) semi-structured; and (iii) unstructured. These will be described in
more detail in the following subsections, before motivating the selection of the most
appropriate interview technique for this research in Section 4.1.4..
4.1.1 Structured interviews
Structured interviews often produce quantitative data when conducted correctly (Dicicco-
Bloom and Crabtree, 2006). The questions asked during a structured interview are con-
trolled, so is the data elicited by the interviewee. During a structured interview, the
interviewer follows a specific set of questions with a predetermined order and a limited
number of response categories (Denzin and Lincoln, 2008). Structured interviews play
a vital role especially when the interviewer knows much about the topic and creates
the questions in a survey-like format with closed-ended questions (Stuckey, 2013). The
questions are compiled as a questionnaire that guides the interviewer with pre-coded
answers.
4.1.2 Semi-structured interviews
Often the sole data sources for qualitative data research projects are semi-structured
interviews. The researcher sets an outline of the predetermined open-ended questions
with other questions emerging from the dialogue between the interviewer and inter-
viewee(s) (Stuckey, 2013). The semi-structured interview is flexible and could cover a
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broader scope than the structured interview approach because the interviewees can give
lengthy and vivid details to the questions asked (Dicicco-Bloom and Crabtree, 2006).
4.1.3 Unstructured interviews
Unstructured interviews are informal and are used to explore general areas of interest
in depth. In this instance, the interviewer has a general topic in mind, but many of the
question are formulated as the interview proceeds, in response to what the interviewee
says. These interviews can also be referred to as in-depth interviews. Although no in-
terview can truly be unstructured, some have less guidance than others(Dicicco-Bloom
and Crabtree, 2006). Unstructured interviews are usually conducted in explorative and
qualitative research to identify important variables in a particular area, to formulate
penetrating questions about them, and to generate hypotheses for further investigation
(Dicicco-Bloom and Crabtree, 2006).
4.1.4 Conclusion: Selected interview technique
The structured interview approach was chosen for this study because of its ability to
control the topics of the interview and to elicit controlled responses. The data collected
using this method is (i) reliable, (ii) standardised, and (iii) repeatable. The interview
format that was selected was questionnaire-based and interviews were conducted face-
to-face.
4.2 Interview process and feedback
The interview process that was followed is set out in this section and the data that was
gathered through the interview is also summarised. The section will also go into detail
in explaining the relevance of each question posed to the interviewees.
4.2.1 Interview process
The interviewees were subjected to an introduction of the thesis by the interviewer
to provide an understanding of the relevance of the interview and how the informa-
tion they provide will contribute to the study. The interviewees were also afforded the
opportunity to recommend changes to the questionnaire guiding the structured inter-
view. This questionnaire had been made available to each interviewee via email prior
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to the interview. The following changes were made to the questionnaire in line with
recommendations by the interviewees:
• Oxygen saturation was added as a physiological sign;
• Congenital anomalies were removed from the list of diseases since they can not
be monitored non-invasively; and
• The order of the diseases in the questionnaire was rearranged to group all the
conditions that affect neonatal babies together.
The basis for the questionnaire was the prioritised list of diseases identified in Sec-
tion 2.2.4, and repeated below for the sake of clarity. The same set of questions was
asked for each disease. The diseases that were included in the questionnaire were:
• Lower respiratory infections
• HIV/AIDS
• Diarrhoeal diseases
• Stroke
• Ischaemic heart disease
• Tuberculosis
• Malaria
• Preterm birth complications
• Birth asphyxia and other infections
• Neonatal sepsis
Figure 4.1 illustrates a portion of the questionnaire. The questions that were asked
for each disease are summarised below; the reasons for including each question in the
questionnaire are also provided:
(a) Choose the physiological signs that can be used to monitor the condi-
tion: In healthcare research, a person’s physiological signs can be monitored for
precise and accurate data for diagnostic purposes. In order to keep the outputs
consistent, a list of physiological signs was presented to the interviewees. The list
was based on the physiological signs that were found from the structured review of
the wearable technology landscape (in Section 3.3). This approach restricted the
physiological signs to those that can be monitored by wearable technology that is
either presently commercially available or is in an advanced stage of development.
Interviewees were, however, allowed the option of adding additional physiological
signs not listed in the structured interview guideline as part of their response.
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(b) Identify the stages of care where the physiological signs identified in
(a) would be useful clinical indicators: The stages of care give an indication
of where these physiological signs play a vital role in health systems and can be
used to assess the health impact for decision-making. Therefore, this information
enables the potential health outcome of the wearable technology to measure these
physiological signals to be determined.
(c) The intended user of the information: The question was posed to indicate
the stakeholders that find the information useful. Intended users were grouped into
two categories, the one consists the patients and other care givers or stakeholders
that do not necessarily have formal medical training, the other consists of the
various medical professionals involved in providing care. This would be relevant
information to individuals seeking to develop or adapt wearable technologies for
these applications.
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Figure 4.1: Part of the questionnaire template used for interview
4.2.2 Interviewees
The interviewees were taken from different medical fields. A total of five subject matter
experts were interviewed ( see Table 4.1). The reasons why only five interviews were
conducted were:
1. The interviews lasted 1 to 2 hours each, so they required a reasonably large period
of time and commitment from the interviewees, all of whom have significant other
demands on their time
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2. The interviewees had some room for personal opinions in the feedback, but the
information was largely factual and there was an expectation that the findings
from the different interviews would be well-aligned.
The majority of the SMEs were employed by Stellenbosch University or the Western
Cape provincial government.
Table 4.1: Subject matter experts interviewed
Interview
Date
Interviewee’s area of expertise Interviewee’s geographi-
cal focus
15/08/2017 General practitioner and project manager of
the Ukwanda Rural Clinic School
Worked in Southern African
countries for several years
and spent the last few
decades working in Western
Cape.
17/08/2017 Paediatrician at Cape Gate Mediclinic Private
Hospital , Head of the Biomedical Engineer-
ing Research Group, Extra-ordinary associate
professor, Department of Anaesthesiology and
Critical Care.
South Africa
22/08/2017 Neonatologist at Tygerberg Hospital Works in Western Cape
06/09/2017 General Practitioner and Programme Coordi-
nator of the Centre of Health Systems and Ser-
vices Research Division of Community Health,
Stellenbosch University.
Works and currently con-
ducting research in Western
Cape
15/09/2017 General Practitioner Worked in Western Cape
There is some bias from the feedback from these experts because:
• Most of the doctors had specialised fields and were knowledgeable about certain
diseases compared to others; and
• The study focuses on the SSA disease landscape and some of the interviewees just
have experience with the diseases that affect the Western Cape or South Africa
in general.
4.2.3 Summary of feedback from interviews
This section provides the feedback that was obtained from the different SMEs based on
the questionnaire or any additional information they provided. Table C.1 provides the
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response from the five interviewees. The detailed description of the interview finding
is provided in Appendix C. For all the different conditions they indicated the physio-
logical signs they felt could play a role in monitoring them either in home or hospital
settings. When analysing the responses from the interviewees the physiological signs
identified were linked to the stages of care and the intended user.
4.2.3.1 Feedback on the physiological signs and stages of care for the re-
spective diseases
The data in Table C.1 shows the predominant physiological signs and the stages of care
that were agreed upon by the subject matter experts. The physiological signs that were
identified by all of the interviewees will be used to cross reference the diseases to the
wearable sensors applied. The responses given were consistent with the physiological
sign found in literature (Refer to Section 2.2.2). The additional physiological signs
that were suggested by the interviewees were haemoglobin levels 1, breathing sounds 2,
bio-impedance (for body fluid and body fat) 3 and perfusion 4.
4.2.3.2 Feedback on the intended user(s)
During the interviews all the interviewees felt that for all the diseases that were pre-
sented to them they shared the sentiment that the patients and the healthcare providers
would benefit from the data collected. Because this is an emerging technology some
of the interviewees highlighted that they might be need to train the stakeholders to
ensure efficient application of the technology. The level of training will be dependent
1The measurement for haemoglobin concentration plays a role in the monitoring of malaria.
Haemoglobin concentration indicates the concentration of red blood cells in the body (Barker et al.,
2016).
2 Continuous monitoring of the breathing sounds can indicate a lung problem such as an obstruction,
inflammation, infection, asthma and fluid in the lungs (Stahlheber, 2015).
3Bio-impedance is a physiological sign that can be used to determine the body composition mea-
surements such as lean mass and fluid volumes estimation. Bio-impedance information can be used
to monitor conditions such as cardiac, pulmonary, renal, neural and infectious diseases (Khalil et al.,
2014).
4 Blood perfusion is an important physiological parameter which can serve as an indicator of
body hemodynamic function. For example, in circulatory failure, blood flow is diverted from the less
important organs such as the skin to the vital organs. Thus monitoring blood perfusion can be an early
marker of the hypo-perfusion of vital tissues (Zakharov et al., 2009).
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on the complexity of the data that needs to be interpreted. This information will be
used in Chapter 6 on considering the potential of wearable technology.
The following points were made throughout the interview process by the SMEs:
• It was suggested that with the level of data presented to the users that it might
be necessary to train stakeholders. This will enable the efficient use of the device
and interpretation of data.
• To develop complex algorithms that can be used to detect diseases when moni-
toring the patients remotely and alert the healthcare providers of the condition
as well as the patient.
• There is probable potential of using wearable technology in hospital settings in
Level 1, 2 and 3 care for neonates to monitor their vitals. In addition to that
the parents of the preemies that have just been released from hospital can benefit
from wearable devices especially if they are still vulnerable to infections.
• Patients that have chronic conditions such as cardiovascular diseases and hyper-
tension will benefit immensely from this technology as it will enable them to have
a healthy lifestyle.
• When the healthcare providers are using wearable devices it would be beneficial,
especially for patients suffering from chronic conditions, to have access to the
medical history of the patient.
• There are three different parties involved in the monitoring of diseases using
wearable technology, namely healthcare providers, patients and medical insurance
companies. Medical insurance companies use wearable devices to monitor the
activities of their beneficiaries ensuring they lead a healthy lifestyle.
Wearable technology can benefit various stakeholders and this technology plays dif-
ferent roles for the parties involved (Burri et al., 2011). Wearable technologies are
interesting interventions because they can be used for self-management or remote mon-
itoring. Table 4.2 summarises the findings from the feedback that was provided by the
SMEs on their perspective on the wearable technology requirements for the intended
user.
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Table 4.2: A summary of the SMEs’ perspective on requirements to make wearable
technology accessible to intended users (or stakeholders)
Stakeholders Technical Quality Accessibility Efficiency Costs
Patients Wearable
device, smart
phones and
computers
Better care re-
ceived given the
sensors are reli-
able
Mobile net-
work cover-
age, Internet
access and
usage
Training
based on
computer
literacy in the
region
Data transfer
and storage
Healthcare
providers
Computers,
laptops ,
smart phones
Better care given,
less administra-
tive work
Mobile net-
work cover-
age, Internet
access and
usage
Training
based on
computer
literacy in
the region
hospitals
Data transfer,
servers and
storage
The interview process provided insight on the medical perspective and on how it
is necessary to have a better understanding of the disease state analysis so that valid
recommendations can be made based on this research.
4.3 Discussion of findings
In wearable technology a number of wearable sensors are being developed to mea-
sure physiological signs. Currently motion sensors, temperature sensors and heart rate
monitors are widely used for fitness tracking. The list of the wearable sensors that are
currently being used is provided in Table 3.1 in Chapter 3. For this study the list of
physiological signs that were presented to the interviewees will be matched up to their
wearable sensors as illustrated in Figure 4.3.
Figure 4.3 also illustrates that there are physiological signs that can be measured
using multiple sensors. The sensors may be used to measure the same physiological
signs; however, different algorithms have to be developed to analyse the data. These
physiological signs are:
• Heart rate that can either be monitored using ECG electrodes (Guo et al., 2016),
piezoelectric film sensor (Park et al., 2015) or PPG (Kroll et al., 2016).
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• Temperature measured using infrared thermopile (Texas Instruments, 2017), ther-
mometers and thermistor (Hughes-Riley et al., 2017).
• Motion can be measured using either accelerometer, gyroscope, pedometer and
electromagnetic sensors (Majumder et al., 2017).
• Breathing rate using either a respiratory inductive plethysmography (RIP) sensor,
bio-impedance sensor (De Cannie`re et al., 2015) and thermistor (Retory et al.,
2016).
• Body water levels for hydration can be determined using skin hydration sensor
(Yao et al., 2017), bio-impedance (body fluids) (De Cannie`re et al., 2015) and
trans-epidermal water loss sensor (Zak et al., 2012).
• Haemoglobin can be measured using pulse CO-oximeter (Lindner and Exadakty-
los, 2013) and chemical sensors that can detect the presence of haemoglobinuria
in urine.
The physiological sign that were mentioned by the interviewees that have no sensors
yet developed for wearable sensing is breathing sounds.
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Table 4.3: Sensors cross-referenced to their physiological signs
4.3.1 Feedback on the physiological signs and stages of care for the
respective diseases
The section contains the detailed discussion on the physiological signs and the stages of
care linked to the respective diseases. The discussions are based on the results presented
in Table C.1.
4.3.1.1 Detailed feedback on physiological signs linked to diseases
This section contains a brief description of the expected use of monitoring various
physiological signs for each of the diseases included in this research. These descriptions
are based on the synthesised feedback received from the various SMEs.
Lower respiratory infections -This is a disease known to affect the respiratory
tract. Based on the feedback from some of the SMEs when the body is infected there
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is a possibility of an immune response that is characterised by temperature increase
(fever), heart rate to increase, increased breathing rate and the oxygen saturation levels
will decrease. According to the SMEs these physiological signs can be monitored in the
home or hospital setting and can provide reliable results.
HIV/AIDS - This is monitored efficiently through blood tests. The physiological
signs that can be monitored for this condition are aimed at identifying the oppor-
tunistic infections in Stage 3 of the HIV infection. The physiological signs that are
of importance include heart rate, temperature, breathing rate, oxygen saturation and
brain activity. Opportunistic infections include diseases such as tuberculosis, pneumo-
nia and meningitis. During the first two stages of infection the virus is dormant and
no clear signs and symptoms can be used to clearly link it to its presence. There the
use of wearable technology in the first two stages can be challenging. In other medical
cases, HIV medicines present side effects that can affect the well-being of the patient.
The side effects can be manageable or life threatening. Therefore a patient should
be monitored to prevent the life-threatening side effects such as liver failure, kidney
problems, heart disease, diabetes and nervous system as well as psychiatric effects.
Diarrhoeal diseases - These diseases can be monitored using body water levels in
the form of trans-epidermal water loss levels or bio-impedance and urine composition.
When a person is suffering from diarrhoea they lose a lot of fluids from the body and the
dehydration can be monitored non-invasively. The loss of fluids affects the heart rate,
breathing rate, temperature, oxygen saturation, blood pressure and blood sugar levels.
The monitoring of these physiological signs can be used in home or hospital settings as
they will be able to recommend the amount of fluids and electrolytes required for the
body to return to normalcy.
Stroke - A stroke is an acute condition which occurs when the blood pressure in-
creases so drastically that it affects the functionality of the body. The physiological
signs that are important for the monitoring of this condition are motion, blood pres-
sure, brain activity, heart rate, heart electrical activity and breathing rate. All these
physiological signs can be used to identify a stroke and monitor a hypertensive patient
as well as a stroke survivor.
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Ischaemic heart diseases - These diseases affect the heart activity therefore can be
monitored or detected using the heart rate, heart electrical activity and blood pressure.
There are devices that have been developed with the main purpose of identifying and
detecting ischaemic heart diseases.
Tuberculosis - This is a form of lower respiratory infection characterised by night
sweats, fever and fatigue. The physiological signs that can be used to monitor tuber-
culosis are heart rate, temperature, breathing rate and oxygen saturation. One of the
interviewees highlighted that tuberculosis meningitis can be monitored by sleep quality
and brain activity as the infected person experiences delirium, seizures and drowsiness.
Malaria - The physiological signs that are important when monitoring malaria are
heart rate, temperature, oxygen saturation, blood pressure, blood sugar levels and
haemoglobin levels. The one challenge with malaria is that the symptoms may not
develop for several months making it difficult to detect the presence of the infection.
Preterm birth complications - These are conditions that affect babies that are
born weighing 500 grams to 2500 grams. There are a number of complications that
were mentioned by one of the interviewees such as jaundice, anaemia, metabolism
and heart defects. Preemies are known to lose heat through their skin so there is a
need for constant monitoring of temperature. The vital signs need to be monitored
continuously for preemies because their organs are not fully developed as highlighted
by one of the interviewees who works in the Neonatal Intensive Care Unit at Tygerberg
Hospital. The physiological signs that need to be monitored are heart rate, temperature,
oxygen saturation, blood pressure, blood sugar levels and urine composition. One of
the interviewees commented that having a device that can monitor these signs non-
invasively will add value in the intensive care unit as at the moment preemies are
monitored invasively.
Birth asphyxia and other infections - Birth asphyxia is a condition which occurs
when the baby is deprived of oxygen before or during child birth. According to the
interviewees both the mother and the baby need to be monitored. The physiological
signs that require constant monitoring are heart rate, temperature, breathing rate,
oxygen saturation, blood pressure and blood sugar levels.
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Neonatal sepsis - Early-onset sepsis is associated with acquisition of micro-organisms
from the mother. Transplacental infection or an ascending infection from the cervix
may be caused by organisms that colonise the mother’s genitourinary (GU) tract; the
neonate acquires the micro-organisms as it passes through the colonised birth canal at
delivery. According to the feedback from the SMEs, the vital signs that are necessary
for the monitoring of neonatal sepsis are heart rate, temperature, motion, breathing
rate and blood sugar levels.
4.3.2 Summarised feedback on stages of care
Detailed information on the various stages of care where SMEs indicated that mon-
itoring of physiological signs would be useful has been provided in Table C.1. This
information is summarised in a significantly less detailed format in Figure 4.4, to en-
able some high-level conclusions to be drawn.
Communicable diseases would benefit from wearable devices by using them for treat-
ment and diagnostic purposes. These conditions are characterised by fever, increased
heart rate, perfusion and elevated blood pressure in some instances blood sugar lev-
els. For non-communicable diseases, especially chronic conditions, the wearable devices
can be applied in all stages of care. Stroke is an acute NCD and can be prevented,
diagnosed and rehabilitated using wearable devices.
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Table 4.4: Sensors cross-referenced to their physiological signs
4.3.3 Sensors for the diseases
The information from Figure 4.5 and Table C.1 was used to cross-reference the sen-
sors to the diseases that are being considered for this study. A total of 24 sensors are
provided in Figure 4.3. A total of 13 of the 24 sensors can be used to monitor all the
diseases being considered in this study. The sensors that were identified to monitor
most of the diseases are utilised specifically for vital signs and motion activity.
On the market there are wearable devices that have a multisensor system (Samanta
et al., 2014; Shen et al., 2012; Swan, 2012). A criteria has to be used to determine the
important sensors that can be used for monitoring the respective condition. This will
be conducted in Chapter 5.
Lower respiratory infections and tuberculosis have the least number of wearable
sensors to monitor the disease. Pre-term birth complications, neonatal sepsis, stroke
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and ischaemic heart diseases are conditions which require constant monitoring of the
vital signs, therefore these have the highest number of possible sensors that can be
applied.
Table 4.5: Sensors cross-referenced to their diseases
4.4 Conclusion: Cross-reference diseases to wearable sen-
sors
This chapter began by a giving background of the interview process and the different
types of interviews. This was followed by the findings from the interviews through a
brief description of the questionnaire, subject matter experts and interview responses.
Finally, the physiological signs that were identified from the interviews was used to
cross-reference the diseases to the wearable sensors.
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DEFINE CRITERIA FOR
PRIORITISING WEARABLE
DEVICES
This section aims at defining the set of criteria that will be used for priority-setting
in the wearable sensors sector in healthcare in SSA. The set of criteria used for this
study will be determined from those that were predominantly used in previous studies
that focus on priority-setting in healthcare. This section provides the different methods
that can be used to weigh the selected set of criteria to determine a composite score.
Finally, information will be provided on the scales that will be used to score the set of
criteria that will be identified.
5.1 Background
Priority-setting is important in healthcare policy-making because no health system can
afford all the health interventions they intend on introducing (Kapiriri and Norheim,
2004). SSA faces a challenge between the need for healthcare services and limited fund-
ing available. Priority-setting brings about transparent approaches and explicit debate
about the principles and criteria used to make decisions on allocating healthcare re-
sources.
103
Stellenbosch University  https://scholar.sun.ac.za
5.1 Background
A set of criteria can be determined in order to enable the prioritisation of new
technologies (Shani et al., 2000). The criteria chosen for the health intervention priority-
setting can either be patient-related, disease-related or society-related. However in this
study the focus will be disease-related as that is in the scope of this study. The process
illustrated in Figure 5.1 will be utilised for this study to select the criteria for prioritising
wearable sensors in SSA.
Figure 5.1: Illustration for the process followed for priority-setting for this study.
5.1.1 Published studies where priority-setting was investigated
The information provided in Table 5.1 gives the characteristics of nine studies conducted
for priority-setting. The articles that were reviewed for this study were obtained from
the Scopus database. In literature, there are no studies that are aimed specifically
at priority-setting for wearable devices. Therefore, the articles that were reviewed fo-
cused on the introduction of various health interventions in healthcare. All the studies
were published after 2004. Six of those studies were conducted in developing countries,
namely Uganda, South Africa, Ghana and Nepal. The remainder of the articles focused
on developed countries, namely Canada and The Netherlands.
Most of the studies (7 out of 9) primarily aimed at defining criteria for priority-
setting in healthcare. The other two studies aimed at performing a field test on the
framework developed for priority-setting and development of a model for health tech-
nology assessment, respectively. Eight of the studies reviewed focused on prioritisation
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conducted at national level, while one of the studies did not highlight the level where
the prioritisation process was conducted. The studies covered a wide range of priority-
setting areas: one study prioritised interventions across the healthcare system, two
studies across several disease areas, two studies focused on health technologies and four
studies concentrated on health interventions. All the criteria that were selected for
each of the studies were identified through previous systematic reviews.
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Table 5.1: The previous studies reviewed to obtain the criteria for priority-setting
N
u
m
b
e
r
A
u
t
h
o
r
Study Objective Country Decision-
making
level
Area of
prioritisa-
tion
How to
identify
criteria
1 Kapiriri
and
Norheim
(2004)
Criteria for priority-
setting in health care in
Uganda: exploration of
stakeholders’ values
To explore stakeholders’ accep-
tance of criteria for setting prior-
ities for the health care system in
Uganda
Uganda National
level
Health sys-
tem
Criteria
identified
from a
previous
study
2 Tromp
and Bal-
tussen
(2012)
Mapping of multiple crite-
ria for priority-setting of
health interventions: an
aid for decision-makers
Aim to develop a conceptual
mapping of criteria, based on
the World Health Organization’s
Health Systems Performance and
Health Systems Building Blocks
frameworks. This map can be an
aid to decision makers to identify
the relevant criteria for priority-
setting in their specific context.
The Nether-
lands
National
level
Health inter-
ventions
Literature
review
3 Noorani
et al.
(2007)
Priority setting for health
technology assessments: A
systematic review of cur-
rent practical approaches
This study sought to iden-
tify and compare various prac-
tical and current approaches
of health technology assessment
(HTA) priority-setting
Canada n/a Health tech-
nologies
Literature
review
Continued on next page
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Table 5.1 – Continued from previous page
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r
Study Objective Country Decision-
making
level
Area of
prioritisa-
tion
How to
identify
criteria
4 Miot et al.
(2012)
Field testing of a multi
criteria decision analysis
(MCDA) framework for
coverage of a screening test
for cervical cancer in South
Africa
The objective of the study was to
field test the framework for deci-
sion making on a screening test
by a private health plan in South
Africa.
South Africa National
level
Health in-
tervention
for cervi-
cal cancer
screening
Literature
review of the
CADTH,
NICE and
South
Africa’s
Health
Department
5 Baltussen
et al.
(2013)
Balancing efficiency, eq-
uity and feasibility of HIV
treatment in South Africa
– development of program-
matic guidance
Aim: Propose an alternative ap-
proach that provides a better evi-
dence base and outlines a fair pol-
icy process to improve priority-
setting in HIV treatment.
South Africa National
level
Health in-
terventions
for HIV
treatment
Based on
a previous
study
6 Mathew
(2017)
KNOW ESSENTIALS: A
tool for informed decisions
in the absence of formal
HTA systems
Developing a new model for eval-
uating health technologies for
resource-limited setting lacking
health technology assessment sys-
tems.
Developing
coun-
tries and
resource-
limited
settings
National
level
Health inter-
ventions
Literature
review
Continued on next page
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Study Objective Country Decision-
making
level
Area of
prioritisa-
tion
How to
identify
criteria
7 Baltussen
et al.
(2006)
Towards a multi-criteria
approach for priority-
setting: an application to
Ghana
Many criteria have been pro-
posed to guide priority-setting in
health, but their relative impor-
tance has not yet been deter-
mined in a way that allows a rank
ordering of interventions
Ghana National
level
Several dis-
ease area
Literature
review
8 Husereau
et al.
(2010)
Priority setting for health
technology assessment at
CADTH
The aim of this study was
to describe a current practi-
cal approach of priority-setting
of health technology assessment
(HTA) research that involves
multi-criteria decision analysis
and a deliberative process.
Canada National
level
Health tech-
nology
Through a
previously
published
systematic
review
9 Baltussen
et al.
(2007)
Priority setting using mul-
tiple criteria: should a lung
health programme be imple-
mented in Nepal?
To identify and weigh the various
criteria for priority-setting, and
to assess whether a recently eval-
uated lung health programme in
Nepal should be considered a pri-
ority in that country.
Nepal National
level
Several dis-
ease area
Through a
previously
published
systematic
review
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5.1.2 Defining criteria
After reviewing the nine articles listed in Table 5.1, a total of 43 criteria that can be
used during priority-setting were identified (see Appendix D, Table D.1). The selected
criteria are listed in Table 5.2, the table also indicates in which of the nine studies
listed in Table D.1 each criteria has been used for priority-setting. The criteria that
were most frequently identified for priority-setting were: cost-effectiveness, severity of
the condition and budget impact (6 studies). These were followed by cost of treatment,
size of population affected by disease, burden of disease, effectiveness of treatment and
age. Other criteria included improvement of patient-reported outcomes and number of
people benefiting. The cost of treatment and effectiveness criteria overlap; therefore
these can be combined when evaluating the cost-effectiveness analysis if necessary.
Table 5.2: The criteria that have been identified in previous studies for priority-setting.
Number Criteria [1] [2] [3] [4] [5] [6] [7] [8] [9] Total
1 Cost-effectiveness 1 1 1 1 1 1 6
2 Severity of the condition 1 1 1 1 1 1 6
3 Budget impact 1 1 1 1 1 1 6
4 Costs of treatment 1 1 1 1 1 5
5 Size of population affected
by disease (Target group)
1 1 1 1 1 5
6 Burden of disease 1 1 1 1 1 5
7 Effectiveness of treatment 1 1 1 1 1 5
8 Age 1 1 1 1 1 5
9 Improvement of patient-
reported outcomes
1 1 1 1 4
10 Number of people benefit-
ing
1 1 1 1 4
The criteria were grouped into three different categories as performed in a previ-
ous study by Mathew (2017). The categories were economics, knowledge of need and
intervention outcomes as shown in Figure 5.2. The economics category contains the
follwing three criteria: unit cost or treatment cost, cost-effectiveness and budget impact
analysis. The criteria in the knowledge of need category are: disease burden, disease
severity, and size of population affected by disease. The interventions outcomes that
are considered for this study are improvement of patient-reported outcomes, effective-
ness and number of people benefiting from the intervention. In the remainder of this
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section, a brief overview of each of the three categories of criteria is provided.
Figure 5.2: Categories for the selected criteria
5.1.2.1 Economics
In this context health economics is concerned with the costs that new interventions
exert on the health system, government and society (Husereau et al., 2010). Health
economics help determine the value of the new health interventions in the health system
and the impact on the health expenditure of a country relative to the DALYs averted.
The costs could be in the form of direct and indirect costs1 associated with the health
intervention. The costs could be in terms of (i) cost of the health technology, (ii) cost
of providing the technology, and (iii) cost-effectiveness (cost-to-benefit ratio) (Mathew,
2017).
WHO-CHOICE was a project developed by WHO in order to provide evidence
when priority-setting about impact and cost-effectiveness (World Health Organization
1As stated in Chapter 2 direct costs refer to price that can be completely attributed to the produc-
tion of specific goods or services (Investopedia, 2016). Indirect costs refer to the productivity loss that
is faced as a result of absenteeism at work caused by either illness, presenteeism or premature death
(Luppa et al., 2007)
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(WHO), 2014b). WHO-CHOICE provides data on the cost-effectiveness of some health
interventions in 14 different epidemiological regions for leading causes of disease bur-
den, including analysis of the interactions inherent in many combined interventions. In
order to perform detailed cost-effectiveness the WHO-CHOICE OneHealth tool can be
utilised (World Health Organization (WHO), 2014b).
A budget impact analysis is an assessment that approximates the financial outcomes
after the inclusion of a new intervention in a system. The budget impact analysis takes
into account the population of the affected people and multiplies it by the unit cost of
an intervention to determine the total budget required to fund the intervention. The
main purpose of the budget impact analysis is to determine whether an intervention is
affordable (U.S. Department of Veterans Affairs, 2016).
If an intervention can not meet the paying capacity of the stakeholders then it can be
neglected by the decision-makers. This can be used as a feasibility indicator on whether
it is possible to add an intervention rather than keeping the current intervention(s) in
place.
5.1.2.2 Knowledge of need
For this study, the disease burden metric used is the DALY metric that is mentioned
in Chapter 2. This metric has been used in previous studies when determining the dis-
ease impact (Baltussen et al., 2006; Kapiriri and Norheim, 2004; Mathew, 2017; Miot
et al., 2012). The severity of the disease is measured using the disability weights. The
disability weights indicate the health levels of an individual associated with non-fatal
outcomes (Haagsma et al., 2015). Therefore, the severity of the disease that is targeted
can be used to determine the value of the new health intervention(Miot et al., 2012).
In determining the need for the intervention it is necessary to have knowledge of
the number of people affected by the condition (shows the intended coverage of the
intervention) among a specified population at a specified time. The number of affected
people can be specified as the annual number of new cases (annual incidence) and/or
proportion of the population affected at a certain point in time (prevalence) (Miot
et al., 2012).
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5.1.2.3 Intervention outcomes
When a health intervention is introduced it is vital to have knowledge on the outcomes
it provides in order to gauge the value it will add. In reality the management of a single
healthcare condition can lead to multiple desirable outcomes. Stakeholders are usually
interested in knowing the health outcomes through the mortality, morbidity or quality
of life. When going through the decision making process it is necessary to use these
health outcomes to make evidence-based decisions (Mathew, 2017).
The improvement in patient-reported outcomes are used to assess the capacity of
the proposed intervention to produce beneficial changes in patient-reported outcomes
(e.g., quality of life) above and beyond beneficial changes produced by alternative inter-
ventions (Miot et al., 2012; Tromp and Baltussen, 2012). This assessment is important
because it provides an idea of the improvement caused by interventions from a patient-
centred perspective.
Effectiveness of health interventions was estimated based on published information
on the magnitude of health gain (Hutubessy et al., 2003; Miot et al., 2012). Effec-
tiveness was obtained by adjusting efficacy by a factor between 0 and 1 to allow for
less than perfect adherence to recommended practices (Evans et al., 2005). Efficacy is
based on research data and estimates whether a health technology could work at all. It
is evidence-based and readily available through systematic reviews, randomised trials,
etc. Evidence of efficacy ought to be used only if evidence of effectiveness in the local
population is not readily available (Mathew, 2017).
The number of people benefiting from an intervention reflects the economies of scale
(Tromp and Baltussen, 2012). The economies of scale theory states that as more units
are produced the cheaper the unit cost. Therefore, interventions that target a large
number of people make the unit cost lower based on the economies of scale.
5.2 The availability of data
In order to perform evidence-based priority-setting for the application of wearable tech-
nologies to the prioritised diseases in the SSA landscape, there is a need to determine
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whether the necessary data to calculate the various criteria scores is available. In this
section, the availability of data to evaluate each of the ten criteria will be considered.
5.2.1 Data availability for various economic criteria
There are a variety of databases that can be used to perform economic evaluations.
However there is a lack of data in developing countries. The WHO-CHOICE project
provides information that can be used to estimate cost-effectiveness and budget impact
analysis (World Health Organization (WHO), 2014b).
5.2.1.1 Data availability for cost-effectiveness criteria
The unit cost is the cost incurred by a manufacturer to produce, store and sell one unit
of a particular product (Tromp and Baltussen, 2012). The data for wearable sensors
is available in catalogues for big manufacturing companies such as Digikey, Sensonor
Electronics and Mouser Electronics (DigiKey Electronics, 2017; Mouser Electronics,
2017; Sensonor, 2017).
5.2.1.2 Cost-effectiveness
When performing a cost-effectiveness analysis there is a need to determine the costs
incurred with the current health interventions. The analysis is performed by setting
up different scenarios (Evans et al., 2005):
• The no-intervention scenario - This is to evaluate the cost-effectiveness when the
interventions are ceased over a period of time.
• Determine the effects of all the new interventions by either adding them singly
or in different combinations in the health system.
The data that is used for cost-effectiveness can be collected from the World Bank
health sector databases (The World Bank, 2016). These databases provide the data
of the costs and effectiveness of health interventions aimed at major health problems
for developing countries. In turn, the World Health Organization estimated costs per
DALY for a wide range of health interventions for 14 epidemiological sub-regions (World
Health Organization (WHO), 2014b). The burden of disease can be measured using
the DALY metric highlighted in Chapter 2. In order to have an entire overview of
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the effects of the intervention other criteria have been defined. These include medical
criteria (such as severity of disease) and non-medical criteria (such as patient age).
There is not enough information on the application of wearable sensors that can
be used to perform cost-effectiveness analysis from these databases. The formulas pro-
vided in Chapter 2 can be used to determine the total cost of the interventions at a
population level. The coverage of the intervention can be assumed to be 80 percent as
done in previous studies (Hansen and Chapman, 2008).
Determining the costs associated with the healthcare providers is still questionable
because there still needs to be a clear-cut distinction on their contribution and how
much it will cost. When determining direct cost aspects such as travel cost may be
removed, because wearable devices allow remote monitoring (Burri et al., 2011).
Table 5.3: Direct and indirect costs associated with remote monitoring through the
payer’s perspective
Costs Available Unavailable Comment
Direct costs
Medical Services
X
These values are associated with the
consultation fees paid. The fees will be
less compared to a regular in-office con-
sultation.
Medication Cost
X
This could be costs associated with in-
sulin pumps
Intervention cost
X
The wearable device cost and the home
transmitter cost
Travel Cost
X
Because it is remote monitoring the
travel costs are reduced therefore esti-
mating them can be difficult because it
depends on the number of emergency
cases.
Indirect cost
Productivity loss
due to absentism
X
This can be determined because the
data is collected for every person using
a wearable device because there is ac-
cess to personal records through EMR
cost Continued on next page
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Table 5.3 – Continued from previous page
Costs Available Unavailable Comment
Productivity loss
due to presentism
X
Productivity loss
due to premature
death X
Additional
costs asso-
ciated with
indirect costs
for remote
monitoring
Patient education
or training
X
Patient training provides them infor-
mation regarding the proper use and
installation.
Maintenance and
services of server
X
This is associated with maintenance
of the server, telecommunications costs
and staffing of the technical support
helpline.
Impact on device
longevity
X
This is a long-term cost analysis of
technical aspects of remote monitoring
and costs associated with replacement
and frequency of maintenance services
Administrative
work associated
with setting
up electronic
medical records
X
Electronic medical records makes it
easy for patients and physicians to have
access to the patients history on the
server.
The data available to perform cost-effectiveness for wearable sensors is not sufficient
to draw comprehensive conclusions from it. This study aims at determining the areas
of application, therefore making it infeasible to carry out a cost-effectiveness analysis
at this point in time. In the future data will be available when wearable sensors have
actively entered the SSA health system.
5.2.1.3 Data availability for budget impact analysis criteria
The budget impact analysis is performed alongside cost-effectiveness. When performing
a budget impact analysis the data used is over a period of time and the analysis is
focused on the differences between when the interventions were introduced as well as
before that. The difference between the cost of these two scenarios costs is the impact.
The time period when conducting the analysis can be between 1 and 5 years (Restelli
et al., 2017; Sullivan et al., 2013).
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The data that is required to perform the budget analysis include:
• Target population–The target population can be considered using the incidence
rate. The incidence data is available.
• Use and cost of current and new interventions–The cost of the current in-
terventions and new interventions. The impact can be determined through three
changes: the new interventions replace one or more current interventions (substi-
tution), the new intervention is added to the current interventions (combinations)
and the new intervention is used in situations in which there has been no active
intervention (only supportive care) or in patients who have stopped or would not
use available interventions owing to intolerance, inconvenience, loss of effect, or
any other reasons (expansion). These changes are analysed over a period of time
(Sullivan et al., 2013).
For wearable devices no budget impact analysis studies have been performed for
the SSA setting. Therefore, budget impact analysis cannot be used for prioritisation
in this research as there is insufficient data to carry it out.
5.2.2 Data availability for various ’knowledge of need’ criteria
When decision-making it is essential to know whether there is a justifiable need for
the new technology to address the healthcare challenge (Mathew, 2017). The challenge
in developing countries is that they are faced with technologies that do not address
local primary needs (Wright and Walley, 1998). If health services are to respond to
the changing health needs of their local populations, then planners and managers need
useful and timely information about the health status of these populations (Wright and
Walley, 1998). For this study the data that can be used to identify the need of the local
population is in terms of disease severity, disease burden, size of population affected by
disease, urgency of need of care and alternative interventions.
5.2.2.1 Data availability for disease burden criteria
The data for the DALY metric is available in the public domains such as World Health
Organization databases for the year 2016 (World Health Organization (WHO), 2016).
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The data is arranged as cause-specific and age-specific for the prominent diseases, glob-
ally.For this study, the cause-specific data will be most relevant because of the need
to prioritise through the knowledge of the healthcare challenges linked to the disease
burden for the top diseases that are burdening SSA, as provided in Chapter 2.
5.2.2.2 Data availability for disease severity
Disability weights are quantitative estimates of health losses. The data for the different
disability weights for the various diseases found globally can be found from GBD studies
(Haagsma et al., 2015). The GBD study that was conducted in 2013 estimated disability
weights for 235 health states. The disability weights that will be considered for this
study will be for the top diseases burdening SSA.
5.2.2.3 Data availability for size of population affected by disease
The data for the incidence or prevalence rate is available from the GBD study (Murray,
2015a). It would be ideal to use prevalence because it give the number of people affected
by a disease over a period of time. In the case where prevalence data is not available
incidence, of a disease is used instead (Husereau et al., 2010; Miot et al., 2012).
5.2.3 Data availability for intervention outcome-related criteria
In order to determine the availability of data on intervention outcomes, a literature
review is performed to get information on the clinical trials or clinical evaluation of
wearable sensors. These outcomes outline how effective and safe an intervention is
when being used to address a healthcare challenge.
5.2.3.1 Data availability for patient outcomes criteria
The data for the patient outcomes of the wearable sensors are not available for some of
the diseases being considered for this study. The data is acquired through randomised
clinical trials and systematic reviews. The information on the improvement of patient-
reported outcomes may be available for wearable sensors designed to monitor NCDs
but not for infectious diseases. This is because devices for cardiovascular diseases (AiQ,
2016) and diabetes are already available on the market (Abott, 2016). Due to the fact
that wearable devices have not yet been applied to many of the diseases for which its
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application is being considered in this research, the improvement of patient-reported
outcomes criteria can not be used for prioritisation of interventions in this research.
5.2.3.2 Data availability for effectiveness or efficacy criteria
The effectiveness of the wearable sensors is challenging to determine because of the
scarcity of clinical trials on the applications that are being suggested for this study
(Burri et al., 2011). Therefore for this study efficacy is going to be used for prioritisa-
tion. Efficacy is the capability of a health intervention to produce the desirable health
outcomes.
Efficacy data for the wearable sensors is available in the form of accuracy, sensitiv-
ity1 and specificity2. This data is available in literature where various investigations
have been conducted to determine the performance of these wearable sensors. There-
fore, this information is necessary because it shows whether the sensor can deliver
accurate outcomes that meet the medical requirements.
5.2.3.3 Data availability for number of people benefiting criteria
The estimates of the number of people to benefit from the wearable sensors can not
be determined now before a detailed business model is produced. The business model
will be designed specifically to address the tackling of the diseases in SSA. Therefore,
the data is not available and this criteria will be excluded from further considerations
(Tromp and Baltussen, 2012).
5.2.4 Conclusion: Availability of data for priority-setting
In summary the short list of the criteria that will be used further for this study are:
(See illustration in Figure 5.3.)
• For the economic category, the unit costs of the sensors will be used;
• For the knowledge of need category, the following three criteria will be used:
1Sensitivity is the ratio of the incremental change in the sensor’s output to the incremental change
of the measured input (Du, 2015)
2Specificity (also known as selectivity) is the sensing system’s ability to measure a target measured
in the presence of others interferences (Du, 2015).
118
Stellenbosch University  https://scholar.sun.ac.za
5.3 Scoring the defined criteria
(i) burden of disease;
(ii) disease severity;
(iii) size of population affected by the diseases;
• Intervention outcomes in the form of efficacy
Figure 5.3: Categories for the selected criteria
5.3 Scoring the defined criteria
The criteria that are identified during priority-setting can easily be contradicted in
terms of importance. Therefore, there is a need to determine the weights for the defined
criteria (Baltussen and Niessen, 2006). The different weights allow rank ordering of
interventions so that it becomes easier when prioritising based on a composite score.
5.3.1 Composite score
A composite score is the total score for the intervention against each criteria that will
be considered. This score is used to rank the different interventions that are being
investigated. The composite score is dependent on the weights attached to each eval-
uation criterion that reflect the relative importance of each criterion. Each criterion is
assigned a numerical score based on the scale developed. The more favourable options
are given a higher score and less favourable options score lower. The scoring can be
based on a value function, which translates the weight on the criterion to a value score
on the scale (Baltussen et al., 2006). The methods that can be used to determine this
composite score include the simple linear additive evaluation model, analytical hierar-
chy process and outranking methods.
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The simple linear additive evaluation model is applied when it can either be proved,
or reasonably assumed, that the criteria are preferentially independent 1 of each other.
The linear model shows how an option’s values on the many criteria can be combined
into a composite score. This is done through multiplication of the value scored for
each criterion by the weight of that criterion, and then adding all those weighted scores
together (Baltussen et al., 2006). The formula that can be used to determine the
composite score is
Si =
∑
j
wjxij (5.3.1)
where Si is the composite score of the i
th intervention, wj is a predetermined weight
of the jth criterion and xij is assigned quantitative score of each criteria.
5.3.2 Weighting methods
As discussed, criteria can be given either equal or differentiated weights, reflecting the
relative importance of the various criteria. Assigning differentiated weights significantly
influences outcomes of the composite score (Freudenberg, 2003) and this approach
should therefore only be followed after careful consideration. Greater weight should
be given to components which are considered to be more significant in the context of
the composite score. The different criteria can be weighted using different approaches
namely equal weighting, statistical models and participatory methods (Freudenberg,
2003; Nardo et al., 2005; Pizzol et al., 2017).
Equal weighting is when all the variables are given the same weight. When there
is insufficient knowledge of causal relationships or a lack of consensus then a prudent
approach is to assign all the variables an equal weighting in the composite score (Nardo
et al., 2005; Pizzol et al., 2017). For instance, Youngkong et al. (2012) performed a
study where they had to perform a multi-criteria decision analysis for health inter-
ventions that are in the universal health coverage benefit package in Thailand. In this
study, the panel agreed to use the equal weighting method because they could not meet
1Preferential independence is when the preference order over one attribute does not change regard-
less of where the values are fixed.
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a consensus on the weights to be used.
Statistical models that are considered for the weighting methods include principal
component analysis, regression analysis and factor analysis. These could be used to
group individual criteria according to their degree of correlation. In order for this
method to be applied there needs to be a correlation between the different criteria
(Freudenberg, 2003; Nardo et al., 2005). For example, in a study performed by Bal-
tussen et al. (2007), they used the regression analysis method to determine the weights
for the different criteria that can be used for a decision-making process to determine if
a lung-health programme should be implemented in Nepal.
The participatory method includes the involvement of various stakeholders such as
subject matter experts, citizens and government officials. These stakeholders assist in
the assigning of weights for the different criteria defined. This approach is feasible at the
national level when there is a well-defined base of evidence to motivate differentiating
between the relative importance of the various criteria. For international comparisons
the challenge is that the results are likely to be contradictory as the value that is at-
tached to various criteria likely differs from one region or country to another, based on
contextual factors. Opinion-based weighting approaches can be quite subjective and
introduce new distortions to a composite score (Nardo et al., 2005). In previous studies
the weights that were used were dependent on the opinion that was provided by the
public, health providers and government officials (Miot et al., 2012; Noorani et al., 2007)
For this study the method that is selected is equal weighting because there is insuf-
ficient knowledge of the causal relationship between the different criteria. Conducting
a participatory method and obtaining weightings from health experts and the public is
beyond the scope of this research.
5.4 Criteria scales
This section provides the scale that will be used to ensure that the various technologies
and their potential applications are evaluated in a consistent manner for each crite-
rion. The scale simplifies the evaluation and makes it possible to compare criteria with
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different dimensions. The scores that are determined from the scales can be used to
calculate the composite score for each criteria.
In this study, in the event that a criteria is considered to have high priority it is
given a score of 5 and when it has lowest priority it is assigned a score of 1. This is
illustrated in Table 5.4 where a scoring scale is provided for each criterion. The scales
provided in Table 5.4 are briefly discussed::
(i) The most expensive sensors that are currently on the market are approximately
$2000 per unit cost and the lowest cost for the sensors identified in Chapter 3 was
$0.59 (DigiKey Electronics, 2017). Decision-makers favour sensors that have the
lowest unit cost because this shows minimum costs associated with the production
of a single unit.
(ii) Youngkong et al. (2012) used the disability weights to estimate the severity of
diseases based on the GBD study weights (World Health Organization, 2004).
When a person is perfectly healthy the disability weight is 0 and in a fatal condi-
tion it is 1. Therefore, interventions that target fatal conditions are most likely to
be prioritised by decision-makers because they add more value to the healthcare
system.
(iii) The size of population affected by disease indicates the impact of the disease on
the population and can be expressed in terms of prevalence. For this study the
prevalence rate per 100,000 will used to prioritise the diseases. If the prevalence of
the disease affects less than 10 percent of the total population in a specific area it
is defined as a rare disease, receives a low score. In the case when the prevalence
rate is above 30 percent then it is considered as high.
(iv) Burden of diseases is scaled according to the percentage of the DALYs of that
disease to the total DALYs in SSA. According to the World Health Organization
(WHO) (2016) databases the high burden diseases in each region were approxi-
mately 10 percent of the regions’ total DALYs.
(v) Efficacy of wearable sensors was scored based on the scale developed by U.S. Food
and Drug Administration (2013) that stated the lowest accuracy that is acceptable
is 60 percent for medical purposes.
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In addition to these criteria, criterion will be considered to focus on the possible ap-
plications of wearable sensors based on the SMEs feedback. This information data will
be useful in prioritising wearable sensors as it indicates the importance of each sensor.
The application will cover the different stages of care as highlighted in Chapter 4. The
score was based on the responses from the SMEs. In order to have a clearer picture on
the adoptability of wearable sensors a TRL assessment was added as a criterion. The
data is available from literature and will be used to define the levels for the respective
wearable sensors.
Table 5.4 indicates the different scales and the scores that are used to quantify each
criterion shortlisted for this study. The scores will be used in Chapter 6 to determine
the composite score and prioritise the diseases and the wearable sensors.
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Table 5.4: The scores for the different criteria
Criteria Parameter Scale Score Comments
Unit cost US dollar
more than $1501 1
The society favours interventions that are within their
paying capacity and not expensive.
$100-150 2
$50-100 3
$1-50 4
less than $1 5
Severity of the condition Disability weight
less than 0 1 The society is prone to prioritise interventions that target
the severely ill people because of their need for medical
attention. Therefore an improvement in health from a
severe condition is valued more than from a less severe
condition
0,01 -0,2 2
0,21-0,4 3
0,41-0,6 4
more than 0,6 5
Size of population af-
fected by disease
Incidence rate
less than 100 1
Decision-makers may want to give preference to health
interventions that target a larger population because they
have a larger impact for society
100-499 2
500-999 3
1000-1499 4
more than 1500 5
Burden of disease % DALYs in SSA
less than 1 % 1
Interventions that focus on high burden disease are more
likely to be prioritised
2-3 % 2
4-6 % 3
7-9 % 4
more than 10 % 5
Efficacy of health inter-
ventions
Accuracy, specificity
and sensitivity
less than 60% 1
Societies favour interventions that are highly effective
for treatment, rehabilitation, diagnostic and preventative
purposes.
61-70% 2
71-80% 3
81-90% 4
Continued on next page
1The sensors that cost over $500 were based on the manufacturers that produce expensive sensors on the market whereas for the same products
there are sensors available at cheaper prices of less than a $1
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Table 5.4 – Continued from previous page
Criteria Parameter Scale Score Comments
More than 90% 5
Applications of wearable
sensors
Number of identified
applications
less than 1 1
Societies favour interventions that can be used to address
a wide variety of application during disease management.
1 2
2 3
3 4
More than 4 5
Technology Maturity TRL Assessment
TRL 1-2 1
Societies favour interventions that have been fully devel-
oped and can be easily adopted by people with little or
less resistance.
TRL 3 2
TRL 4-5 3
TRL 6-7 4
More than TRL 8 5
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5.5 Conclusion: Define criteria for prioritising wearable
devices
The purpose of this chapter was to define the criteria that can be used to prioritise
the wearable sensors. This process included a literature review to identify the various
criteria that are utilised when prioritising health interventions. Then the lists were
short-listed based on the frequency of use in previous studies and the availability of
data, followed by the description of the scoring methods and motivating the weighting
methods used in this study. Finally, the scales set from previous studies and the score
(from 1 to 5) that will be used for priority-setting were defined. Therefore, Table 5.4
will be used in Chapter 6 to prioritise the diseases and the wearable sensors.
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CHAPTER 6
POTENTIAL OF WEARABLE
SENSORS
This chapter comprises a prioritisation exercise to make recommendations on wearable
technologies applications that have significant potential, presented in Sections 6.1 to
6.4. In Section 6.5 a stakeholder perspective analysis is conducted, which should also
be taken into consideration when further developing the recommended applications.
6.1 Introduction: Prioritisation approach
The prioritisation approach was used to determine the potential of wearable technol-
ogy. The approach highlights the wearable sensors and diseases that will receive high-
est priority when introducing wearable technology in SSA. The prioritisation approach
has been used to determine the potential of health interventions in order to enable
decision-makers to make informed decisions especially in regions that are resource lim-
ited (Kapiriri and Norheim, 2004).
Figure 6.1 shows the process followed for the prioritisation approach. The prioriti-
sation is divided into two different steps namely: (i) feasibility filter, and (ii) impact
and affordability assessment.
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(a) The process followed during Step 1 of the prioritisation approach
(b) The process followed during Step 2 of the Prioritisation Approach
Figure 6.1: The process followed during the prioritization approach
Step 1 of prioritisation is a feasibility filter. During this step only the following two
criteria are considered: efficacy, and TRL. Sensors will be further considered for the
remainder of the study if they pass the specified threshold in terms of both of these
criteria as shown in Figure 6.1a.
Step 2 of the prioritisation is an impact and affordability assessment which relies
on a heat map approach, only sensors that passed the minimum feasibility threshold in
Step 1 are included for consideration in Step 2. The heat maps therefore contain only
the following criteria: DALYs, incidence rate, disease severity, number of applications
and unit cost. In this step efficacy and TRL are omitted from the heat maps as they
have been taken into account during the feasibility filtering performed in Step 1. The
process followed for Step 2 is shown in Figure 6.1b.
The results of the two prioritisation steps inform a qualitative discussion outlining
the potential of wearable technology for each of the diseases discussed in this study.
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Finally, recommendations will be made based on wearable applications that appear to
show significant potential and should therefore be prioritised for development.
6.2 Prioritisation Step 1: Feasibility filter
This section aims at assessing the feasibility terms of the TRL and the efficacy sep-
arately and provide a summary of the sensors that are excluded from further con-
sideration based on a joint consideration of the two criteria. In this section general
recommendations are provided for wearable technology after the TRL assessment.
6.2.1 Technology readiness of wearable sensors
The feasibility cut-off point for the technology readiness is TRL 6 because at this
level the prototype is fully functional and awaiting testing on the subjects. Research
and development of wearable devices is possible through public and private financial
support. The financial support in SSA is focused on the reduction of infectious diseases
such as TB, HIV and malaria. Limited funds will force policy-makers to favour the
introduction of wearable devices that require minimum or no research and develop-
ment costs. Therefore sensors that have a TRL below level 6 will be excluded from the
rest of the study.
6.2.1.1 Technology readiness assessment of sensors
The indicators that were utilised to allocate the wearable sensors in their respective
levels are:
• Research and development–the availability of data on the research conducted
towards the development of the technology.
• Clinical trials–research on the health-outcomes or efficiency of the readings of the
wearable sensors.
• Technical performance–the availability of discoverable technical performance in-
formation.
• Regulatory environment–the maturity of the planning, permitting and standards
relating to the technology.
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• Industry supply chain and skills–the development of a competitive and efficient
industry product and skills supply chain required to support a commercially viable
sector.
Technology maturity is used to determine the level of development and the perfor-
mance of the technology. Figure 6.2 illustrates the maturity of wearable sensors that
have currently been developed.
The accelerometers, magnetic sensors, gyroscopes, pedometer, PPGs, ECG elec-
trodes, pulse oximeter, blood pressure meter, infra-red thermopile, respiratory meter,
biosensor and EEG have reached their technology maturity level TRL 9 where the
technology has undergone all the levels. In the market the demand for accelerometers
is growing and the driving force for the markets are factors such as huge demand from
the consumer electronics industry; stringent government regulations; the emergence of
efficient, economic and compact MEMS technology; growing adoption of automation
and rising demand from emerging economies. Accelerometers have the highest market
share, followed by ECGs and PPGs.
ECG and accelerometers have reached the highest level of commercial readiness
compared to all the devices because of their use in the industry. This is because there
are several types of ECG electrodes being developed and there is immense competition
to produce effective and efficient electrodes for healthcare purposes both at hospital
and home settings. Apple has developed a version of Series 4 smartwatch with an ECG
sensor which has recently been FDA approved will soon be available on the market.
Pedometers, magnetic sensors, blood pressure meter and biosensors are at a stage
where they are experiencing commercial scale-up. During commercial scale-up the
wearable sensors are introduced to the market on a bigger scale and target a bigger
market. Policies are starting to be implemented to regulate the use of these wearable
sensors. The companies that are currently dominating the wearable technology market
are:
• Fitbit • Samsung
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• Apple
• Xiaomi
• ODG
The wearable sensors that are below the threshold are pulse CO-oximetry, transepi-
dermal water loss sensor, electrodermal activity sensor, phonocardiography, EMG elec-
trodes and impedance cardiography. These sensors are still undergoing research and
development and prototypes that have been developed have not undergone clinical
trials, therefore they will not be considered for further studies.
131
Stellenbosch University  https://scholar.sun.ac.za
6
.2
P
rio
ritisa
tio
n
S
te
p
1
:
F
e
a
sib
ility
fi
lte
r
Figure 6.2: The TRL Assessment of the wearable sensors
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6.2.1.2 Infeasible sensors, according to technology readiness assessment
The wearable sensors that are below the threshold include:
• Pulse CO-oximetry;
• Transepidermal water loss sensor;
• Electrodermal activity sensor;
• Phonocardiography; and
• Impedence cardiography.
6.2.1.3 General recommendations based on technology readiness assess-
ment
This section briefly describes the general recommendations that can be made for wear-
able technology after the technology readiness assessment. The general recommenda-
tions that can be made are:
• As of now the wearable sensors that have been identified are already competitive
on the market can be introduced to SSA and will not need much research and
development.
• Perform clinical trials with some of these wearable sensors on people of African
ethnicity as most of the devices were tested on Caucasian people. Previous studies
have proven that PPG’s efficiency is affected by the level of melanin.
• Perform pilot studies and determine the adoption and commercial readiness on
the application of wearable sensors in healthcare facilities in the region.
• Perform a technology acceptance study and get more detail on the factors that
affect the adoption of wearable sensors and the development.
• The introduction of sensors such as accelerometers and gyroscopes will be easier
as already people have been exposed to them through using them in smart phones.
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6.2.2 Efficacy of sensors
In this section the efficacy of the wearable sensors will be assessed using the three
criteria identified in Chapter 5, namely accuracy, sensitivity and specificity. The U.S.
Food and Drug Administration (2013) stated that the lowest accuracy that is acceptable
is 60 percent for medical purposes, the reason being if the wearable sensor is unreliable
it puts the user at high risk. Using the scale developed in Chapter 5 the feasibility
cut-off score is 3.
6.2.2.1 Efficacy assessment of sensors
Table 6.1 provides the data of the wearable sensors that will be used for priority-setting
in Section 6.1. The accuracy of temperature sensors namely infra-red thermopile and
thermistors is stated as the tolerance (as shown in Table 6.1) were the tolerance is
±9.5 ◦C and ±0.2 ◦C, respectively. For the rest of the sensors they utilise ’gain error’
which depends on the magnitude of the input signal and is expressed as a percentage
of the reading, such as 90 percent.
Table 6.1: The data collected on wearable sensors for the prioritisation process
Wearable Sensors Accuracy Sensitivity Specificity Sources
Accelerometer 93% 83% 67% (DigiKey Electronics, 2017;
Yang and Hsu, 2010)
ECG electrodes 97-98% 87,5-
99,34%
91,67-
99,31%
(Digikey, 2017; Guo et al.,
2016; Harmon et al., 2015;
Shyamkumar et al., 2014)
PPG 89 % 91% 88% (NeuroSky, 2016; Yu et al.,
2006),
Respiratory meter
(force sensors), nasal
pressure transducer
75± 13% 92% 72% (BaHammam, 2004; Mouser
Electronics, 2017; Yang et al.,
2015)
EEG electrodes 63% 62-70% 86-90% (Rubin et al., 2014)
Biosensors or Chemi-
cal Sensors
89% (Bruen et al., 2017)
EMG electrodes 80% 77% 71% (DigiKey Electronics, 2017)
Infrared thermopile ±9.5 ◦C (DigiKey Electronics, 2017)
Oximeter 99,47% 100% 100% (Floyd et al., 2015; Jubran,
1999; Khalifa et al., 2012)
Blood pressure meter 44% 80% 68% (Shahbabu et al., 2016)
Continued on next page
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Table 6.1 – Continued from previous page
Wearable Sensors Accuracy Sensitivity Specificity Sources
Gyroscope 78± 1% 91% 92% (DigiKey Electronics, 2017;
Sensonor, 2017)
Pedometer 56% (Husted and Llewellyn, 2017)
Electro-dermal activ-
ity sensor
89% 93,90% 85,36% (Zangro´niz et al., 2017)
Thermistor-negative
temperature coeffi-
cient (NTC) sensor,
nasal or oronasal
thermistor
±0.2 ◦C (Mouser Electronics, 2017)
Magnetic sensors 71% (Kunze et al., 2010; Mouser
Electronics, 2017)
Phonocardiography no avail-
able data
Impedance cardiog-
raphy
no avail-
able data
Transepidermal Wa-
ter Loss Sensor
no avail-
able data
Pulse CO-Oximetry 63,9-
83,1%
43,5-
91,8%
54.5-100% (Barker et al., 2016; DigiKey
Electronics, 2017)
A detailed discussion of the efficacy of the respective wearable sensors is provided
in Appendix E Table E.1.
6.2.2.2 Infeasible sensors, according to efficacy assessment
The wearable sensors that are disqualified based on the threshold efficacy level are:
• Infra-red thermopile;
• EEG;
• Blood pressure meter;
• Pedometer;
• Phonocardiography;
• Impedance cardiography;
• Transepidermal water loss sensor;
and
• Pulse CO-oximetry
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6.2.3 Conclusion: Feasibility filter
This section contains a list of sensors that are excluded from the remainder of the
prioritisation exercise. They were disqualified based on either the TRL assessment or
the efficacy feasibility filtering. The list is as follows:
• infra-red thermopile;
• EEG;
• Blood pressure meter;
• Pedometer;
• Phonocardiography;
• Impedence cardiogra-
phy;
• Electrodermal activ-
ity sensor;
• Transepidermal water
loss sensor; and
• Pulse CO-oximetry
6.3 Prioritisation Step 2: Impact and affordability
This section aims at assessing the impact and the affordability in terms of the following
criteria, defined in Chapter 5: the burden of disease, the severity of the disease, the
size of the population affected, and the unit cost. In addition, considering the number
of potential applications of each sensor for each disease.
6.3.1 Input data: Impact and affordability
This section contains the data that will be used to determine the impact and affordabil-
ity of wearable sensors. Table 6.2 provides the data of the diseases that are considered
for the rest of the study. The data was collected from the WHO database and previous
studies conducted by Beck et al. (2010); Haagsma et al. (2015); Murray (2015a); World
Health Organization (2004) to estimate the incidence rate and disability weights.
Table 6.2: The data collected for the disease burden, incidence rate and disability
weights for the diseases considered for prioritisation
Diseases % DALYs 1 Incidence per 100000
people 2
Disability weights 3
Lower respiratory infections 10,30% 13103 0,28
Diarrhoeal diseases 7,10% 91242 0,11
Preterm birth complications 5,10% 364 0,11
Tuberculosis 2,90% 272 0,27
Neonatal sepsis and infections 2,50% 260 0,28
Continued on next page
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Table 6.2 – Continued from previous page
Diseases % DALYs Incidence per 100000
people
Disease severity
Stroke 2,10% 3158 0,92
Ischaemic heart disease 1,80% 50 0,44
1. % DALY column from World Health Organization (WHO) (2016)
2. Incidence per 100000 people data from Beck et al. (2010); Murray (2015a)
3. Disability weights data from Haagsma et al. (2015); World Health Organization (2004)
Table 6.3 provides the data of the unit cost of the wearable sensors that have passed
the threshold from Step 1.
Table 6.3: The data collected for the unit cost of the wearable sensors
Wearable sensor Unit cost
Accelerometer $0,65
Gyroscope $1.80
Magnetic sensors $0.59 to $0.84
ECG electrodes $43 to $250
PPG $20.95 to 75
Respiratory meter $250
Thermistor $0.67 to 1.88.
Pulse oximeter $20 to $30.
Biosensors or chemical sensors $65 to $87.25.
The data used to select the sensors based on the criteria is based on the SMEs
feedback. If the three respondents gave the same answer for an application then it
is considered viable. The data of the feedback is in Chapter 4. The impact of the
wearable sensor will be determined based on the number of possible wearable sensors
that can be used to address the respective diseases.
6.3.2 Impact and affordability heat maps
The heat maps include only the following criteria: the burden of disease, the severity of
the disease, the size of the population affected, the unit cost, and the number of poten-
tial applications of each sensor for each disease. The sensors that have been disqualified
in Step 1 are excluded from the heat maps. In the heat maps the green-coloured cells
indicate the highest score of 5 and the lowest score of 1 is indicated by the red-coloured
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cells. The scores were based on the information provided in Table 5.4.
The diseases that have the highest burden based on the three criteria of burden of
disease, disease severity and the size of population are (refer to Figure 6.3):
• Lower respiratory infections (see Figure 6.3a);
• Stroke (see Figure 6.3b);
• Diarrhoeal diseases (refer to Figure 6.3d);
• TB (see Figure 6.3e); and
• HIV/AIDS (see Figure 6.3i).
The diseases that have the highest disease impact scores as well as score for all the
sensors are lower respiratory infections (see Figure 6.3a), stroke (see Figure 6.3b), di-
arrhoeal diseases (refer to Figure 6.3d) and tuberculosis (see Figure 6.3e).
Looking at the heat maps the diseases that have the highest potential to apply
wearable technology are ischaemic heart diseases and stroke. They have the highest
potential of wearable sensors that can be used. Based on the unit cost respiratory
meters and ECGs will be excluded because they are pricey.
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(a) Lower respiratory infections (b) Stroke
(c) Diarrhoeal diseases (d) Preterm birth complications
(e) Tuberculosis (f) Neonatal sepsis
(g) Ischaemic heart diseases (h) Birth Asphyxia (i) HIV/AIDS
Figure 6.3: The results for the prioritisation of wearable sensors for the different diseases
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6.3.3 Impact and affordability: Qualitative discussion
This section provides the qualitative discussion of the each of the diseases’ impact and
affordability assessment. The wearable sensors that have an impact will be identified
then further short-listing will be performed based on the unit cost of the wearable sen-
sors.
Lower respiratory infections have a disease severity of 0,28 which is characterised
by coughing, chest tightness, increased breathing rate, breathlessness and wheezing. It
is an acute condition and if not treated can be fatal. The DALYs for LRI is the highest
in the region recording about 10 percent of the total disease burden in the region. The
data in the WHO database indicates that children under the age of five are heavily
burdened by LRI. The incidence rate is approximately 13 000 per 100 000 people in
the population. Based on the feedback from the SMEs, wearable sensors are mainly
used for treatment and diagnostic purposes. The potential applications identified by
the SMEs mainly cater for treatment and diagnostic purposes. The wearable sensors
that will have the highest impact are:
(i) PPG;
(ii) Thermistor;
(iii) Respiratory meter; and
(iv) Pulse Oximeter.
Develop a wearable device that targets children under the age of five because they are
the most susceptible to contract the disease. Based on the disease management of LRI
it is necessary to monitor the temperature for fever and breathing rate for breathless-
ness during treatment and for diagnostic purposes.
Severe acute diarrhoea caused by the rotavirus, shigellosis and cholera has a severity
of 0,11 where the affected person suffers from fluid curtailment. Cholera gravis is the
severest type of diarrhoeal diseases and it is characterised by severe watery diarrhoea,
vomiting and dehydration. The disease burden caused by cholera is high. It occurs as
an endemic in the region causing an average of 2 percent case fatality ratios. SSA has
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the highest proportion of DALYs in the world for diarrhoeal diseases. In high-risk areas
the average is 2 infected people per 1 000 annually. The incidence rate of diarrhoeal
diseases is higher in summer especially in tropical areas. The wearable sensors that
have the highest applications that are above the threshold are:
(i) PPG;
(ii) Thermistor;
(iii) Respiratory meter; and
(iv) Pulse Oximeter.
Develop a wearable device that can measure the fluid level during treatment and di-
agnostic purposes. Patients from diarrhoeal diseases such as cholera lose a lot of elec-
trolytes and fluids as they vomit and pass loose stools.
Preemies are born with underdeveloped organs resulting in complications that can
be fatal. If monitored carefully the baby can be healthy. The complications are depen-
dent on the baby’s weight. The babies born prematurely will either survive, die or live
a life of disability. The disease severity is high. In SSA the incidence rate of preemies
born is 15 percent of total births. Wearable sensors that have highest applications are:
(i) PPG;
(ii) Thermistor;
(iii) Accelerometer;
(iv) Bio-sensor;
(v) ECG;
(vi) Respiratory meter; and
(vii) Pulse oximeter.
The causes of premature complications are unknown 50 percent of the time. De-
velop an intervention that can continuously measure arterial blood gases to regulate
oxygen requirements such as this can be possible using a pulse oximeter. The preemies’
breathing rate needs to be monitored using respirometers as their lungs are not fully
developed. The babies can develop hypothermia therefore there is a need for contin-
uous monitoring of body temperature as they lose heat easily. Bio-sensors are needed
to monitor the body fluid levels and electrolytes composition. Monitoring of high-risk
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pregnant women suffering from diabetes and hypertension is needed using wearable
sensors such as invasive biosensors and blood pressure meters. The monitoring of the
mother’s blood sugar levels if they are diabetic. Bio-sensors can be used to monitor the
preemies for the presence of bilirubin in their urine for liver dysfunctions. The wearable
sensors can be used for treatment and diagnostic purposes.
Tuberculosis is characterised by two levels of severity, depending on whether or not
the infected person has HIV. When a person is infected by HIV and the severity is at
a level of 0,408 and when non-infected it is 0,333. There is a high risk of fatality when
the person is infected by HIV. When the person is under treatment the disease severity
is less as the disease will be contained as long as the patient follows the treatment
religiously. Because of the health interventions that have been developed for TB the
disease burden has reduced over the past years. TB usually affects children under five
and adults above 30 years (these are the ages where the largest part of the population
is infected by HIV). It causes 2.9 percent of the disease burden in the region. The
incidence rate of TB is 272 per 100 000 people in the region. The wearable sensors that
have the highest applications that are above the threshold are:
(i) PPG;
(ii) Thermistor;
(iii) Respiratory meter; and
(iv) Pulse Oximeter.
TB is characterised by persistent cough which is unresponsive to antibiotics. A sensor
can be used that can use a microphone for cough count. The infected person has re-
duced movement which can be monitored using accelerometers and magnetic sensors.
The vital signs that are necessary to measure are temperature and respiratory rate.
The best method for diagnosing TB is the smear test. As identified by the SMEs these
wearable sensors can be applied for treatment and diagnostic purposes.
Neonatal sepsis occurs in stages where there is systemic infection (early sepsis) then
Systemic Inflammatory Response Syndrome (SIRS), organ failure (severe sepsis) and
finally septic shock. The early sepsis is not as severe compared to the septic shock which
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can result in fatality. The severity of neonatal sepsis is approximately 0,28. Neonatal
sepsis accounts for 2,5 percent of the disease burden in the region. The incidence rate
for neonatal sepsis is 260 per 100 000 live births annually. The wearable sensors that
have the highest applications that are above the threshold are:
(i) PPG;
(ii) Thermistor;
(iii) Respiratory meter; and
(iv) Pulse Oximeter.
For a condition such as sepsis there is a need for early recognition by healthcare
providers. When the infection spreads around the body through the bloodstream the
patient will experience a mild hypo-tension which can be detected using the wearable
sensors identified by the SMEs. The wearable sensors will have the highest impact
monitoring the patient for diagnostic and treatment purposes.
Stroke is an acute condition that results in brain attack with a severity scale of
0,92. It is a major cause of disability because the affected person may suffer from
neurological deficits, slight headache, speech deficits, visual problems and confusion.
The disease burden of stroke in SSA is 2,1 percent of the total DALYs in the region.
In SSA stroke affects people in the age group between 30 to 50 which is deemed the
productive age group therefore more YLDs. The incidence rate of stroke is 3158 per
100000 of the population in SSA. Strokes are associated with hypertension, diabetes
and heart diseases. The risk factors are physical inactivity, inadequate diet and alcohol
abuse. The wearable sensors that have the highest applications that are above the
threshold are:
(i) Accelerometer;
(ii) ECG;
(iii) PPG;
(iv) Thermistor;
(v) Magnetic sensors;
(vi) Gyroscope;
(vii) Respiratory meter;
and
(viii) Pulse oximeter.
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Therefore, the wearable sensors can be used for preventive, wellness, diagnosis and
rehabilitative purposes.
Ischaemic heart disease is a chronic condition that can cause acute heart failure.
This condition can be fatal and cause a disease severity of 0,44. This can cause severe
arrhythmias, rupture of ventricular walls, pulmonary or cerebral embolism and recur-
rence. The disease burden of ischaemic heart diseases in SSA are 1,8 percent of the
total DALYs in the region. The incidence rate is relatively low in SSA at an estimated
rate of 50 per 100000 people in the population. It is common amongst the middle aged
people and the elderly. The wearable sensors that have the highest applications that
are above the threshold are:
(i) Accelerometer;
(ii) ECG;
(iii) PPG;
(iv) Magnetic sensors;
(v) Gyroscope;
(vi) Respiratory meter; and
(vii) Pulse oximeter.
Develop a wearable device that monitors the heart activity using ECG and PPG.
The disease is also influenced by lifestyle and wearable devices can be used to monitor
the level of activity using pedometers, accelerometers and gyroscopes. The wearable
sensors can be used for preventive, wellness, treatment, diagnostic, and rehabilitative
purposes.
For HIV the disability weights vary with whether the infected person is on ARV
treatment or not. If the person is on ARVs the disease severity will be 0,135 and when
not on ARVs and it develops to AIDS it is 0,505. Currently, about 66 percent of adults
and 59 percent of children are on ARVs. The disease burden of HIV or AIDS was
estimated to be 7 percent. The incidence rate of HIV or AIDS was estimated to be 2
549 per 100 000 people in the population in 2015. The wearable sensors that have the
highest applications that are above the threshold are:
(i) PPG;
(ii) Thermistor;
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(iii) Respiratory meter; and
(iv) Pulse Oximeter.
Develop wearable devices that will focus mainly on identifying the opportunistic in-
fections. There is a need to assess the vital signs for cardiovascular and respiratory
systems. The wearable sensors are mainly used during treatment and diagnosis of HIV
or AIDS.
Birth asphyxia is when a child’s brain has experienced oxygen deprivation. The
disability weights for the disease is 0.505 which is characterised by seizures, low heart
rate, weak reflexes, not breathing or very weak breathing and too much acid in the
blood. The disease burden affects 5 percent of the population in the region and inci-
dence rate is approximately 20 percent of the live births. Babies born in sub-Saharan
Africa have a very high risk of birth asphyxia. The wearable sensors that have the
highest applications that are above the threshold are:
(i) PPG;
(ii) Thermistor;
(iii) Biosensor;
(iv) Respiratory meter; and
(v) Pulse Oximeter.
The wearable sensors that will be excluded because they are too pricey are ECG
and the respiratory meter because they both have unit cost approximately above $250.
Below is a list of all the diseases and the potential wearable sensors that will have an
impact and relatively affordable.
• Lower respiratory infection–PPG, thermistor and pulse oximeter.
• Diarrhoeal diseases–PPG, thermistor and pulse oximeter.
• Premature birth complications–PPG, thermistor, accelerometer, pulse oxime-
ter, magnetic sensor, gyroscope and biosensor.
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• TB–PPG, thermistor and pulse oximeter.
• Stroke –PPG, accelerometer, magnetic sensor, gyroscope, thermistor and biosen-
sor.
• Ischaemic heart diseases–PPG, accelerometer, magnetic sensor, gyroscope,
pulse oximeter and biosensor.
• HIV or AIDS–PPG, thermistor and pulse oximeter.
• Birth asphyxia–PPG, thermistor, biosensor and pulse oximeter.
A thermistor can serve two purposes; as a temperature sensor and as a respiratory
meter. Biosensors can be used to determine electrolyte composition, blood sugar levels
and urine composition. These wearable sensors that have multiple purposes can be
developed in such a manner that they have algorithms that can be used to interpret
all the readings at once to monitor the patient. The wearable sensors that will most
likely have the highest impact based on the potential application looking at the overall
applications for most diseases are PPGs, thermistors, pulse oximeter and biosensors.
These sensors can be grouped to form a wearable medical kit that can be used for the
monitoring of multiple diseases through the use of complex algorithms.
6.4 Prioritisation conclusion
In this section, recommendations will be made for the diseases that should be prioritised
for the development of wearable technology. The findings will be based on the results
from Section 6.2 and 6.3. The diseases that will be considered based on the potential
applications are ischaemic heart diseases, stroke and premature birth complications.
Ischaemic heart diseases are chronic conditions that require regular monitoring of
heart activity and daily activities. They are monitored using heart rate, respiratory
rate, blood pressure, oxygen saturation, heart electrical activity and urine composition.
From this list the wearable sensors that can be used based on the findings in Section 6.2
and 6.3 are namely: PPG, accelerometer, magnetic sensor, gyroscope, pulse oximeter
and biosensor. Based on the findings the suitable sensors that can be incorporated in
the wearable device for heart monitoring are a PPG and pulse oximeter. The pulse
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oximeter can be used in the diagnosis of acute heart failure using the oxygen satu-
ration. Biosensors can measure the C-reactive protein in bloodstreams, which, when
elevated, indicates inflammation that could be linked to heart attack, stroke, coronary
artery disease, and a host of other medical diagnosis. The other best way to manage
heart diseases is through monitoring daily activities such as step counts using wearable
devices with accelerometers and gyroscopes.
Currently, most of the wearable devices on the market are designed for addressing
heart diseases and are even being sold in SSA. The patient engagement in the monitor-
ing of heart diseases allows patients to monitor and track their own progress, and make
real-time decisions based on the data collected. As a result, they are more likely to take
responsibility for their own health. ECG, blood pressure meter and respiratory meters
are currently pricey therefore research should be put in to ensure the development of
cheaper sensors that can be used in the region. ECG is important because it can be
used for the monitoring of the heart’s electrical activity. Research needs to be done to
determine the adoption rate of these wearable devices in SSA and the acceptability of
this technology. The wearable sensors can be used for preventive, wellness, treatment,
diagnostic and rehabilitative purposes.
Fatality due to stroke is on the rise and can be reduced through making early and
accurate detection. Endovascular therapy within 24 hours of stroke onset is considered
the window of opportunity for treating emergent large-vessel occlusion. The chances
of a good outcome, however, decrease by about 20 percent for every hour that passes
before treatment starts. Therefore, developing a wearable device that can accurately
detect a stroke and warn the paramedics immediately so that they come and attend to
the patient can increase the patient’s chances of survival. Therefore, wearable technol-
ogy for treatment and diagnosis purposes will save a lot of lives and will have a high
impact. Based on the wearable sensors that have been identified for the monitoring of
stroke a device can be developed to monitor the users. Wearable technology can be
used for gait analysis technique. This technique uses 3-axis accelerometers, gyroscopes
and magnetic sensors to detect if the cerebellum is affected and any abnormalities in
locomotion which is a huge sign when someone is experiencing a stroke.
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After experiencing a stroke it is necessary to monitor the blood pressure, heart
rhythm, oxygen saturation, blood glucose and body temperature to prevent the re-
occurrence of another stroke. Wearable technology is necessary because there will be
continuous monitoring and availability of real-time data. The patient can manage their
own health and ensure they live a healthy life so that they avoid the occurrence of
another stroke.
The causes of premature complications are unknown 50 percent of the time. There
is a need to develop an intervention that can continuously measure arterial blood gases
to regulate oxygen requirements. Using wearable technology this can be made pos-
sible using a pulse oximeter. The breathing rate of preemies needs to be monitored
using respirometers as their lungs are not fully developed. These babies can develop
hypothermia, therefore there is need for continuous monitoring of body temperature as
they lose heat easily. Use of biosensors is necessary to monitor their body fluid levels
and electrolyte composition. Monitoring of high-risk pregnant women suffering from
diabetes and hypertension can be done using wearable sensors such as invasive biosen-
sors and blood pressure meters. The monitoring of the mothers’ blood sugar levels if
they are diabetic. Biosensors can be used to monitor the preemies for the presence of
bilirubin in their urine for liver dysfunctions. The wearable sensors can be used for
treatment and diagnostic purposes. At the moment preemies are monitored using inva-
sive methods and it will be great to have an intervention that can monitor the babies
continuously non-invasively. This is where wearable technology comes into play and
babies can be continuously monitored without any pain and the wearable devices can
be used at home by the parents and health practitioners will have access to the data
of the babies and monitor their progress after being discharged.
6.5 Stakeholder perspective analysis
As wearable technology is likely to be introduced in the African health systems it will
be ideal to have an understanding of all the parties involved in the delivering of care
to the patients. The purpose of this analysis is to understand how these entities are af-
fected by the healthcare challenge and to determine their requirements (or their stake)
in how it is addressed. This analysis carries forward the findings from the SMEs about
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the intended users of wearable technologies and concludes how each of them influence
the adoption rate. Stakeholders have different perspectives. For instance, some will
benefit if the healthcare challenge is addressed, but others may be adversely affected.
Uncovering these perspectives and any potential conflicts is critical to shaping and
refining the needs statement and needs criteria. It also allows the innovator to antici-
pate resistance, as well as to define and prioritise the requirements that will shape the
eventual solution to maximise its chance of adoption among the most important and
influential stakeholders.
For these reasons, stakeholder analysis should start early in the innovation process,
while needs are being identified and assessed. It can then be repeated as more infor-
mation becomes known and progress is made. The data for the stakeholder analysis
will be determined from the feedback received from the clinical subject matter experts
and previous studies.
6.5.1 Stakeholder analysis of the intended users
Figure 6.5 illustrates the different stakeholders are:
(i) Patients;
(ii) Physicians;
(iii) Nurse Practitioners;
(iv) Health care facilities; and
(v) Medical insurers.
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Figure 6.4: The potential stakeholders involved in wearable technology in healthcare
as per feedback from SMEs.
In order to understand the stakeholders it is necessary to have an understanding
of the cycle of care. The cycle of care analysis indicates the interaction between the
patients and the medical system. There is a need for the understanding of disease
management in the different stages of care and the parties involved at each stage.
In Figure 6.5, the cycle of care is mapped out to show the interaction between
the medical system and the patients. Initially, the patient will be healthy and will be
monitored using wearable devices and real-time data is captured and analysed. Below
are the steps followed during the generic wearable technology cycle of care:
• In a case where the patient is critical and the paramedics are required then the
patients medical history and vital signs readings are sent to them. This data will
be utilised so that the paramedics can immediately identify what is wrong with
the patient.
• In another instance the data is automatically sent to the physician especially
when an anomaly is detected in real time. The physician can either call in the
patient for further laboratory tests or the physician can review the data and make
a diagnosis based on the data recorded from the patient.
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• During the treatment process the patient is monitored using a wearable device to
monitor their progress either at home or in the hospital setting.
Figure 6.5: Cycle of care analysis for wearable devices.
Once all key stakeholders in a clinical area have been identified, comprehensive
analysis can be performed to further evaluate the barriers that might cause a stake-
holder to resist the adoption of a new innovation, as well as the benefits that may drive
their adoption. An effective stakeholder analysis analyses the costs and benefits to each
stakeholder identified. Direct costs and benefits should be considered (for example loss
or gain in revenue, decrease or increase in profitability, decrease or increase in time
away from work).
The analysis summarises the key stakeholders, outlines the primary benefits and
costs associated with a new solution to address the defined need, and provides a sub-
jective assessment of the overall net impact of a new technology on each stakeholder
(see Table 6.4, 6.5, 6.6 and 6.7).
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Table 6.4: Patients’ stakeholder interests
Clinical out-
comes
Safety Convenience Perceived risk
Reduced invasive-
ness
Monitoring using a
wearable device has
minimal risk associ-
ated with it.
It can be used in real-time and can be worn as a
watch. The battery life can be of concern to the user
because that would mean downtime when the device
is being charged. Internet connectivity and might re-
quire training for proper use of the device. Wearable
technology allows for the patient to monitor their own
vitals.
Security issues, reliability of the data. Reaction to
the technology may vary based on people’s view
on technology. Technology forward people will be
willing to try out wearable technology. Then those
that have techno-phobia will be reluctant to adopt
the technology
Table 6.5: Physicians’ stakeholder interests
Agency Clinical outcomes Risks Work-flow Ease of use Reputation
Concerns
with confi-
dentiality of
the patient’s
medical
history
and data
collected.
Provide more ac-
curate diagnosis
because of the avail-
ability of data and
assistance of the
complex algorithms
that can be utilised
to detect anoma-
lies in the patient’s
health
The reliability of
the data may re-
sult in a doctor
making a wrong
call resulting in
malpractice and
put risk on the
life of the patient.
Wearable technology re-
quires for the medical to be
trained on how to use it and
the workflow will include
having regular access to
data that reports on the
patients and giving medical
expertise remotely without
them coming to the hos-
pital. Remote monitoring
of outpatients. Reduce the
number of patient visits.
Wearable technology will
ease the work of doc-
tors especially those that
have conditions that re-
quire regular monitoring.
Can be used for preven-
tive purposes, treatment
and diagnostic purposes.
This will require train-
ing to improve technical
skills
This will increase their repu-
tation for giving efficient ser-
vices and are up to date with
their patients. The introduc-
tion will reduce their visibil-
ity but they will be in con-
stant interaction with their
in or out patients. This will
increase patient satisfaction.
In SSA there are less practi-
tioners compared to the pa-
tients therefore wearable de-
vices will increase access.
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Table 6.6: Medical facilities stakeholder interests
Economic Impact Risk Reputation
Increase of capital expenditure–the hospital and patients will re-
quire access to a PDA, computers and reliable internet connection.
Reduce the number of visits by patients and stays in hospitals as
they can be monitored remotely.
Wearable technology may put the
hospital at risk of the patients med-
ical records being hacked.
A hospital can gain momentum for being
technology forward and can attract a cer-
tain group of early adopters.
Table 6.7: Medical insurers stakeholder interests
Clinical outcomes Competition Reputation
Wearable technology has the potential to
improve the health of a person longer
term.Through the elimination of symptoms
earlier before they prevail or even drug side
effects for conditions such as HIV/AIDS.
In SA medical insurers have already started encour-
aging the use of wearable devices and they collect the
data. Momentum and Discovery have already started
encouraging the use of wearable devices in order to
give incentives. This has attracted a lot of health-
conscious patients.
Wearable technology is perceived as costly
at the moment and payers may be reluc-
tant based on this fact as there are other
cheaper alternative forms of treatment.
Table 6.8: The stakeholder analysis summary
Stakeholders Primary Benefits Primary Costs Assessment of net impact
Patients Increased accessibility, Self-management,
Better care received, Quality of life, Re-
duced mortality and morbidity
Need for wearable device, smart
phone and Internet costs.
Negative: The costs required for patient to
use the wearable device efficiently include inter-
net costs, the device and training of use wearable
devices.
Continued on next page
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Table 6.8 – Continued from previous page
Stakeholders Primary Benefits Primary Costs Assessment of net impact
Physicians Increased access to patient data, Better
care given, increased reputation, increased
flexibility and reduced follow up visits, less
administrative work, Easy referrals espe-
cially with the transfer of data
Learning technical skills and avail-
ability of regular and reliable In-
ternet connection
Positive: This will ease the work of the doctors
and there will be more effective in the provision of
their services as they will be reduced paper work
and data will be at their disposal. Physicians
are more likely to embrace a technology that ease
their work and does not alter their work-flow.
Facilities Networking of patient data, increase their
reputation, increased satisfaction of per-
sonnel, more efficient use of hospital re-
sources.
Transmitter purchase, Internet
connections such as LAN and Wi-
Fi. Mobile devices for the person-
nel, database servicing, set up a
helpline, data analysis, patient ed-
ucation, restructuring of the hos-
pital departments.
Negative: The capital expenditure that the hos-
pital might potentially face will be high in order to
set up the wearable technology system. Most hos-
pitals in the region do not have access to Internet
connections and electronic medical records.
Medical In-
surers
Easy access to data on patient’s health-
care use, better patient care, management
of healthcare system
Transmitter, fewer cost-intensive
clinical events
Positive: Less cost will be incurred by the payers.
They can possibly set up an incentive programme
were people are promoted for healthy living there-
fore improving the quality of life of the patients
especially for NCDs which have high health ex-
penditures.
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6.5 Stakeholder perspective analysis
Patients are the primary stakeholders in this instance. Based on the information
on the stakeholder interests presented in Table 6.4 it shows that the primary benefits
of wearable technology from the patient’s perspective are increased access to health
practitioners, improved care delivery, increased quality of life and reduced mortality as
well as morbidity. The primary costs are associated with acquiring the wearable device
and the internet costs associated with the transfer of data. Weighing on the benefits
and costs of wearable technologies on the patient, the technology will negatively im-
pact them and they might face some level of resistance, the main reason being the costs
associated with the use of a wearable device daily especially data cost for the synchro-
nisation of data from the wearable device to the hospital server ?. Wearable technology
can increase the access of patients to healthcare providers especially in remote areas. In
SSA there are already early adopters that have started incorporating wearable devices
mainly for fitness tracking. Therefore, these are the people that view wearable devices
positively. On the other hand the majority of the people will view the technology as a
luxury and very pricey based on the costs associated with using the device.
With mHealth technologies, the data collection applications can monitor and track
health indicators in real time providing insight on valuable data enabling health work-
ers to better serve the patients and patients to be more proactive in their own health.
There are always concerns by health providers on the issue of liability. The main con-
cern is the issue of security and accuracy of the data collected. Therefore the doctor
will need to have constant access to data. The primary costs are associated with train-
ing of physicians, the technical skills and Internet connections but the overall impact
of the technology is positive.
In SSA there is limited access to the Internet because of the high costs of data and
low Internet connectivity. Most hospitals still use traditional paper-based methods and
it may take time for them to use electronic medical records because of the high cost of
set-up and maintenance as this requires more IT people working in the hospital as part
of the hospital staff. This is due to poor existing infrastructure, frequent power outages
and network failure. In facilities with electronic records, use is sub-optimal because of
the need for parallel entry of data to paper and computer which increases the workload
of overstretched staff. Hospitals will have to increase the capacity of computers and
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tablets giving doctors real-time access to their patients data increasing the accuracy of
diagnosis and treatment. The introduction of wearable technology in the hospital will
increase capital expenditure and direct cost. The main challenge is the fact that most
hospitals are not equipped for proper data analytics and data overload as there will be
real-time readings. Therefore, wearable technology from the viewpoint of the facilities
in SSA may have a negative impact as more has to be done to develop a functional
system.
Medical insurers can benefit through offering incentives for healthy living, therefore
reducing the health expenditure. This helps promote people to increase health through
improved lifestyle (Shekar, 2012). In South Africa there is Momentum, a medical
insurer, they have an initiative called Active Dayz™which gives you points when you
reach 10 000 steps using a wearable device. These rewards points will then be used for
cash back and discounts on Momentum products.
6.5.2 General recommendations based on the stakeholder perspective
analysis
The recommendations to ensure reduced resistance from the intended stakeholders of
wearable technology:
• At the moment in SSA there is a lack of healthcare providers that are technically
versed. There is a need to train the healthcare providers on how to be more
technically versed and use wearable devices effectively. The healthcare providers
will need to know how to interpret the data presented to them. The patients also
need to be trained on how to use the device accurately so that reliable readings
are collected.
• Design a wearable device that will be user friendly to the end users. In previous
studies they have gathered that wearable technology users stop using the device
within 6 months. More research has to be performed to determine why the end
users stop using the devices.
• The use of incentives by medical insurers to ensure better quality of life for their
patients and allowing them the capability to monitor the patients’ data and their
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activity levels. This will allow them to reduce their expenditure on patients
especially for chronic diseases that can be prevented through a change in lifestyle.
• Improve the ICT platforms that can be used by patients, healthcare providers,
medical facilities and medical insurers to improve the assess to data and ensure
infrastructures are set up to increase connectivity.
• Perform a detailed cost analysis (economic impact and opportunity cost) so that
facilities can perform a detailed cost-benefit analysis. In literature there is a
lack of information on cost-analysis for the use of mHealth technologies especially
wearable technologies as this is an emerging technology.
6.6 Conclusion: Prioritisation of wearable technology
This chapter presented the prioritisation exercise of the wearable sensors and short-
listed diseases in SSA. The results from the prioritisation exercise were presented. Re-
sults were discussed in detail and general recommendations were made. Finally the
stakeholder perspective analysis was presented for all the entities that will be affected
by the introduction of wearable devices.
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CHAPTER 7
SUMMARY AND CONCLUSIONS
This chapter intends to provide a summary of the research findings of each chapter,
discuss the research contributions and recommendations for future studies.
7.1 Project summary
The project aimed at determining the potential of wearable technology in SSA based
on the disease landscape. A prioritisation approach was used to determine the wearable
sensors that will have the highest impact based on the feasibility, impact and afford-
ability. A stakeholder perspective analysis was performed and is discussed.
Chapter 1 introduced the project, rationale, research design and methodology and
research structure. Chapters 2 and 3 presented the background to the disease landscape
and wearable technology. Chapter 2 introduced the comprehensive overview of diseases
in SSA. This included information on the quantifying of diseases, cost-effectiveness
analysis, communicable and non-communicable diseases. Finally,the chapter presented
the data of the SSA disease landscape based on DALYs, and fatality rate and disease
were selected for further studies. Chapter 3 provided the background of the wearable
technology landscape well as the key enabling technologies associated with wearables.
Based on the data collected of the wearable devices in Appendix B, Table B.7 the key
enabling technologies were identified and an TRL assessment to determine the technol-
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ogy maturity was carried out.
Chapter 4 presented the feedback that was collected from the interviews conducted
with clinical SMEs who provided information based on their expertise to identify the
physiological signs, stages of care and intended user(s) of wearable technology for the
respective diseases. The data was used to cross-reference the diseases to wearable sen-
sors using the physiological signs identified by the SMEs.
In Chapter 5, a brief description of the prioritisation approach was presented and
previous studies were used to define the sets of criteria that were used for the priori-
tisation of wearable sensors. The defined sets of criteria were short-listed by checking
the availability of data. The methods that are used for the prioritisation of wearable
devices were described briefly and the one that was going to be considered for the rest
of the study was selected. The criteria scales were set based on the data from literature
and how they scaled the set of criteria in those studies.
Chapter 6 discussed the prioritisation approach was performed in two steps namely:
(i) feasibility filtering and (ii) impact and affordability assessments. This was used to
identify the wearable technology that would have the highest impact in the region and
the diseases that would be addressed effectively using wearable devices. Based on these
findings general recommendations were made. A stakeholder perspective analysis gave
an idea of the adoption of the technology based on how the intended user(s) perceive
wearable technology. Chapter 7 discussed the project summary, research contribution
and the possibility of future work.
7.2 Research Findings
The main finding from this study was that the wearable sensors that are feasible to
be introduced to the region are accelerometer, PPG, Thermistor, pulse oximeter, gyro-
scope, magnetic sensor and biosensors. The exercise to reach this conclusion is presented
in Figure 7.1. The first step in assessing the feasibility was in terms of the TRL and
efficacy separately. The TRL had a cut-off point at TRL 6 where the prototype has
been developed and can start being used for clinical trial. A couple of sensors were
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considered to be infeasible according to the TRL. Considering the wearable sensors the
data of their efficacy was used to determine their performance and if they meet the rec-
ommended FDA standards. A collective of the wearable sensors that were considered to
be infeasible by both the TRL and efficacy assessment were disregarded for the rest of
the study, as they require more work for development and improved performance. This
would be a burden for SSA based on its stringent resources and healthcare expenditure
funds.
Step 2 aimed at assessing the impact and affordability of the wearable technology.
This is performed using the set of defined criteria from Chapter 5 which were: disease
burden, disease severity, incidence rate, applications and unit cost of the wearable sen-
sors. The impact was determined using the heatmaps. For each disease the wearable
sensors that would have the highest impact were considered based on the number of
possible applications for the different stages of care. The final list of wearable sensor
was selected based on the unit cost (as shown in Figure 7.1). The diseases that were
considered to benefit immensely from wearable technology were ischaemic heart dis-
eases, stroke and premature birth complications. These diseases were selected based:
(i) on the applications; (ii) a large number of feasible wearable sensors that can mon-
itor the disease; and (iii) the data can be used to detect diseases with conclusive results.
Figure 7.1: The findings from the study
Based on the stakeholder analysis the patient will be resistant to wearable devices
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because of their current price. An average person in the region can not afford to buy
a wearable device. However, the elite or early adopters have already started using
wearable devices to monitor their daily activities. Physicians will appreciate the use
of wearable devices as this will ease their work and allow them to be more effective
in their provision of healthcare services. Wearable devices will not disrupt their work
flow but will make it easier by allowing them to have access to data, to make informed
decisions and to reduce the chances of inaccurate diagnosis. The downside will be that
the physicians would have to go through training on how to interpret the data and
make sound recommendations for patients. Overall, the physicians will be receptive to
wearable devices.
The medical facilities will have to incorporate the use of wearable technology in
their structures by restructuring of the hospital departments or divisions. The avail-
ability of wearable devices will allow for the medical facilities to use their resources
efficiently. The downside is the capital expenditure associated with the introduction
of wearable technology infrastructure. Most hospitals in the region are still developing
ICT platforms for their hospitals therefore integration of wearable technology will be
financially intensive as a system has to be built from the ground up.
The medical insurers are advocating the use of wearable technology to increase the
health of their medical insurance users through self-management. They encourage the
improvement of lifestyle through incentives. For example Momentum has a programme
called Multiply whereby users get points if they take 10 000 steps a day and do a
work-out that burns a certain amount of calories. This will reduce members’ health
expenditure by reduction of cost-intensive clinical events.
7.3 Research contributions
This research contributes to both the academic literature and the potential introduction
of wearable technology in the SSA health systems.
(i) It adds to the academic literature by providing an approach that can be used to
determine the potential of wearable technology in SSA through prioritisation.
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(ii) It documents the current SSA disease landscape and the wearable technology
landscape.
(iii) It assesses the feasibility of the current wearable sensors that have been developed
through TRL and efficacy assessment and can be introduced in SSA with minimal
work as product development will require more resources.
(iv) It adds to the literature by identifying the wearable sensors that can be applied
in SSA to address the prominent diseases based on their impact and affordability.
(v) The project provides information on the different stakeholders’ perspectives and
the potential resistance they might raise based on how they perceive wearable
technology.
(vi) The data limitations faced in this study were presented with regard to health
economics, specifically budgetary impact, cost-effectiveness and opportunity cost
and this may inform future research.
7.4 Opportunities for further work
It is recommended that the following opportunities are explored further to add value
to determining the potential of wearable technology in SSA:
(i) Conduct interviews and develop a framework that can be used for the technology-
acceptance model specifically for wearable technology. This study will be used to
determine other factors that can lead to resistance against wearable devices in
SSA that can be used by developers and decision-makers.
(ii) Future studies can be performed by increasing a defined set of criteria by adding
cost-effectiveness and budget impact. These will assist policy-makers in identify-
ing the wearable devices that will be sustainable, based on the costs and health
outcomes of the users. The data will be essential especially for countries or regions
that are resource limited.
(iii) Use the approach that was developed on a country level and develop a business
model for wearable technology in healthcare on different settings either hospital
setting or country setting. Business models provide insight on how wearable
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devices can be made economically feasible through value creation and revenue
streams.
7.5 Closing summary
In Chapter 7 a summary of the project was described, and the research findings were
provided. Thereafter, the contributions of this research were explained, and the possible
opportunities for furthering this research were described.
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APPENDIX A
MORE DETAIL ON THE DISEASE
LANDSCAPE
The appendix presents additional information on the global disease landscape in the
form of cause-specific mortality mentioned in Chapter 2. The other section describes
the diseases that are being considered in this study.
A.1 The top causes of deaths in the different global re-
gions
This section provides information on the causes of deaths in the different regions in
the world according to the World Health Organization (WHO) (2016) database. The
different regions are: East Asia and Pacific (Table A.1), Europe and Central Asia (Table
A.2), Latin America and Caribbean (Table A.3), Middle East and North Africa (Table
A.4), North America (Table A.5) and South Asia (Table A.6).
Table A.1: Causes of Death in East Asia and Pacific
Rank Causes of death Deaths thousands
(000)
1 Stroke 3 012
2 Ischaemic heart disease 2 459
3 Chronic obstructive pulmonary disease 1 284
4 Trachea, bronchus, lung cancers 872
5 Lower respiratory infections 673
6 Liver cancer 547
Continued on next page
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A.1 The top causes of deaths in the different global regions
Table A.1 – Continued from previous page
Rank Causes of death Deaths thousands
(000)
7 Alzheimer disease and other dementias 471
8 Stomach cancer 432
9 Diabetes mellitus 421
10 Road injury 408
11 Kidney diseases 373
12 Hypertensive heart disease 365
13 Cirrhosis of the liver 328
14 Colon and rectum cancers 280
15 Tuberculosis 253
16 Self-harm 229
17 Oesophagus cancer 227
18 Falls 174
19 Pancreas cancer 128
20 Breast cancer 121
Table A.2: Causes of Death in Europe and Central Asia
Rank Causes of death Deaths thousands
(000)
1 Ischaemic heart disease 2 423
2 Stroke 1 136
3 Alzheimer disease and other dementias 417
4 Trachea, bronchus, lung cancers 411
5 Chronic obstructive pulmonary disease 333
6 Lower respiratory infections 260
7 Colon and rectum cancers 259
8 Diabetes mellitus 174
9 Cardiomyopathy, myocarditis, endocarditis 172
10 Breast cancer 160
11 Hypertensive heart disease 142
12 Kidney diseases 140
13 Stomach cancer 138
14 Self-harm 127
15 Pancreas cancer 120
16 Prostate cancer 119
17 Cirrhosis of the liver 115
18 Falls 94
19 Lymphomas, multiple myeloma 88
20 Road injury 80
Table A.3: Causes of Death in Latin America and Carribean
Rank Causes of death Deaths thousands
(000)
1 Ischaemic heart disease 534
2 Stroke 280
Continued on next page
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A.1 The top causes of deaths in the different global regions
Table A.3 – Continued from previous page
Rank Causes of death Deaths thousands
(000)
3 Diabetes mellitus 243
4 Lower respiratory infections 233
5 Interpersonal violence 167
6 Chronic obstructive pulmonary disease 153
7 Road injury 119
8 Kidney diseases 105
9 Cirrhosis of the liver 98
10 Trachea, bronchus, lung cancers 76
11 Alzheimer disease and other dementias 68
12 Hypertensive heart disease 62
13 Stomach cancer 56
14 Colon and rectum cancers 55
15 Prostate cancer 53
16 Congenital anomalies 51
17 Breast cancer 49
18 HIV/AIDS 46
19 Self-harm 45
20 Preterm birth complications 38
Table A.4: Causes of Death in Middle East and North Africa
Rank Causes of death Deaths thousands
(000)
1 Ischaemic heart disease 455
2 Stroke 227
3 Collective violence and legal intervention 108
4 Lower respiratory infections 94
5 Diabetes mellitus 94
6 Road injury 86
7 Alzheimer disease and other dementias 81
8 Cirrhosis of the liver 77
9 Kidney diseases 67
10 Preterm birth complications 53
11 Congenital anomalies 48
12 Chronic obstructive pulmonary disease 45
13 Hypertensive heart disease 42
14 Cardiomyopathy, myocarditis, endocarditis 32
15 Trachea, bronchus, lung cancers 29
16 Birth asphyxia and birth trauma 29
17 Breast cancer 27
18 Liver cancer 24
19 Lymphomas, multiple myeloma 21
20 Colon and rectum cancers 21
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Table A.5: Causes of Death in North America
Rank Causes of death Deaths thousands (000)
1 Ischaemic heart disease 517
2 Alzheimer disease and other dementias 287
3 Chronic obstructive pulmonary disease 195
4 Trachea, bronchus, lung cancers 182
5 Stroke 145
6 Lower respiratory infections 87
7 Diabetes mellitus 87
8 Colon and rectum cancers 70
9 Kidney diseases 64
10 Breast cancer 53
11 Self-harm 50
12 Cirrhosis of the liver 50
13 Pancreas cancer 45
14 Lymphomas, multiple myeloma 44
15 Hypertensive heart disease 41
16 Falls 38
17 Road injury 37
18 Prostate cancer 37
19 Drug use disorders 36
20 Cardiomyopathy, myocarditis, endocarditis 33
Table A.6: Causes of Death in South Asia
Rank Causes of death Deaths thousands
(000)
1 Ischaemic heart disease 1 915
2 Chronic obstructive pulmonary disease 1 051
3 Stroke 982
4 Lower respiratory infections 802
5 Tuberculosis 603
6 Diarrhoeal diseases 530
7 Preterm birth complications 474
8 Diabetes mellitus 402
9 Road injury 340
10 Cirrhosis of the liver 314
11 Kidney diseases 304
12 Self-harm 230
13 Birth asphyxia and birth trauma 225
14 Falls 220
15 Hypertensive heart disease 193
16 Congenital anomalies 166
17 Alzheimer disease and other dementias 162
18 Neonatal sepsis and infections 161
19 Asthma 146
20 Rheumatic heart disease 132
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A.2 Detailed description of the top diseases
A.2 Detailed description of the top diseases
This section provides detailed information on the diseases that are being considered in this studies. For
each diseases there is a short description of the signs and symptoms, causes, preventative measure and
treatments.
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Table A.7: Detailed descriptions of the top leading disease in Sub-Sahara Africa in 2015
Disease Description Signs and Symptoms Causes Preventative Mea-
sures
Treatments
HIV/AIDS It is a retro- virus that
affects the immune sys-
tem of infected per-
sons by destroying cer-
tain white blood cells,
called T-cells, which the
body relies on to fight in-
fection. (Mayosi et al.,
2009)
Initial stages have flu-like
symptoms. In due course,
start suffering from diseases
that indicate a weak im-
mune system namely TB,
shingles, oral or vaginal
thrush and herpes simplex
virus. If the immune system
is suppressed to less than
200 then the person is con-
sidered to have AIDS
Transmitted through body
fluids mainly blood, semen
and vaginal fluid. It is
mainly transmitted through
sex, sharing sharp objects
with an infected person,
through mother-to-child
transmission through preg-
nancy, giving birth and
breastfeeding
No vaccine available.
Use of condoms to
prevent the transmis-
sion during sexual in-
tercourse.
Antiretroviral drugs
can be used to re-
duce the viral load of
HIV in the body and
delay the progres-
sion of HIV infection
to AIDS. The use
of Nevirapine to re-
duce mother-to-child
transmission.
Lower res-
piratory
infections
These infections include
acute bronchitis and
bronchiolitis, influenza
and pneumonia
For bronchitis the cough
is typically a yellow-grey
phlegm. Then the infected
person suffers from a sore
throat and wheezing. Pneu-
monia - symptoms occur af-
ter 24 to 48 hours. Cough
which may be dry or pro-
duce thick yellow, green,
brown or blood-stained mu-
cus. May experience diffi-
culty breathing, rapid heart
beat, fever, sweating and
shivering, chest pain, and
loss of appetite. Then
influenza the infected per-
son gets a fever, feels tired
and weak, headache, general
aches and pains, dry chesty
cough.
Identifying the causative
agents for bronchitis is
quite difficult. In the
clinical studies they have
managed to identify less
than 30% of the causative
agents. Almost 90 % of
the causes are related to
viruses such as adenovirus,
coronvirus, para-influenza,
influenza and rhino-virus
and 10 % to bacteria such
as Bordetella Pertussis.
Respiratory syncytial virus
is the most common cause
of severe acute infection of
bronchiolitis.
For influenza it
can be prevented
using antivirals such
as adamantanes
and neuraminidase
vaccination
For the treatment of
bronchitis and pneu-
monia use antibiotics
Continued on next page
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Table A.7 – Continued from previous page
Disease Description Signs and Symptoms Causes Preventative Mea-
sures
Treatments
Diarrhoeal
diseases
this is passing of three
or more loose or liquid
stools per day. Diar-
rhoea is a symptom of
an infection. Types of
diarrhoea are : cholera,
dysentry and frequent
diarrhoea
dehydration resulting in
thirst, decreased skin elas-
ticity, sunken eyes. In
severe cases shock, with
diminished conciousness,
lack of urine
Can be caused by bacterial ,
viral, parasitic organisms
safe drinking water,
use of improved san-
itation, hand wash-
ing with soap, exclu-
sive breastfeeding for
the first six months
of life, rotavirus vac-
cination
Use of oral rehydra-
tion salts solution,
intravenous drip,
zinc supplements
Malaria Caused by Plasmodium
parasite.
Fever, headaches, chills
and vomiting if not treated
within 24 hours it can
progress to severe illness,
often leading to death. In
children the following symp-
toms may occur such as
severe anaemia, respiratory
distress or cerebral malaria.
The parasites are spread to
people through the bites of
infected female Anopheles
mosquitoes, called malaria
vectors.
Vector control is the
main way to reduce
and prevent malaria.
The two forms are
use of insecticide-
treated mosquito
nets and indoor
residual spraying.
Antimalarial drugs
(chemoprophylaxis)
are used to prevent
travellers from get-
ting infected. Drugs
for pregnant women
in order to avoid
transmission.
Treatment using
artemisinin-based
combination therapy
(ACT).
Continued on next page
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Table A.7 – Continued from previous page
Disease Description Signs and Symptoms Causes Preventative Mea-
sures
Treatments
Stroke occurs when the blood
supply to part of your
brain in interrupted or
severely reduced, depriv-
ing brain tissue of oxy-
gen and nutrients
trouble with understanding
and speaking and paralysis,
numbness of the face, arm
or leg, trouble with seeing in
one or both eyes, headache
and trouble with walking
may be caused by a blocked
artery or leaking or bursting
of a blood vessel
Lower the blood
pressure by reducing
salt content, avoid
high-cholesterol, be
more active through
exercise, and quit
smoking. Lose
weight by trying not
to eat more than
1500 to 2000 calories
a day. Exercise more
ad treat diabetes
Thrombolysis is a
treatment to dissolve
dangerous clots in
blood vessels or
surgery.
Pre-term
birth com-
plications
these are deliveries that
occur at less than 37
weeks gestational age.
Some of the signs are in-
fection or inflammation,
uteroplacental ischaemia
or haemorrhage, uterine
overdistension, stress and
other immunologically
mediated processes.
spontaneous labour with in-
tact membranes, pre-term
premature rupture of the
membranes and labour in-
duction, black race, pe-
riodontal disease and low
maternal body-mass index,
short cervical length and a
raised cervical vaginal foetal
fibronectin concentration.
use of maternal
progesterone supple-
mentation, surgical
closure of the cervix
with cerclage, pre-
vention of exposure
of pregnant women
to cigarette smoke,
judicious of fertility
treatments and dedi-
cated pre-term birth
prevention clinics.
treating intra-
uterine infections,
improvements in
maternal nutrition
and lifestyle modifi-
cations to ameliorate
maternal stress, use
of papillomavirus
vaccination in girls
and women
Continued on next page
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Table A.7 – Continued from previous page
Disease Description Signs and Symptoms Causes Preventative Mea-
sures
Treatments
Birth
asphyxia
and birth
trauma
Asphyxia means lack of
oxygen. Birth asphyxia
happens when a baby’s
brain and other organs
do not get enough oxy-
gen, during or right after
birth. Cells cannot work
properly and this waste
products build up in the
cells and cause tempo-
rary or permanent dam-
age.
baby is not breathing or
breathing very weak. Skin
colour is bluish or pale,
heart rate is low muscle
tone is poor or reflexes are
weak, too much acid in the
blood the amniotic fluid is
stained with meconium (first
stool) the baby is experienc-
ing seizures.
too little oxygen in the
mother’s blood before and
during birth. Problem
with the placenta separat-
ing from the uterus too soon.
Very long or difficult deliv-
ery. Baby airway is blocked,
anaemia
Using a cardiograph
for screening the fa-
tal well-being during
labour and to iden-
tify the possibility of
asphyxia
Breathing sup-
port until they can
breathe well enough
on their own, In a
severe case then a
mechanical venti-
lation, respiratory
therapy, fluid and
medicine to control
blood pressure and
prevent seizures.
Ischaemic
heart
disease
Also known as coronary
heart disease. In which
a waxy substance called
plaque builds inside the
coronary arteries. The
function of these arteries
is to supply oxygen-rich
blood to your heart mus-
cle.
Angina is chest pain or dis-
comfort that occurs if an
area of your heart does
not get enough oxygen-rich
blood, shortness of breath,
heart attack, arrhythmia is
a problem with rate of the
heart beat.
There are a risk factors
associated with the dis-
eases namely: a family
history of heart disease,
high blood pressure, smok-
ing, high cholesterol, obe-
sity, sedentary lifestyle.
This can be pre-
vented by making
lifestyle changes such
as maintaining a
healthy diet and
avoiding high risk
behaviours includ-
ing smoking and
excessive alcohol
uptake.
Medications and
surgery depending
on the severity of the
damage done to the
heart. Changing to a
healthy lifestyle.
Continued on next page
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Table A.7 – Continued from previous page
Disease Description Signs and Symptoms Causes Preventative Mea-
sures
Treatments
Tuberculosis it is an infectious dis-
ease caused by Mycobac-
terium tuberculosis as
well as other mycobacte-
ria species such as M. bo-
vis and M. africanum
The symptoms are:
lethargy, weight loss,
fever and night sweats. The
infection affects the lungs
resulting in coughing, chest
pain and coughing up blood
and sputum.
TB is spread when the germs
of the infected person are re-
leased into the air through
coughing, sneezing and talk-
ing and inhaled by another
person
Early detection sys-
tems to avoid the
spread of the dis-
ease by identifying
the infected people
effectively. Vacci-
nation using the
TB vaccine called
Baccillus Calmette-
Guerin (BCG). TB
treatment can be ad-
ministered to avoid
the recurrence of
TB especially people
who had active TB.
Coughing etiquette,
when someone is
infected they should
contain their sputum
and should sleep
alone.
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APPENDIX B
MORE DETAIL ON WEARABLE
TECHNOLOGY
This appendix contains additional information on topics presented and discussed in Chapter 3.
B.1 Structured Review
In this section, the findings from the structured review described in Section 3.3.
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B.1.1 Detailed Inclusion and Exclusion Criteria
Table B.1: Inclusion and exclusion criteria of the different articles reviewed
P
a
p
e
r
N
u
m
b
e
r
Reference Paper Title I n
c
l
u
s
i
o
n
E
x
c
l
u
s
i
o
n
Reason for selection
1 Pantelopoulos
and Bour-
bakis (2010)
A survey of wearable sensor-based systems for health
monitoring and prognosis
X Describes components in a wearable system
such as physiological sensors, transmission
modules and processing capabilities (real time
decision support systems)
2 Chan et al.
(2009)
Smart homes - Current features and future perspec-
tives
X Describes components such as vital signs,
sounds, images and body motion measured,
communication means (wireless or wired net-
works), sleep patterns, daily activities. Soft-
ware used for data analysis and application
3 Tao et al.
(2012)
Gait analysis using wearable sensors. X Application of the device and features of wear-
able sensors
4 Xinguo Yu
(2008)
Ambulatory monitoring of physical activities in pa-
tients with Parkinson’s disease
X Describes the components necessary for mon-
itoring such as sensors, data analysis
5 Salarian et al.
(2007)
Approaches and principles of fall detection for elderly
and patient
X Focuses on characteristics of falls and methods
of fall detection
6 Shull et al.
(2014)
Quantified self and human movement: A review on
the clinical impact of wearable sensing and feedback
for gait analysis and intervention
X Clinical applications, wearable sensors used,
diseases that can be monitored using gait anal-
ysis
7 Zhang and
Sawchuk
(2013)
Human daily activity recognition with sparse repre-
sentation using wearable sensors
X Focuses on sparse representation using wear-
able sensors
8 Pantelopoulos
and Bour-
bakis (2008)
A survey on wearable biosensor systems for health
monitoring
X Important features that can be used to best
desccribe the functionality and characteristics
of wearable biosensors.
Continued on next page
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Table B.1 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
Reference Paper Title I n
c
l
u
s
i
o
n
E
x
c
l
u
s
i
o
n
Reason for selection
9 Raveendranathan
et al. (2012)
From modeling to implementation of virtual sensors
in body sensor networks
X Focuses on modelling and implementation of
Virtual sensors
10 Alam and
Hamida
(2014)
Surveying wearable human assistive technology for
life and safety critical applications: Standards, chal-
lenges and opportunities
X Describes the Applications, characteristics
and requirements of wearable technologies
11 Riazul Islam
et al. (2015)
The Internet of things for health care: A comprehen-
sive survey
X Reviews network platforms, applications, se-
curity and privacy features for wearables in
healthcare.
12 Zollo et al.
(2011)
Quantitative evaluation of upper-limb motor control
in robot-aided rehabilitation
X Provides a performance indices on patient mo-
tor
13 Zhang and
Sawchuk
(2012)
Motion primitive-based human activity recognition
using a Bag-of-Features approach
X Describes human activity modelling and
recognition using wearable sensors
14 Lee et al.
(2016)
A radial basis classifier for the automatic detection of
aspiration in children with dysphagia
X Focuses on the development of a classifier for
automatic classification of aspiration and swal-
low vibration signals non-invasively recorded
on the neck of children with dysphagia
15 Amjadi et al.
(2016)
Stretchable, Skin-Mountable, and Wearable Strain
Sensors and Their Potential Applications: A Review
X Review of wearable strain sensors - applica-
tions, characteristics of strain sensors material
16 Egbogah and
Fapojuwo
(2011)
A survey of system architecture requirements for
health care-based wireless sensor networks
X Review of wireless sensor networks - architec-
ture of hardware and framework of software.
17 Chio-In Ieong
et al. (2012)
Title: A 0.83-µW QRS detection processor using
quadratic spline wavelet transform for wireless ECG
acquisition in 0.35-µm CMOS
X Describing how a processor functions to detect
arrhythmia using a wireless ECG
18 Fu et al.
(2015)
Title: A Bayesian approach for sleep and wake clas-
sification based on dynamic time warping method
X Describes an approach that is used to classify
sleep and wake.
Continued on next page
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Table B.1 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
Reference Paper Title I n
c
l
u
s
i
o
n
E
x
c
l
u
s
i
o
n
Reason for selection
19 Trung and
Lee (2016)
Title: Flexible and Stretchable Physical Sensor Inte-
grated Platforms for Wearable Human-Activity Mon-
itoring and Personal Healthcare
X Provides characteristics that are used for flex-
ible and stretchable physical sensors and ap-
plications
20 Ugulino et al.
(2012)
Title: Wearable computing: Accelerometers’ data
classification of body postures and movements
X Focuses on data analysis method - human ac-
tivity recognition
21 KATAYAMA
et al. (2009)
Channel model on various frequency bands for wear-
able Body Area Network
X Article in Japanese and unavailable
22 Attal et al.
(2015)
Physical human activity recognition using wearable
sensors
X Comparing the different algorithms that can
be used for human activity recognition
23 Chavez-
Santiago
et al. (2012)
Title: Cognitive radio for medical body area networks
using ultra wideband
X Provides the architect of medical body area
networks (MBAN)
24 Watanabe
et al. (2011)
A preliminary test of measurement of joint angles and
stride length with wireless inertial sensors for wear-
able gait evaluation system
X Provides a wearable sensro system for gait
evaluation
25 Xu et al.
(2012)
Title: Equation environment coupling and interfer-
ence on the electric-field intra-body communication
channel
X Investigates the effects of the environment on
the EF-IBC channel.
26 Van
Helleputte
et al. (2014)
18.3 A multi-parameter signal-acquisition SoC for
connected personal health applications
X Investigates a multi sensor interface
27 Cruz et al.
(2008)
The future of extra corporeal support X Characteristics of implantable devices
28 Jara et al.
(2011)
Title: Mobile IP-based protocol for wireless personal
area networks in critical environments
X Investigates the use of low-power personal area
networks.
29 Chen et al.
(2009)
Title: A design of power supply for neonatal moni-
toring with wearable sensors
X Describes the components necessary for
neonatal monitoring with wearable sensors.
Not available
Continued on next page
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Table B.1 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
Reference Paper Title I n
c
l
u
s
i
o
n
E
x
c
l
u
s
i
o
n
Reason for selection
30 Xie et al.
(2012)
Title: Heterogeneous integration of bio-sensing
system-on-chip and printed electronics
X Focuses on the circuits that are used in bio-
sensing applications.
31 Banos et al.
(2014)
Title: PhysioDroid: Combining Wearable Health
Sensors and Mobile Devices for a Ubiquitous, Con-
tinuous, and Personal Monitoring
X Describes a wearable systems for health mon-
itoring
32 Hu et al.
(2008)
Title: Low-cost wireless sensor networks for remote
cardiac patients monitoring applications
X Describes a wireless sensor network that is
used by wearable devices and proposes a sen-
sor network system that composes of wearable
vital sign sensors and workstation monitor.
33 Naslund et al.
(2015)
Title: Feasibility of popular m-health technologies for
activity tracking among individuals with serious men-
tal Illness
X It provides a study on the acceptance of activ-
ity tracking devices.
34 Tolkiehn et al.
(2011b)
Title: Direction sensitive fall detection using a triax-
ial accelerometer and a barometric pressure sensor.
X The wearable system used for fall detection
35 Khattak et al.
(2011)
Title: Towards smart homes using low level sensory
data
X The wearable sensor-based system used to
monitor Alzheimer’s
36 Jayakumar
et al. (2014)
Title: Powering the Internet of Things X The main components that make a wearable
system
37 Butala et al.
(2012)
Title: Wireless system for monitoring and real-time
classification of functional activity
X The main components of wearable devices
used for health monitoring.
38 Cavalli et al.
(2010)
Title: Hemodialysis: Yesterday, today and tomorrow X Describes an innovative technology for
hemodialysis
39 Gaggioli et al.
(2014)
Title: Experiential virtual scenarios with real-time
monitoring (interreality) for the management of psy-
chological stress: A block randomized controlled trial
X It is a study of how virtual reality can help
improve physiological sensors.
40 Tolkiehn et al.
(2011a)
Title: Direction sensitive fall detection using a triax-
ial accelerometer and a barometric pressure sensor
Repeated
Continued on next page
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Table B.1 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
Reference Paper Title I n
c
l
u
s
i
o
n
E
x
c
l
u
s
i
o
n
Reason for selection
41 Ren et al.
(2007)
Title: Experimental evaluation of on-body transmis-
sion characteristics for wireless biosensors
X Comparing the wireless and wired connections
for bio-sensors.
42 Sankaralingam
and Gupta
(2012)
Title: Effects of bending on impedance and radia-
tion characteristics of rectangular wearable antenna
utilizing smart clothes
X Characteristics of a garment-integrated wear-
able device.
43 Hovsepian
et al. (2015)
Title: CStress: Towards a gold standard for continu-
ous stress assessment in the mobile environment
X Development of a stress model used for data
collection
44 Liu and Xiao
(2011)
Title: Temporal accountability and anonymity in
medical sensor networks
X Provides the characteristics of medical sensors
and wearable devices
45 Mahoney
and Mahoney
(2010)
Title: Acceptance of wearable technology by people
with alzheimers disease: Issues and accommodations
X Features necessary for wearable devices for
Alzheimers diseases
46 Lewis et al.
(2007)
Title: Using an electronic activity monitor system as
an intervention modality: A systematic review
X Focuses on the different tracking devices.
47 Ghasemzadeh
et al. (2015)
Title: Power-aware computing in wearable sensor net-
works: An optimal feature selection
X Focuses on features of data analysis techniques
48 Cole et al.
(2014)
Title: Dynamical learning and tracking of tremor and
dyskinesia from wearable sensors
X Testing of wearable sensors algorithms for
tracking of tremor and dyskinesia
49 Bofeng Zhang
et al. (2012)
Title: State of the art in gait analysis using wearable
sensors for healthcare applications
X Focuses on the walking analysis using inertial
sensors.
50 Ribeiro et al.
(2011)
Title: A novel dry active biosignal electrode based on
an hybrid organic-inorganic interface material
X Focuses on the characteristics of the ECG elec-
trodes
51 Di Rienzo
et al. (2010)
Title: Linear and fractal heart rate dynamics dur-
ing sleep at high altitude: Investigation with textile
technology
X Focuses on the characteristics of sleep using
wearable device
Continued on next page
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Table B.1 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
Reference Paper Title I n
c
l
u
s
i
o
n
E
x
c
l
u
s
i
o
n
Reason for selection
52 Hansora et al.
(2015)
Title: Performance of hybrid nano-structured con-
ductive cotton materials as wearable devices: An
overview of materials, fabrication, properties and ap-
plications
X Focuses on the application, characteristics of
different cotton textiles used for wearable de-
vices.
53 He et al.
(2015)
Title: User privacy and data trustworthiness in mo-
bile crowd sensing
X Characteristics of mobile crowding sensing
54 Tanantong
et al. (2014)
Title: Toward continuous ambulatory monitoring us-
ing a wearable and wireless ECG- Recording system:
A study on the effects of signal quality on arrhythmia
detection
X Comparison of 5 well-known arrhythmia clas-
sification algorithms
55 Samanta et al.
(2014)
An energy efficient, minimally intrusive multi-sensor
intelligent system for health monitoring of elderly
people
X Describes the features of wearable systems.
(Not available)
56 Cipresso et al.
(2012)
Title: Inter-reality in the evaluation and treatment of
psychological stress disorders: The INTERSTRESS
project
X Focuses on the evaluation and treatment of
psychological stress disorders
57 Chen et al.
(2011)
Title: Wearable electromyography sensor based
outdoor-indoor seamless pedestrian navigation using
motion recognition method
X Describes the different motions that can be
measured using EMG sensors
58 Segerst˚ahl
and Oinas-
Kukkonen
(2011)
Title: Designing personal exercise monitoring em-
ploying multiple modes of delivery: Implications from
a qualitative study on heart rate monitoring
X Investigates the characteristics of heart rate
monitoring using wearable devices
59 Chan et al.
(2012)
Title: Smart wearable systems: Current status and
future challenges
X
60 Lukowicz
et al. (2004)
Wearable systems for healthcare applications X
Continued on next page
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Table B.1 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
Reference Paper Title I n
c
l
u
s
i
o
n
E
x
c
l
u
s
i
o
n
Reason for selection
61 Patel et al.
(2012)
A review of wearable sensors and systems with appli-
cation in rehabilitation
X
62 Swan (2012) Sensor Mania! The Internet of Things, Wearable
Computing, Objective Metrics, and the Quantified
Self 2.0
X
B.1.2 Detailed Structured Review Findings
Table B.2: Sensing Technology
P
a
p
e
r
N
u
m
b
e
r
References Hardware description Physiological signals or vital signs or measurable
1 Pantelopoulos and
Bourbakis (2010)
miniature sensors such as skin/chest electrodes, arm cuff-
based monitor, temperature probe or skin patch, piezo-
electric, pulse oximeter, galvanic skin response, phono-
cardiograph, strip-base glucose meters, scalp-placed elec-
trodes, accelerometer. Smart textiles, actuators, power
supplies, control and processing units.
Biosignals–electrocardiogram (ECG), blood pressure,
body or skin temperature, respiration rate, oxygen sat-
uration, heart rate, perspiration or skin conductivity,
heart sounds, blood glucose, electromyogram (EMG),
electroencephalogram (EEG), body movements
2 Chan et al. (2009) Sensors - accelerometer, thermal conductivity sensor,
skin temperature sensor, skin electrical conductivity, two
lead ECG, respiratory meter, enzyme electrodes
Vital signs or biomedical signals - blood pressure, respi-
ration, body temperature, heart or pulse rate, body or
weight or fat, blood oxygenation, ECG, activity, blood
glucose
Continued on next page
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Table B.2 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Hardware description Physiological signals or vital signs or measurable
3 Tao et al. (2012) Sensors - accelerometer, gyroscope and magnetoresis-
tive, flexible goniometer, piezoelectic fabric, force sen-
sors, electromyography (EMG) sensor, video cameras
motion, mobility, fall
4 Salarian et al. (2007) Sensors - bi axial accelerometer, gyroscope
5 Shull et al. (2014) Sensors - accelerometer, gyroscope, magnetometers, go-
niometer, force sensitive resistor, bend sensors, electric
field sensor
motion, mobility, fall
6 Pantelopoulos and
Bourbakis (2008)
miniature sensors such as skin/chest electrodes, arm cuff-
based monitor, temperature probe or skin patch, piezo-
electric, pulse oximeter, galvanic skin response, phono-
cardiograph, strip-base glucose meters, scalp-placed elec-
trodes, accelerometer. Smart textiles, actuators, power
supplies, control and processing units, microcontroller
board.
Heart rate, blood pressure, body and skin temperature,
ECG
7 Alam and Hamida
(2014)
sensors - accelerometer, gyroscope, gas sensor physiological parameters: temperature, blood pressure,
heart pulse rate, energy expenditure, stress level, glucose
concentration, blood flow, ECG, respiratory rate, blood
pH etc. Surrounding environment: toxic gases, humidity,
heat, etc. location using GPS position. Body movement:
body posture and orientation, activity, fall detection, etc.
EMG, EEG, blood oxygenation
8 Riazul Islam et al.
(2015)
medical terminals into hybrid computing grids. Sensors-
EEG sensor, BP sensor, EMG sensor, ECG sensor.
Vital signs - blood pressure, body temperature, ECG and
oxygen saturation
9 Egbogah and Fapo-
juwo (2011)
sensors such as pulse oximeters, electrocardiographs and
accelerometers. Battery power, physiological monitors
(sensors), GUI display information
Continued on next page
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Table B.2 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Hardware description Physiological signals or vital signs or measurable
10 Trung and Lee (2016) Electrodes of electrogram systems, rigid circuit boards,
power supplies, temperature sensor, pressure sensor
(Piezoelectric) and strain sensors. Temperature sensors
- pyroelectric detectors, resistive temperature detectors,
thermistors
ECG, EEG, EMG, body and skin temperature, blood
pressure, pulse, skin strain and infared radiation. The
voice, heart beat rate, muscle movement, bodily motion.
11 Cruz et al. (2008) Solute sensor and volume sensor. Control module solute concentration
12 Banos et al. (2014) mobile 12 lead ECG, plethysmogram, wearable monitor-
ing device, radio frequency transceiver
measure ECG, heart rate, oxygen saturation, Blood flow
rate, non-invasive blood pressure, skin temperature, fluid
status, posture, activity, acceleration data. Measuring
physiological and behavioural data.
13 Hu et al. (2008) Sensor board ECG, heart rate, pulse oximeter, blood pressure
14 Khattak et al. (2011) wireless sensor network, video, accelerometer, 2D camera
and 3D camera,
location and physiological data and environmental data
15 Butala et al. (2012) sensors, micro-electro-mechanical systems (MEMS) de-
vices, low powered, microcontroller, accelerometer, gy-
roscope, coin cell battery, circuit board, smart phone,
laptop or computer, graphical user interface (GUI) , RF
Transceiver
ECG/EKG, pulse, blood oxygen, blood glucose, temper-
ature, gait, limb movement, etc.
16 Sankaralingam and
Gupta (2012)
17 Liu and Xiao (2011) micro-electro-mechanical systems (MEMS), cryptogra-
phy, and digital electronics,
ECG, heart rate, blood pressure, pulse oximetry
18 Mahoney and Ma-
honey (2010)
ECG sensors, accelerometers, fall detection, breathing and heart rate, skin temperature
and activity
19 Segerst˚ahl and
Oinas-Kukkonen
(2011)
EMG sensors, gyroscope EMG, human locomotion,
Continued on next page
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Table B.2 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Hardware description Physiological signals or vital signs or measurable
20 Chan et al. (2012) Microfluidics and micro-fabrication. Sensors: skin elec-
trodes, scalp-placed electrodes, accelerometer, piezoelec-
tric, phonograph, glucose meter, pulse oximeter, temper-
ature probe or skin patch, woven metal electrodes.
body and skin temperature, heart rate, ECGs, EEGs,
EMGs or blood oxygenation, activity, mobility fall, res-
piration rate, heart sounds, blood glucose, galvanic skin
response
21 Lukowicz et al.
(2004)
Textile sensors, textile actuators, ultra-thin solar cells,
power generation device, microsystems that contain a
sensor, power generators and processor, electronic sen-
sors,
22 Patel et al. (2012) Wearable sensors, sensing , body worn sensors, PPG sen-
sor, microphone, biochemical sensors, glucose monitor,
pH sensor, accelerometer,
heart rate, respiratory rate, blood pressure, blood oxygen
saturation, muscle activity, body temperature, position,
movement
23 Swan (2012) Sensors - accelerometer, GSR sensor, temperature sensor,
heart rate sensor, glucose monitors, battery technology
movement, sound, light, electrical potential, tempera-
ture, moisture, location, heart rate, heart rate variability,
galvanic skin response or skin conductivity, ECG, EMG,
EEG, PPG
Table B.3: Disease(s) or condition(s)
Paper Number References Disease(s) or Condition(s)
1 Pantelopoulos and Bourbakis (2010) Parkinson’s disease, epilepsy seizure detection,chronic diseases such as
CVD, sleep apnoea,
2 Chan et al. (2009) Diseases such as asthma, diabetes, chronic obstructive pulmonary dis-
ease, heart diseases.
3 Tao et al. (2012)
4 Salarian et al. (2007) Parkinson’s disease motor abnormalities such as tremor, bradykiesia
and gait
Continued on next page
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Table B.3 – Continued from previous page
Paper Number References Disease(s) or Condition(s)
5 Shull et al. (2014) osteoarthritis, Parkinson’s disease, hemiplegia, head trauma, Improving
walking stability, reduce joint loading
6 Pantelopoulos and Bourbakis (2008)
7 Alam and Hamida (2014)
8 Riazul Islam et al. (2015)
9 Egbogah and Fapojuwo (2011)
10 Trung and Lee (2016) Malignancy and cancer, diabetic foot ulceration, hypertension, CVD,
sleep apnea, Parkinson’s disease, posture and movement, wound healing
11 Cruz et al. (2008) Congestive heart failure, kidney failure
12 Banos et al. (2014) cardiac arrhythmias, sleep disorders, ischeamic cardiac events
13 Hu et al. (2008) cardiac diseases
14 Khattak et al. (2011) Alzheimer’s disease, heart attacks
15 Butala et al. (2012) Parkinson’s disease
16 Sankaralingam and Gupta (2012)
17 Liu and Xiao (2011) patient’s physical status
18 Mahoney and Mahoney (2010)
19 Segerst˚ahl and Oinas-Kukkonen (2011) human locomotion,
20 Chan et al. (2012) Cardiovascular diseases, diabetes mellitus, renal diseases, respiratory
diseases, cancer, posture, motion control, neurological disorders and
brain simulation, Parkinson’s disease, stress, recognizing emotions, sud-
den infant death syndrome
21 Lukowicz et al. (2004)
22 Patel et al. (2012) congestive heart failure, chronic obstructive pulmonary disease, stroke
survivors
23 Swan (2012) mental performance optimisation, emotion reading, mapping and man-
agement programs
Table B.4: ICT - Data Communication
Paper Number References Communication Devices
Data Transfer
Wired connec-
tions
Wireless connections
Continued on next page
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Table B.4 – Continued from previous page
Paper Number References Communication Devices
Data Transfer
Wired connec-
tions
Wireless connections
1 Pantelopoulos and
Bourbakis (2010)
Smart phones, PC and lap-
tops and Central node -
Personal Digital Assistant
(PDA) or a microcontroller
board.
Wired networks Wireless communication - short-range such
as Body area network (BAN) include Blue-
tooth and ZigBee. Long range data
transmission to a remote station or de-
vice - WLAN, GSM, GPRS, UMTS and
WiMAX.
2 Chan et al. (2009) PDA Wired - Telecommu-
nications systems,
connections in tex-
tiles,
Wireless networks to a service centre,
GPRS, Telecommunications systems,
3 Tao et al. (2012)
4 Salarian et al. (2007)
5 Shull et al. (2014)
6 Pantelopoulos and
Bourbakis (2008)
Central node - Personal
Digital Assistant (PDA)
or a microcontroller
board.Smart phones, PC
and laptops
Wired networks. Wireless communication - short-range such
as Body area network (BAN) include Blue-
tooth and ZigBee. Long range data
transmission to a remote station or de-
vice - WLAN, GSM, GPRS, UMTS and
WiMAX.
7 Alam and Hamida
(2014)
Smart phones Wireless sensor networks, WiFi Access
Points or Broadband Cellular networks eg
GSM, GPRS, 3G, LTE, etc. Personal
Area Network (PAN) - Bluetooth, Blue-
tooth Low Energy (BLE), Wireless sensors
network (WSN) - Zigbee and Ultra Wide-
band (UWB) and Wireless Local Area Net-
work (WLAN) - WiFi.
8 Riazul Islam et al.
(2015)
laptops, smart phones, gate-
ways
Networks: WiMAX, Internet protocol (IP)
network and global system for a mo-
bile (GSM) and access service networks.
WPAN, WBAN, 6LoWAN, WSN, UWB,
BLE, NFC, RFID
Continued on next page
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Table B.4 – Continued from previous page
Paper Number References Communication Devices
Data Transfer
Wired connec-
tions
Wireless connections
9 Egbogah and Fapo-
juwo (2011)
PDA devices, Network gate-
ways
relay points, Routing
methodology : mul-
ticast, intra-cluster
and inter-cluster
data relay
Internet, wireless sensor networks,
10 Trung and Lee (2016) transmission mod-
ules
11 Cruz et al. (2008) PDA Wireless network. Direct connection
12 Banos et al. (2014) Mobile device can be smart
phone or tablet. Gateways
Bluetooth connection, WiFi or 3G net-
work. API platform. Apple iOS platform
and Android,
13 Hu et al. (2008) wearable devices, receiv-
ing stations, Wireless sensor
network grouped into 2 de-
vices: mobile platforms and
receiving station. Mobile
platforms: patient data col-
lection are distributed using
wearable devices.
USB connections. wireless sensor networks, data transfer
through the workstation using a MATLAB
server is created to transfer from a Java
runtime environment into the MATLAB
workspace via local host connection, IEEE
802.15.4-compliant radio capabilities.
14 Khattak et al. (2011) Gateway such as PDAs or
cell phones, GPRS modem.
Body networks
15 Butala et al. (2012) Dongle, mobile devices such
as smart phone, laptop or
computer,
Near field communication, wireless
connection- Bluetooth (IEEE 802. 15.1),
ZigBee (IEEE 802. 15.4) and ANT.
Android and iOS operating systems.
API used to configure, transmit and
receive messages to and from the dongle.
Smartphone App
16 Sankaralingam and
Gupta (2012)
Wearable antenna plays an
important role in the opti-
mal design of wearable de-
vices
Bluetooth industrial, scientific and medical
(ISM) band used for WLAN applications.
Continued on next page
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Table B.4 – Continued from previous page
Paper Number References Communication Devices
Data Transfer
Wired connec-
tions
Wireless connections
17 Liu and Xiao (2011) PDA which can be wearable
device
Wired channels can
also be used to trans-
fer information to the
remote center
Wireless communication. Wireless trans-
mission of data to monitor centers via a
wireless channel.
18 Mahoney and Ma-
honey (2010)
Remotely communicate the location using
GPRS or GSM network
19 Segerst˚ahl and
Oinas-Kukkonen
(2011)
20 Chan et al. (2012) Gateways - PDA as a wear-
able computer.Smart phones
Data transmission via wireless body com-
munication networks. The Body area net-
work (BAN) consists of wearable sensor
Then Personal Area Network (PAN) can
include smart phone sensor, video sensor,
and environmental sensors. Gateways that
operate via a wide area network (WAN)
such as WLAN, GSM, GPRS, UMTS and
WiMAX, 4th generation (LTE), Bluetooth
and ZigBee. Application program interface
(API),
21 Lukowicz et al.
(2004)
mobile computers and
PDAs, mobile phones,
Bluetooth, wireless LAN (WLAN), con-
nection using a BAN, cellular connection
22 Patel et al. (2012) mobile phones or personal
computers,
Wireless communication using Internet,
ZigBee and Bluetooth tethering communi-
cation systems. Ultra-wide-band (UWB)
impulse radio, Information transmitted to
hospital servers. Data transmitted from
sensor network to information gateways
such as mobile phones or personal comput-
ers. Universal broadband connectivity, 4th
generation (LTE),
Continued on next page
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Table B.4 – Continued from previous page
Paper Number References Communication Devices
Data Transfer
Wired connec-
tions
Wireless connections
23 Swan (2012) mobile phones Wi-Fi, Bluetooth, ANT, ZigBee, USB, 2G,
3G, and 4G. Bluetooth low-enery (BTLE),
API for example Dropbox, Facebook, Fit-
bit, Flickr, Instagram
Table B.5: ICT - Data handling
P
a
p
e
r
N
u
m
b
e
r
References Storage and compu-
tation
Data analysis Data encryption and security
1 Pantelopoulos and
Bourbakis (2010)
Data extraction and decision making Encrypted transmission of measured sig-
nals and authentication requirement for
private data access.
2 Chan et al. (2009) Software used to evaluate data col-
lected from motor activity and health
data to detect emergency situations.
Nearest neighbour technique, signal
processing techniques, devices capable
of integrated analysis support for mak-
ing decisions and diagnosis
3 Tao et al. (2012) Transfer of data to cen-
tralised medical location
and processed by trained
medical personnel.
Gait kinematics, gait kinetics and
EMG signal processing
4 Salarian et al. (2007) Analysis algorithm for detection of
Stand-sit and sit-stand transitions,
walking periods and lying periods
Continued on next page
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Table B.5 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Storage and compu-
tation
Data analysis Data encryption and security
5 Shull et al. (2014) Kinematics and kinetics for gait analy-
sis
6 Pantelopoulos and
Bourbakis (2008)
Decision support system, signal pro-
cessing
Privacy of medical data
7 Alam and Hamida
(2014)
Cloud server Communication systems should have some
security. 3 levels of security: Level 0 - un-
secured communication, Level 1 - authenti-
cation but no encryption, Level 2 - authen-
tication and encryption. Data storage se-
curity requirement, data access security re-
quirements, data communication security
requirements
8 Riazul Islam et al.
(2015)
Features of security and privacy - secu-
rity requirements such as confidentiality,
integrity, authentication, availability, data
freshness, etc. vulnerabilities, threat mod-
els and countermeasures. Proposed Secu-
rity model
9 Egbogah and Fapo-
juwo (2011)
Back-end servers, remote
storage for further anal-
ysis.
Extraction and classification tech-
niques, ECG data mining
Low overhead and low complexity encryp-
tion and decryption security scheme. Ses-
sion keys (SK) issued by gateways.
10 Trung and Lee (2016)
11 Cruz et al. (2008)
Continued on next page
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Table B.5 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Storage and compu-
tation
Data analysis Data encryption and security
12 Banos et al. (2014) remote persistent stor-
age system to store data
from multiple users.
Cloud computing and
the big data
Medical applications that provide clin-
icians with medical calculators and de-
cision support that apply to General
Practice, internal medicine, cardiology,
surgery, neurology, etc. Limited pro-
prietary processing of the information-
filtering and low level knowledge ex-
traction
Security provided by operating systems,
authentication through the application
13 Hu et al. (2008) Receiving station meant
for data gathering and
communicates actively
with mobile platforms
Signal processing, image processing
and pattern recognition. Feature ex-
traction locates points of interests from
multidimensional space. Feature ex-
traction algorithm
14 Khattak et al. (2011) Cloud computing Human activity recognition and manip-
ulation system
Cloud computing secured
15 Butala et al. (2012)
16 Sankaralingam and
Gupta (2012)
17 Liu and Xiao (2011) Real-time data analysis using a profes-
sional software
End-to-end security scheme: sensor to sen-
sor communication protected using low
cost symmetrical ciphers and authentica-
tion and encryption through extremely
light-weight security schemes. User
anonymity - protects the user’s privacy and
also complies with the principle of least in-
formation. Information integrity
Continued on next page
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Table B.5 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Storage and compu-
tation
Data analysis Data encryption and security
18 Mahoney and Ma-
honey (2010)
19 Segerst˚ahl and
Oinas-Kukkonen
(2011)
Motion recognition assisted pedestrian
dead reckoning (PDR) algorithm, az-
imuth to calculate position
20 Chan et al. (2012) Real-time processing of data.
21 Lukowicz et al.
(2004)
Signal processing
22 Patel et al. (2012) Cloud-based systems, re-
mote centre, hospital
servers
Signal processing, pattern recogni-
tion and artificial intelligence-based
methodologies
23 Swan (2012) cloud services - ven-
dors such as AT&T and
Qualcomm, Microsoft’s
Azure, Amazon web
Image recognition, emotion detection
Table B.6: Wearable Technology Healthcare Services
P
a
p
e
r
N
u
m
b
e
r
References Stages of Care Intended User
1 Pantelopoulos and
Bourbakis (2010)
Ambient assisted living, preventative, diagnosis, rehabil-
itation, health and wellness
Continued on next page
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Table B.6 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Stages of Care Intended User
2 Chan et al. (2009) disease management, assisted living, preventative, diag-
nostic, wellness
elderly people, disabled people, patients, people who suf-
fer from chronic conditions, hospital based health profes-
sionals
3 Tao et al. (2012) rehabilitation, health diagnostics, wellness
4 Salarian et al. (2007) preventative, diagnostic, disease management
5 Shull et al. (2014) Treatment, diagnostic, Subject type: healthy, chronic conditions, handicapped
6 Pantelopoulos and
Bourbakis (2008)
7 Alam and Hamida
(2014)
disease management, assisted living, treatment, preven-
tative, emergency services
8 Riazul Islam et al.
(2015)
Assisted living, community healthcare, children health
information, rehabilitation system, medication manage-
ment,
9 Egbogah and Fapo-
juwo (2011)
Preventative, diagnostic, disease management, emer-
gency management
Patients, doctors and nurses
10 Trung and Lee (2016) diagnostics, preventative, treatment, health and wellness
11 Cruz et al. (2008) treatment of diseases, diagnostic and therapeutic inter-
ventions
Patients
12 Banos et al. (2014) disease management, wellness, prognosis, diagnostics, patients, relatives, caregivers, practitioners, institutions
and companies
13 Hu et al. (2008) diagnostics Cardiac patients
14 Khattak et al. (2011) health and wellness, emergency services, clinical care ser-
vices,
15 Butala et al. (2012) rehabilitation, preventative and recuperative, disease
management,
16 Sankaralingam and
Gupta (2012)
17 Liu and Xiao (2011) Medical records doctors, nurses, patient
Continued on next page
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Table B.6 – Continued from previous page
P
a
p
e
r
N
u
m
b
e
r
References Stages of Care Intended User
18 Mahoney and Ma-
honey (2010)
19 Segerst˚ahl and
Oinas-Kukkonen
(2011)
medical diagnosis, rehabilitation
20 Chan et al. (2012) emergency services, preventative, diagnostic, treatment,
health and wellness
healthcare providers alerted in case of emergency, hand-
icapped, elderly, suffering from chronic diseases and in-
jured with special needs
21 Lukowicz et al.
(2004)
Health monitoring, assisted living systems, mobile treat-
ment and novel information management tools for medi-
cal personnel, fitness
22 Patel et al. (2012) rehabilitation, assisted living Family members, caregivers, clinical personnel
23 Swan (2012) wellness
B.2 Reviewed wearable devices
This section gives the details on the wearable devices reviewed for the analysis for Chapter 3.
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Table B.7: Reviewed wearable devices
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
1 Wearable
sweat
sensors
Use of
sweat to
look for
signs of
diseases.
Sodium
and potas-
sium in
sweat help
detect
dehydra-
tion and
muscle
cramps.
Glucose
for blood
sugar
levels.
Lactate
level in-
dicate
blood flow
problems
and skin
temper-
ature for
overheat-
ing.
TRL 4
- Tech-
nology
develop-
ment and
the safety
of the
device is
demon-
strated
The data is fed to a
flexible board of mi-
crochips that pro-
cesses signals from
sensors.
Thermometer,
blood sugar
monitor and
biomarkers
Sync data to
Bluetooth to
wirelessly trans-
mit data to a
smart phone.
Smart
phone app
that plots
data in real
time.
molecules
ranging
from com-
plex pro-
teins to
electrically
charged
ions , skin
tempera-
ture, glucose
levels, lac-
tate levels,
sodium and
potassium
lack of
body
fluids,
muscle
cramps
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
2 Allergy
Amulet
Can
detect
food al-
lergy and
provide
additional
informa-
tion to the
consumer
about the
food they
are about
to eat
TRL 8
- Com-
pleted
clinical
evalua-
tions and
ready
for the
market
Disposable
chemistry-based
test strip that
detects the pres-
ence or absence of
allergens.
Chemistry-based
strips
Sync data to a
smart phone to
alert the user
Chemistry-
based test
strips
Peanut pro-
tein per tril-
lion (ppt)
food al-
lergy
Continued on next page242
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
3 TZOA Detects
harmful
particles
in the air
TRL 9 -
Commer-
cialisation
Laser/photo-diode
for particle detec-
tion
Optical partic-
ulate sensor,
humidity sensor,
pressure sensor,
UV sensor and
ambient light
sensor
USB, SD card
and Bluetooth.
SD card and
Bluetooth are
for data read
out and USB for
internal configu-
ration. TZOA-R
App available for
Android phones
Smart
phone app
Internal
Sensors to
measure air
quality, tem-
perature,
humidity,
atmospheric
pressure,
ambient
light and
UV(sun)
exposure
Prevents
inhala-
tion of
particles
called
PM2.5
that
affect
people
with
respi-
ratory
condi-
tions,
cardio-
vascular
diseases
and
autoim-
mune
disor-
ders.
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
4 Google
con-
tact
lens
Scan bar-
codes,
price
tags and
coupons,
authen-
ticate
identi-
ties, help
manage
allergies,
monitor
blood
alcohol
content
and body
tempera-
ture, track
glucose
levels, and
generate
solar and
ambient-
light
sourced
power.
TRL 5 -
Developed
proto-
types and
still un-
dergoing
various
clinical
research
smart solar-
powered contact
lenses
glucose measur-
ing sensor, light
sensors
electronic circuits
, radio, sync data
using Bluetooth,
smart-phone
Smart
phone app
blood sugar
levels
diabetes
and
eyesight
im-
prove-
ment
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
5 Code4armourProvides
a medical
person-
nel with
personal
health in-
formation
about the
wearer
TRL 9 -
Commer-
cialization
Product
launched
in 2014
worn on the wrist No sensors Smart phone smart
phone app
with per-
sonal health
information
Personal
Medical
records
Autism,
alzheimer’s,
demen-
tia,
asthama,
dia-
betes,
non-
verbal
people,
heart
condi-
tions
6 Monica
AN24
Accurate
foetal
moni-
toring
for BMI
patients
TRL 9 -
Commer-
cialisation
Abu Blue R and
Ambu Blue VLC
ECG electrodes and
internal processor
that extracts data
in real time
ECG Sensor and
EMG Sensor
Monica IF24
interface device,
Bluetooth
L&D moni-
tor
heart electri-
cal activity
Foetal
health
7 OM
Bra
Records
the heart
rate and
other vital
data for
fitness and
everyday
use.
TRL 9 -
Commer-
cialization
The fitness data
is continuously
recorded onto small
box attached to
the shirt can also
be connected to
the phone via
Bluetooth.
heart rate mon-
itor, respiratory
monitor and pe-
dometer
Internet connec-
tion, Bluetooth,
smart phone
Smartphone
app and
online
information
heart rate,
step count
and breath-
ing rate
Healthy
lifestyle
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
8 Empatica
E4
Wrist-
band
Is a data
provider.
TRL 9 -
Commer-
cialization
The data is
recorded and stored
in an internal mem-
ory. The data are
downloaded via
USB through the
Empatica Manager.
accelerometer ,
clock and heart
rate monitor,
Photo plethys-
mography (PPG)
sensor, Electro-
dermal activity
sensor, infrared
thermopile
Bluetooth Smart
phone Real-
time and
mobile API
app and
the Empat-
ica cloud
platform
skin tem-
perature,
heart rate,
blood vol-
ume pulse,
sympathetic
nervous
system
arousal
stress
levels
and
cardiac
activity
9 Insulet
Omin-
pod
Insulin
man-
agement
system
TRL 9-
Have per-
formed
studies
on Post
market
surveil-
lance
A pod that is worn
anywhere on the
body. The pod col-
lects the data
test strip port Wireless commu-
nication between
Pod and PDM
(Personal Dia-
betes Manager).
PDM has
a built in
blood glu-
cose meter,
extensive
food library
with car-
bohydrate
counts
and bolus
calculator.
blood sugar
levels, insu-
lation levels
diabetes
10 Bodytel
Pres-
suretel
Blood
pressure
monitor
and man-
agement
system
TRL 9 -
Commer-
cialization
Worn on the arm.
It is compatible
with iOS and An-
droid smart phones
and tablets as
well as Nokia and
Symbian phones
running on Java
applications.
Blood pressure
meter
Bluetooth-
enabled device,
compatible with
smart phones or
tablets and online
patient diary on
Body Tel Centre
blood pres-
sure
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
11 Quell drug free
pain relief
RL 9 -
Commer-
cialization
Can be worn any-
where on the body.
Stimulates the
sensory nerves.
The sensory nerves
carry neural pulses
to the brain. These
neural pulses
trigger a natural re-
sponse that blocks
pain signals in your
body.
Accelerometer sleep moni-
toring
Chronic
pain
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
12 NOVII
wire-
less
patch
system
accurate
foetal
moni-
toring
for BMI
patients
TRL 9 -
Commer-
cialization
Worn on the torso.
It uses a peel and
stick patch to send
raw data to existing
foetal monitors via
Bluetooth
ECG and EMG
sensor
Bluetooth The Mon-
ica Novii
monitors
foetal heart
rate (FHR),
maternal
heart rate
(MHR) and
uterine ac-
tivity (UA),
all with a
single ’peel
and stick’
patch.
Muscle
and
nerve
disor-
ders,
coro-
nary
heart
disease,
heart
failure,
arrhyth-
mia,
con-
genital
heart
disease,
car-
diomy-
opathy,
heart
failure.
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
13 Unaliwear
kanega
Offers re-
minders to
the wearer
when to
take med-
ications
and can
detect
when the
user has
fallen.
Offers
directions
to the user
TRL 8 -
Still un-
dergoing
device
tests
Worn on the wrist.
Standalone smart
watch. Voice ac-
tivated and allows
its user to interact
with it hands free.
Accelerometer smart watch,
voice activated
directions, GPS
Movement
detection,
fall detec-
tion
Old age
people
14 Smart
Diaper
It is a
passive
system
that uses
chemical
markers
that react
with the
child’s
urine and
change
colour ac-
cordingly.
TRL 9 -
Launched
in May
Worn on the pelvis
and the patch on
the diaper can be
photographed using
a smart phone
and then can be
assessed using an
app. data stored on
Amazon’s S3 and
Amazon databases.
Chemical mark-
ers
Phone app and
cloud service
Algorithms
used to
analyse the
data and
water levels,
sugar levels
and urine
composition
Screen
type
1 dia-
betes,
dehy-
dration,
urinary
tract in-
fections
and
kidney
prob-
lems
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
15 Netatmo
June
UV moni-
tor that’s
designed
to keep
you safe
from the
sun’s
harmful
rays.
TRL 9 -
Commer-
cialization
It is a bracelet de-
signed to resemble a
piece of jewellery.
UVA and UVB
sensors
Connects to the
smart phone
through a low-
power Bluetooth
connection
Smartphone
app for
data anal-
ysis and
gives the
UV index
in real time.
UV index in
real time.
skin
cancer
and skin
diseases
16 Sunfriend UV moni-
tor that’s
designed
to keep
you safe
from the
sun’s
harmful
rays.
TRL 9 -
Commer-
cialization
- The
price
of the
product
is going
down
Worn on the wrist
and it comprises
microprocessor
UVA and UVB
sensors
LEDs to indicate
the levels of sun
exposure.
Customised
algorithms
in the
device
UV index in
real time.
skin dis-
eases
17 Hygreen Hand
hygiene
tracking
system
to record
and re-
mind
users to
wash their
hands.
TRL 9 -
Commer-
cialization
The system com-
prises of wall-
mounted sensors
and a clippable
wearable device
worn on each user.
Data is stored on
a database called
HyMark
sensor to detect
hand hygiene ac-
tivity
LED, wireless sig-
nals to the Hospi-
tal systems
Analysis
done in
Excel
Hand wash Spread
of infec-
tions
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
18 Sproutling
baby
moni-
tor
Used to
sense a
child’s
well-being
and envi-
ronment
and pro-
vide useful
insights
for a
parent.
TRL 8 Worn on the baby’s
ankle. This device
is for babies from 0
to 18 months old.
Accelerometer,
thermometer,
heart rate moni-
tor, hygrometer,
ambient light
sensor and micro-
phone.
Companion app
on the smart
phone for iOS
users
smart baby
monitors
Heart rate,
motion
and posi-
tion. The
baby’s sleep
patterns
Baby’s
well
being
19 Fitguard Detects
head in-
juries for
athletes
TRL 8
- Com-
pleted
clinical
tests
awaiting
for the
product
to be
released.
The device has an
acceleration sensor
detects head move-
ment.
Accelerometer LED used to in-
dicate the force of
impact and Blue-
tooth technology
transfers data to
FIT smart phone
app.
The
amount
of acceler-
ation will
determine
the force
of the head
impact
which can
be used
to analyse
severity
of head
injuries.
Processes
through
propriety
algorithm
Linear and
angular
acceleration
Head
tremors
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
20 Sensus
Pain
Man-
age-
ment
system
This de-
vice is
worn on
the leg
that pro-
vides relief
of chronic
pain to
the user.
This
device
com-
fortably
stimu-
late the
sensory
nerves in
the legs.
TRL 9 -
Commer-
cialization
This device is worn
on the leg, just be-
low the knee and it
is activated by sim-
ply one push of a
button.
No sensor No communica-
tion hardware
No data
analysis
No measur-
able
leg
chronic
pain
Continued on next page
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Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
21 Chrono
solu-
tion
This de-
vice helps
smokers
to stop
smok-
ing by
gradually
decreasing
amounts
of nicotine
to the
user. The
device
has an
electrode.
TRL 9 -
Commer-
cialization
It’s worn on the
wrist. It has wire-
less connectivity
that synchronize
the information to
smart phones.
Detects the crav-
ings of the user
and it provides
small amounts
of nicotine ac-
cording to the
cravings.
Bluetooth con-
nect wirelessly
to the smart
phone. Com-
patibility with
iOS, Android,
Windows and
Nokia devices.
Smart
phone app
Nicotine lev-
els
Prevent
diseases
asso-
ciated
with
smoking
Continued on next page
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22 Rewalk
per-
sonal
6.0
It is for
clinical
rehabil-
itation
for peo-
ple that
suffered
lower limb
injuries.
Good for
exercise
and
TRL 8 -
Phase III
Clinical
trials
Worn on the body
and it is adjustable
to fit anyone whose
height ranges be-
tween 160 cm to 190
cm. It is a wearable
exoskeleton.
Undisclosed No communica-
tion hardware
No data
analysis
No measur-
able
Improve
bowel
and
bladder
func-
tion,
mental
health,
posture
and
balance,
sleep
and
fatigue,
decrease
body
fat and
pain.
23 Esight
eye-
wear
A digital
eyewear
that en-
ables
people
with low
vision to
see.
TRL 8 -
Clinically
validated
Worn on the body
and
uses advanced,
high-resolution
video camera to
capture what the
wearer is looking
at and the images
are processed
in real-time and
then projected
onto the two
LED screens.
Low vi-
sion eye-
sight
Continued on next page
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24 Hyginex
wrist-
band
This de-
vice warns
the doc-
tors and
nurses
if they
need to
wash their
hands.
TRL 8 -
Commer-
cialization
- Pilot
studies
It is worn on the
wrist and has built
in sensors that de-
tects if the hand is
clean or not. It also
equipped with
Microbial sensors
and overbed Bea-
con sensor.
hand washes Prevent
infec-
tious
diseases
Continued on next page
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25 Swipe
sense
A com-
plete
hygiene
system
that
monitors
hygiene
control
using
wearable
hand
sanitizer
with mon-
itoring
sensors,
wall
mounted
dis-
pensers,
flexible
data col-
lection
badges
and data
collections
hubs.
TRL 7:
Tech-
nology
Transfer
Worn on the body
(anywhere). Cloud
based platform that
all the data is col-
lected.
Monitoring
sensors and
dispensers
Communication
hubs that are
centralised. Data
is transfer via
Wi-Fi or Eth-
ernet to secure
servers.
Data anal-
ysed using
an applica-
tion
hand washes Prevent
infec-
tious
diseases
Continued on next page
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26 Ultroz
elite
Aims to
reduce
pain, treat
muscle
spasms,
treat joint
conjec-
ture and
increase
circula-
tion.
TRL 6 -
Preclinical
evalu-
ations
finished
This technological
device massages
the internal tissue
and creates heat to
warm the muscle.
No sensor No communica-
tion hardware
No data
analysis
No measur-
able
splints,
suspen-
sory
liga-
ments
and
tendons,
muscle
strains,
stiff
joints,
arthritis
and
bone
fracture
27 Surrosense
RX
system
The Sur-
roSense
Rx Sys-
tem is a
wearable
device
that helps
prevent
foot ul-
cers by
collecting
pressure
data.
TRL 9 -
Commer-
cialization
This technology has
real-time feedback
and the sensors on
the shoe inserts and
wirelessly transmits
data to the smart
watch.
Pressure sensor Data transmitted
wirelessly to the
smart watch from
shoe inserts.
The data is
analysed to
an Orpyx
Connect
account.
Information
presented
as digi-
tal charts
and data
tracking.
pressure lev-
els
Foot ul-
cers
Continued on next page
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28 Zoll
Lifevest
Wearable
defibrilla-
tor used
for cardiac
monitor-
ing and
to pro-
tect the
user from
cardiac
arrest.
TRL 9-
Clinical
trials
completed
and FDA
approval.
Ongoing
clinical
trials
Garment that de-
tects and delivers
shocks
ECG electrodes,
therapy pads
USB cable con-
nection between
the lifevest and
the monitor
Data anal-
ysed used
using
complex
algorithms
for arrhyth-
mias
Heart
rhythm
Cardiac
arrest.
Heart
attack,
car-
diomy-
opathy
and
con-
gestive
heart
failure.
29 Zio
XT
Patch
Wearable
device
that con-
tinuously
measures
heart rate
in a dis-
creet and
wireless
manner.
TRL 9 -
Commer-
cialization
Worn anywhere
on the body and
the technology
records heartbeats
during sleeping
time as well as
other day-to-day
activities, up to
14 days. After the
recording period,
the data is sent to
the iRhythm clini-
cal app for analysis,
using FDA-cleared
algorithms.
ECG sensor
and another one
which is not
disclosed
Proprietary
algorithm
Heart rate Cardiovascular
diseases
Continued on next page
258
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
B
.2
R
e
v
ie
w
e
d
w
e
a
ra
b
le
d
e
v
ic
e
s
Table B.7 – Continued from previous page
Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
30 SentimotoSmart
wearable
watch
that cap-
tures the
users’
physiolog-
ical and
environ-
mental
data, in
order to
deter-
mine their
overall
physical
well-
being.
Wearable
device
taken
off the
market
Worn on the wrist
and measurements
can be viewed on
mobile devices us-
ing the cloud ana-
lytic software.
Accelerometer,
heart rate moni-
tor, thermometer
and hygrometer
Sentimoto
includes
sensors that
analyse
heart rate,
body tem-
perature,
activity
level, room
tempera-
ture and
humidity.
old peo-
ple carer
Continued on next page
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31 Visi
Mobile
A wear-
able de-
vice worn
around
the wrist
which
allows
clinicians
to be in
touch with
their pa-
tients and
check on
their vital
signs at
any given
moment.
TRL 9 -
Commer-
cialization
This device has 3
sensors and it’s able
to transmit data in
a wireless manner,
so vital signs can
be analysed on a re-
mote computer or
portable tablet. By
monitoring health-
related indicators,
Visi Mobile can be
used to alert doc-
tors and nurses if
patients require ur-
gent care.
Oximeter, blood
pressure meter,
ECG Sensor
Monitoring
ECG, heart
rate, pulse
rate, blood
pressure,
and respi-
ration rate
and body
tempera-
ture.
Cardio
activity,
cardio-
vascular
diseases,
respi-
ratory
diseases.
32 Aquapulse
heart
rate
moni-
tor
Heart rate
monitor
designed
by Fi-
nis for
swimmers
to keep
track of
their heart
rate while
swim-
ming.
TRL 9 -
Commer-
cialization
This wearable de-
vice can be at-
tached to the inside
of the goggles strap
near the earlobe.
Infrared sensors,
bone conduc-
tion technology
and heart rate
monitor
Heart rate Cardio
activity
Continued on next page
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33 Phyode
W/Me
Heart rate
monitor
that uses
heart rate
variability
to de-
termine
respi-
ration,
emotion,
and au-
tonomic
nervous
system
state.
TRL 6 -
About to
commence
preclinical
evalua-
tions
It is worn on the
wrist. The wear-
able device pairs
with a mobile ap-
plication that can
be used to assist
with tracking data
and also provides
breathing exercises.
Heart rate mon-
itor, respiratory
monitor and ECG
sensor
heart rate Autonomic
nervous
system
34 Seraphim
sense
angel
wrist-
band
An ac-
tivity
monitor
with vital
sign capa-
bilities.
TRL 6 -
About to
commence
preclinical
evalua-
tions
It is worn on the
wrist. It is de-
signed to have a
minimalist appear-
ance and has no dis-
play. However, all
the information on
the wearable device
is easily accessible
and open to further
development.
Oximeter, ac-
celerometer,
gyroscope and
heart rate moni-
tor.
Pulse, blood
oxygenation,
acceleration,
steps skin
tempera-
ture, sleep
quality,
activity.
Healthy
lifestyle
Continued on next page
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35 Interaxon
muse
Mental
activity
tracking
device
that helps
reduce
stress and
settle the
mind.
TRL 9 -
Commer-
cialization
Worn on the head
and uses 7 sensors
that are applied to
the occipital lobes.
EEG sensor and
Accelerometer
Bluetooth Brain activ-
ity
Mental
health
36 IMEC
EEG
head-
set
Wearable
health
moni-
tor with
electroen-
cephalo-
graphic
(EEG) ca-
pabilities.
TRL 5 -
Developed
prototype
It is designed to
be worn during
daily activities and
allows for comfort-
able, continuous,
and reliable health
monitoring. It is
sensitive, intel-
ligent, compact,
and low-power and
is able to deliver
real-time data to
Bluetooth enabled
devices.
EEG sensor,
ECG sensor
and respiratory
monitor
Heart rate,
activity,
breath rate,
heart elec-
tric activity.
Health
moni-
toring
for all
diseases
Continued on next page
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37 Leaf
health-
care
ulcer
sensor
This de-
vice is
designed
to alert
a person
when it
is time to
turn and
do some
moving in
order to
combat
no moving
around.
TRL 5 -
Developed
prototype
and un-
dergoing
clinical
research
Single use, dispos-
able device that is
adhered to a pa-
tient’s chest. Real-
time patient status
Tri-axial ac-
celerometer
Movement,
orientation,
position
and activity
measure-
ment
Pressure
sores
38 iSono
Health
This de-
vice is
used to
monitor
breast
health.
TRL 5 -
Developed
prototype
3D ultrasound tech-
nology coupled with
our powerful ma-
chine learning algo-
rithm allows you to
track any changes
over time without
any radiation at the
convenience of your
home. The ultra-
sound scanner gets
attached to a wear-
able accessory; 2 to
3 minutes a month
is all that it takes
for you to auto-
matically scan your
breasts.
Ultrasound scan-
ner
Detect any
changes in
the breast
Breast
cancer,
breast
lumps
Continued on next page
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39 Abbott
Dia-
betes
Care
Glucose
monitor-
ing system
for people
who suf-
fer from
diabetes.
TRL 9 -
Commer-
cialization
This is a sensor
placed on the back
of the upper arm for
14 days. It is a
companion app and
smart phone acces-
sible product where
then a doctor can
read over the in-
formation when the
patient goes to the
doctor.
Blood sugar mon-
itor
Blood sugar
levels
Diabetes
40 HealthPatch
MD
New tech-
nology for
healthcare
profes-
sionals to
be able to
keep tabs
on the
vital in-
formation
of their
patients.
TRL 9 -
Commer-
cialization
The HealthPatch®
MD biosensor has
two components:
the reusable sensor
module and the
disposable patch.
ECG sensors, 3
axis accelerome-
ter, thermistor
HealthPatch
pairs over Blue-
tooth Low-
Energy with
a mobile de-
vice for WiFi
connectivity
Heart rate,
breathing,
tempera-
ture, steps
and even
detects body
position.
Health
moni-
toring
for all
diseases
Continued on next page
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41 Adamm The de-
vice and
the app
will be
able to
alert you
when you
experi-
encing an
asthma
situation,
jour-
nalling,
treatment
plans,
displays,
and the
tracking
and in-
formation
on the
treating
of symp-
toms.
TRL 7:
Tech-
nology
Transfer
A patch-type,
flexible wearable
with a rechargeable
battery that can
be worn anywhere
on the upper torso,
front or back. Move
it around from
day to day as you
choose.
Cough counter,
Respiration
pattern, heart-
beat sensor and
thermometer
Cough
counting,
respiration,
wheeze and
heart rate
Asthma
42 Nuubo
nECG
Min-
der
This
wearable
device is
an activity
monitor.
TRL 7:
Tech-
nology
Transfer
This device is de-
signed to record
ECG signals (when
paired with Nu-
ubo’s nECG Shirt)
as well as body po-
sition and physical
activity.
Accelerometer
and ECG
Activity
and cardiac
activity
Healthy
lifestyle
Continued on next page
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43 Preventice
body-
guardian
The Body-
Guardian
is a wear-
able body
sensor
that is
capable of
recording
biometric
data for
clinical
use.
TRL 9 -
Commer-
cialization
The technological
device is designed
to adhere to the
body without
impairing user mo-
bility. All data is
delivered securely
to the cloud-based
Preventice Care
Platform which can
be viewed by the
user’s doctors.
ECG sensor and
respiratory moni-
tor
Heart rate,
breathing
rate,
Cardiac
activity
Continued on next page
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44 T.ware
T.Jacket
The T.
Ware T.
Jacket
is an in-
telligent
jacket
that re-
produces
dynamic
pressure
to simu-
late hugs.
This
wearable
device is
generally
used in
child-
care, to
soothe
and
comfort
autistic
children
even when
direct con-
tact is not
possible.
TRL 9 -
Commer-
cialization
The system is re-
motely controlled
via a smart phone’s
application, which
can also be used
by parents or care-
givers to track
children’s level
of activity and
response to the T.
Jacket.
accelerometer activity autism
Continued on next page
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45 Withings
Blood
pres-
sure
moni-
tor
The With-
ings Blood
Pressure
Monitor is
a wearable
technol-
ogy worn
on the
arm that
measures
blood
pressure
and heart
rate.
TRL 7
- Tech-
nology
transfer
collabo-
rated with
Nokia
Connected to an
iOS device it tracks,
saves and displays
data that can then
be used as a per-
sonal or medical
health recorder.
heart rate mon-
itor and blood
pressure meter
heart rate
and blood
pressure
hypertension
46 Hexoskin Comfortable
way to
monitor
precise
cardiac,
respi-
ratory,
sleep and
activity
data
TRL 9 -
Commer-
cialization
Hexoskin shirt and
device used for the
data collection.
ECG, accelerom-
eter
Hexoskin app
available for An-
droid and iOS.
The data syncs
HxServices for
online dashboard.
Bluetooth pair-
ing between the
device and the
phone
Raw data
is synced to
the online.
There is a
ViviSense
data analy-
sis software
Heart rate
zones,
breathing
rate, minute
ventilation,
heart rate
maximum,
resting
heart rate,
heart rate
recovery, ca-
dence. Sleep
activity,
step count,
calories
Heart
condi-
tions,
healthy
lifestyle
Continued on next page
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47 Sony
smart-
band,
Jaw-
bobe
UP
series,
Mio
Ac-
tive,
Ami-
igo
It is track-
ing device
worn on
the wrist.
TRL 9 -
Commer-
cialisation
Data is collected on
to the smart phone
app
Heart rate, GPS,
accelerometer
Bluetooth, Host
app (Android or
iOS compatible)
LED indicators,
NFC, USB
Data anal-
ysis on
the smart
phone app
Measure
pulse and
stress level,
heart rate,
activity and
step count
Heart
condi-
tions
and
healthy
lifestyles
Continued on next page
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48 Somaxis It is
a,wearable
sensor
that is
used for
Muscles,
Heart,
Brain,
Posture,
and,Movement.
It is,used
for re-
search, er-
gonomics,
physical
therapy,
occupa-
tional
therapy,
Biofeed-
back,sports
science,
and phys-
ical reha-
bilitation.
TRL 6 -
Not yet
certified
Data is collected on
the halospere app
that is recorded the
sensor
Cricket EMG,
ECG, EEG and
accelerometer
Data from the
sensor is synced
via Bluetooth to
the Chirp app
that wirelessly to
Halosphere cloud
server.
Data is
analysed
externally
to Halo-
sphere
software
on the
computer.
Muscle ten-
sion, heart
and brain
activity and
posture
Occupational
therapy
and
physical
rehabili-
tation
Continued on next page
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49 Zio
iRhythm
Captures
beat-
to-beat
cardiac
rhythm
for up to
14 days,
contin-
uously
recording
and stor-
ing both
symp-
tomatic
and
asymp-
tomatic
events 24
hours a
day.
TRL 9 -
Commer-
cialization
Continuous data
collection from the
Zio monitor
ECG Wireless connec-
tion between the
patch and the
software
Complex
algorithms
that can
detect when
there is
arrhythmia
Heart
rhythms
Arrhythmias
50 Emotiv It’s a de-
vice used
to mea-
sure brain
activity
TRL 9 -
Commer-
cialization
EEG measure the
brain activity and
data is recorded
EEG Wireless connec-
tion Windows,
OSX, Linux,
Android and
iOS compatible.
Bluetooth
Application
for Emotiv
mobile
Performance
metrics,
mental
commands,
facial ex-
pressions
Brain
fitness
and
perfor-
mance
Continued on next page
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51 Neurosky TRL 9 -
Commer-
cialisation
Neurosky chip and
collect electrical
signals
EEG and ECG Phone Apps, web
apps and cloud
server. iOS, An-
droid, PC and
Mac compatible
Biometric
algorithms
that trans-
late data
from ECG
to heart-
health
index
Heart rate,
heart age,
breathing
index, blood
pressure,
emotion
intensity.
The brain
activity
is trans-
lated signal
to brain
activity
Heart
diseases,
brain
activity
and
mental
effort
52 EQ02
LifeMon-
itor
This is
a multi-
parameter
ambu-
latory
moni-
toring
device.
TRL 9 -
Commer-
cialisation
LifeMonitor senses
and records data
from the user.
Accelerometer,
ECG, infared
sensor, heart rate
monitor, pedome-
ter, respirometer,
thermometer,
GPS
Wirelessly con-
nect the device
to the Sensor
Electronics Mod-
ule (SEM) and
the sensor belt.
Bluetooth and
proprietary.
eqView
software
Heart rate,
respira-
tory rate,
skin tem-
perature,
accelerom-
eter, body
position,
motion sta-
tus, fall
alert.
Health
vital
signs
Continued on next page
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53 3L
Labs
foot-
logger
A wear-
able
fitness
tracking
device
that
aims at
spotting
health
problems
early, as
well as
logging
daily
activity.
TRL 6 -
Preclinical
evaluation
LASIS server for
data collection
Pressure sensor Wireless connec-
tion via Blue-
tooth, Wi-Fi,
SMS transfer
LASIS
server for
analysis
Motion sta-
tus, fall de-
tection.
Detection
of de-
mentia,
spinal
disease,
acci-
dents
from
falling,
rehabil-
itation
(stroke,
paral-
ysis),
recov-
ery, gait
correc-
tion
Continued on next page
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Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
54 BalanSensThe first
wearable
device
that mea-
sures the
centre of
mass of a
patient,
provid-
ing an
accurate
balance
assess-
ment for
clinicians.
TRL 9 -
Commer-
cialisation
BalanSens app that
collects and records
the data
Accelerometer,
gyroscope
Wireless connect
via Bluetooth.
Compatible with
Android, iOS and
Windows
App has
instant
charting
and analy-
sis
Sway index,
sway veloc-
ity, centre of
mass motion
and sway
area of the
patient
Balance
assess-
ment
55 SoundBiteA unique
wearable
hearing
aid de-
signed to
be worn
on the in-
side of the
mouth.
TRL 7:
Tech-
nology
Transfer
Audio signal send
to the bone conduc-
tion speaker.
No sensor Wireless connec-
tion via Wi-Fi
The BTE
(behind the
ear) unit
uses digi-
tal signal
processing
technology
to process
the sound
and trans-
mit the
sound to
the ITU
( In the
mouth)
piece.
vibrations Hearing
prob-
lems
Continued on next page
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Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
56 BTS
Sur-
face
EMG
A wear-
able
synchro-
myography
device
used for
moni-
toring
muscular
activity.
TRL 9 -
Commer-
cialization
Wireless gel elec-
trodes that amplify
the signal received
by the electromyo-
gram.
EMG Sensor Wireless connec-
tion via Wi-Fi.
Compatibility
with Windows.
Data is
send to
the com-
puter and
analysed in
real-time.
There are
3 models
FREEEMG,
FREE-
WALK and
TMJOINT
Muscular ac-
tivity
Orthopaedic
and
neuro-
logical
dysfunc-
tions,
mus-
cular
activity
and cor-
rection
occlu-
sion
interfer-
ences.
57 Metria
IH1
A dis-
posable
wearable
device
that de-
tects the
user’s skin
tempera-
ture and
activity.
TRL 6 -
Preclinical
evaluation
The device is worn
on the upper left
arm and sticks to
the skin of the user
and data is col-
lected.
Accelerometer,
galvanometer,
thermometer
USB connection
used to transfer
data from the de-
vice to a com-
puter. Compat-
ibility: Windows
and OSX
Data is
viewed and
analysed on
a computer
or smart
device.
Activity and
skin temper-
ature
Health
Continued on next page
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Number Device Function
Technology
maturity
Key enabling technologies Physiological
signs
Diseases
Data collection
hardware
Sensors Communication
Hardware
Data analy-
sis
58 Vincense It facil-
itates
real-time
patient
care
through
continual
remote
monitor-
ing of
vital signs
in an un-
obtrusive
and non-
invasive
manner.
TRL 9 -
Commer-
cialization
Data collected by
the device continu-
ously.
Oximeter, in-
frared sensor,
thermometer
and heart rate
monitor.
Wireless connec-
tion Wi-Fi, data
connection, Blue-
tooth and An-
droid compatibil-
ity
Android
aoo and
web in-
terface
VinCense.
Heart rate,
tempera-
ture, blood
pressure.
Heart
condi-
tions
276
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
APPENDIX C
DETAILED INTERVIEW
TRANSCRIPTS
The appendix provides the detailed transcripts of the interviews conducted in Chapter 4.
C.1 Detailed interview transcripts
Table C.1 is summarised from the information provided in this section.
C.1.1 Lower respiratory infections
The lower respiratory infections such as influenza, pneumonia, asthma and other chronic conditions.
Choose the physiological signs and their respective stage of care:
• Preventative care – one of the interviewees indicated the importance of the monitoring of the
heart rate variability for preventative care.
• Diagnosis and screening – Two of the three interviewees agreed that temperature, breathing rate
and oxygen saturation can be useful. Two interviewees added that the heart rate is important
and one of them suggested for sepsis. The other one also added monitoring breathing sounds
for diagnosis especially for conditions such as asthma. One of the interviewees suggested blood
sugar levels (for diabetic patients), heart electric activity 1, sleep quality, brain activity and
urine composition. The interviewee highlighted how oxygen saturation, sleep quality and brain
activity can be utilised in the Intensive Care Unit for monitoring patients.
• Treatment of diseases – All the three interviewees acknowledged the importance of temperature,
breathing rate and oxygen saturation. Then two of the interviewee included the heart rate. One
of the interviewees added breathing sounds. One of the interviewees suggested blood sugar levels
(for diabetic patients), heart electric activity, sleep quality, brain activity and urine composition.
The interviewee highlighted how oxygen saturation, sleep quality and brain activity can be
utilised in the Intensive Care Unit for monitoring patients.
• Rehabilitation – One of the interviewee suggested that chronic lower respiratory conditions can
be monitored by temperature, breathing rate and oxygen saturation.
1Also known as electrocardiogram (ECG)
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None of the interviewees saw the relevance of monitoring physiological signs for wellness care.
Choose the intended user who will benefit from the data collected:
All the interviewees agreed that the patients and all the healthcare providers will benefit from this
information. One of the interviewees stressed that if it is for childcare it is for level 1 and level 2 care.
The general comments from the interviewees:
• Some of the interviewees suggested that asthma is a chronic condition that can benefit from
long-term monitoring of oxygen saturation for treatment, diagnosis and screening as well as
rehabilitation purposes.
• One of the interviewees suggested that infected neonatal babies in intensive care unit would
benefit tremendously from non-invasive monitoring of vital signs.
C.1.2 HIV/AIDS
Two of the interviewees agreed that for this condition that it is necessary to identify the stage 1 that
the physiological signs can be monitored. They suggested that opportunist infections can be monitored
using physiological signs. One of the interviewees also implied that side effects from the drugs can be
monitored using physiological signs. Then two of the other interviewees suggested that CD4 count can
be used as point-of-care diagnostic method, but did not see the relevance of wearable technology for this
application. One of the interviewees expressed concerns over the capabilities of wearable technology
because HIV has the the ability to suppress immune response 2. This makes it difficult to detect the
presence of opportunist infections.
Despite having reservations on the application of wearable sensors four of the interviewees provided
their input regarding the important physiological signs.
Choose the physiological signs and their respective stage of care:
• Preventative care – Two of the interviewees agreed on the relevance of monitoring heart rate,
temperature, breathing rate and oxygen saturation. Only one of the interviewees suggested
that there is need to monitor user’s activity levels, blood pressure, blood sugar levels, sleep
quality, brain activity(for opportunistic conditions such as TB meningitis and other stage three
infections) and urine composition.
• Diagnosis and screening – Three of the five interviewees agreed that heart rate, temperature,
breathing rate, oxygen saturation and brain activity can be used for monitoring. Two intervie-
wees added that activity, blood pressure, blood sugar levels and urine composition are important.
One of the interviewees stated that motion, sleep quality, blood volume pulse and body water
levels (in the form of trans-epidermal water loss3 and bio-impedance 4 for dehydration).
1HIV/AIDS has four distinguishable stages namely: acute primary infection, asymptomatic stage
(suppressed immune response), symptomatic HIV infection (opportunistic infections) and AIDS (Avert,
2017).
2Immune response is how the body recognises and defends itself against bacteria, viruses, and any
foreign substances. The body response by showing signs and symptoms to indicate the presence of an
infection or illness.
3 Trans-epidermal water loss defined as the constitutive steady state water vapour loss from the
skin surface, theoretically excluding desorption and sweat gland activity (Mohamad et al., 2012)
4Bio-impedance can be used to express the hydration of the soft tissue by solely considering
impedance components (i.e. resistance and reactants) independently of regression predictions of fluid
volumes or assumptions about the constant chemical composition of the fat-free body (Gatterer et al.,
2014)
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• Treatment of diseases – Four of the interviewees highlighted the use of heart rate, temperature
and breathing rate for the treatment of HIV. Then three interviewees agreed that oxygen satu-
ration and brain activity can be used to monitor this condition. Two of the interviewees saw the
relevance of monitoring activity, blood pressure, blood sugar levels and urine composition. One
of the interviewees suggested that motion, sleep quality, blood volume pulse and body water
levels for monitoring.
Choose the intended user who will benefit from the data collected:
All the interviewees agreed that the patients and all the healthcare providers will benefit from this
information. One of the interviewees stated that the patients will benefit from the information and the
healthcare providers will most likely use the information.
C.1.3 Diarrhoeal diseases
The diarrhoeal diseases that are prominent in SSA are cholera, typhoid and salmonella. These were
the ones that were highlighted during the interview by the interviewee.
Choose the physiological signs and their respective stage of care:
• Preventative care – One of the interviewees suggested the relevance of monitoring the heart rate,
temperature, oxygen saturation, blood pressure, blood sugar levels, urine composition and body
water levels 1. The wearable device can play a significant role to prevent the spread of diarrhoeal
diseases especially in the surge season especially when it is the wet and humid2.
• Diagnosis and screening – Four of the five interviewees agreed that breathing rate, urine com-
position and body water levels can be used for diagnostic purposes. Three interviewees added
that heart rate, temperature, oxygen saturation, blood pressure and blood sugar levels. One
of the interviewees highlighted that motion (severe cases), activity(severe cases), sleep quality
(severe cases), body water levels, pressure levels and galvanic skin response 3 are also important
for diagnostic purposes.
• Treatment of diseases – The same physiological signs identified for diagnosis and screening were
highlighted for treatment of diseases.
Choose the intended user who will benefit from the data collected:
All the interviewees agreed that the patients and all the healthcare providers will benefit from this
information. One of the interviewees stated that the patients will benefit from the information and the
healthcare providers will most likely use the information.
C.1.4 Malaria
Choose the physiological signs and their respective stage of care:
• Diagnosis and screening – Three of the five interviewees agreed that heart rate, temperature,
oxygen saturation, blood pressure and blood sugar levels can be used to diagnose malaria in-
fected people. Two interviewees agreed that the breathing rate and urine composition (for the
haemoglobininuria 4 and protein levels) can be utilised. Only one of the interviewees stipulated
the importance of motion, activity, heart electrical activity, brain activity, blood volume pulse
and haemoglobin(suggested separately but can be measured from the urine composition).
1One of the interviewees suggested body water levels can be determined using bio-impedance or
fluid trans-epidermal water loss techniques.
2The wet seasons are: Below tropic of Capricorn in SSA - wet winters; The equatorial region is wet
throughout the year and areas between the tropics experience wet summers.
3Galvanic skin response is used to detect emotional arousal
4The presence of haemoglobin in the urine and this occurs in the event of severe malaria and
haemolytic anaemia.
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• Treatment of diseases – All of the interviewees agreed that heart rate and temperature can
be important to monitor the treatment of the malaria. Then three interviewees highlighted
that oxygen saturation, blood pressure and blood sugar levels. For physiological signs such as
motion (severe cases), breathing rate, activity (severe cases especially when experiencing limb
joints which affects movements) and urine composition, two interviewees stated them. One of
the interviewees suggested the importance of heart electrical activity, brain activity (cerebral
malaria), blood volume pulse and haemoglobin.
• Rehabilitation – One of the interviewees suggested that activity and motion can be used for
rehabilitation especially if the patient suffered from severe malaria.
C.1.5 Pre-term Birth Complications
Choose the physiological signs and their respective stage of care:
• Preventative and wellness care – One of the interviewees highlighted that heart rate, temper-
ature, motion, activity, blood pressure, blood sugar levels, heart electrical activity and urine
composition for preventative and wellness care.
• Diagnosis and screening – The physiological signs that can be utilised for diagnosis as high-
lighted by four of the five interviewees are heart rate, temperature, oxygen saturation, blood
pressure, blood sugar levels and urine composition(presence of protein). Three of the inter-
viewees highlighted the importance of monitoring motion, breathing rate, activity and heart
electrical activity. Two interviewees stated that brain activity can be used to monitor prem-
mies. Only one interviewees saw the relevance of the following physiological signs: sleep quality,
blood volume pulse, body water levels (for oedema) and pressure levels. One of the interviewees
suggested the monitoring of the blood perfusion (which can be measured non-invasively using
pulse CO-Oximetry).
• Treatment of diseases – Four of the interviewees identified heart rate, temperature and blood
sugar levels to be important. The other physiological signs that were identified by three of
the interviewees were motion, breathing rate, activity, oxygen saturation, blood pressure, heart
electrical activity and urine composition. Then two interviewees agreed upon brain activity
being important. Finally, only one interviewee stated sleep quality, blood volume pulse, body
water levels and pressure levels.
C.1.6 Tuberculosis
Choose the physiological signs and their respective stage of care:
• Preventative care – One of the interviewees highlighted that heart rate, temperature, breathing
rate and sleep quality(night sweats) can be utilised for preventative care.
• Wellness care – one of the interviewees identified heart rate, temperature, breathing rate, oxygen
saturation and blood sugar levels.
• Diagnosis and screening – Four of the interviewees agreed that heart and breathing rate are
important for diagnosis. Then three of the interviewees highlighted temperature and oxygen
saturation as physiological signs that can be used for monitoring tuberculosis. One of the
interviewees stated that motion, activity, blood pressure, blood sugar levels, sleep quality, brain
activity(TB Meningitis for seizures, drowsiness and delirium), urine composition, body water
levels and cough count.
• Treatment of diseases – The physiological signs identified for diagnosis and screening were iden-
tified for treatment.
• Rehabilitation – One of the interviewees identified heart rate, temperature, breathing rate,
oxygen saturation and blood sugar levels for monitoring patients that are in rehabilitation.
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C.1.7 Neonatal sepsis and infections
Choose the physiological signs and their respective stage of care:
• Preventative care – One of the interviewees highlighted that heart rate variability is important
to prevent sepsis.
• Wellness care – One of the interviewees identified heart rate, temperature and breathing rate.
• Diagnosis and screening – All of the interviewees agreed that heart rate, temperature and breath-
ing rate are important for diagnosis especially for premmies. Then four of the interviewees
highlighted motion and blood sugar levels as physiological signs that can be used for monitoring
neonatal sepsis. Three of the interviewees stated that activity, oxygen saturation, blood pres-
sure and heart electrical activity are important for monitoring. Then two of the interviewees
highlighted that brain activity and urine composition can be monitored for diagnosis. One in-
terviewee stated that sleep quality, blood volume pulse and body water levels can be used for
diagnosis.
• Treatment of diseases – Four respondents had similar physiological signs for treatment of neonatal
sepsis. These are heart rate, temperature and breathing rate. Three interviewees agreed that
motion, oxygen saturation, blood pressure, blood sugar levels and heart electrical activities(for
infective endocarditis or rheumatoid arthritis) play a role in treating neonatal sepsis. The
physiological signs that were identified by two interviewees for treating sepsis were activity and
urine composition. Only one interviewee identified sleep quality, brain activity, blood volume
pulse.
C.1.8 Stroke
Two of the interviewees highlighted that there are two different types of strokes namely ischaemic stroke
and haemorrhagic stroke. Ischaemic stroke is characterised by the sudden loss of blood circulation to
an area of the brain, resulting in a corresponding loss of neurological function. Then for haemorrhagic
stroke, bleeding occurs directly into the brain parenchyma. However, it is difficult to distinguish the
two unless a computerised axial tomography (CAT) scan is performed.
Choose the physiological signs and their respective stage of care:
• Preventative care – All the interviewees highlighted the importance of blood pressure as an
important physiological sign to be monitored to prevent a stroke especially for hypertensive
patients. Four of the interviewees also agreed that brain activity will be essential as well to
monitor. Three interviewees agreed that motion, breathing rate, activity and heart electrical
activity (for atrial fibrillation resulting in multiple strokes). Two interviewees identified the fol-
lowing physiological signs are heart rate, blood sugar levels (for diabetic patients hypoglycaemia
can mimic stroke) and blood sugar levels. One of the interviewees highlighted temperature,
sleep activity (patients who suffer from sleep apnoea), urine composition, picture monitoring
(cholesterol under the eye) and body water levels.
• Wellness care – Three of the interviewees stated that blood pressure can be used for wellness.
Two of the interviewees agreed that breathing rate, blood sugar levels, heart electrical activity
and brain activity can be used for wellness and motivate a healthy lifestyle. Only one intervie-
wee suggested the following physiological signs heart rate, temperature, motion, activity, urine
composition, blood volume pulse and body water levels.
• Diagnosis and screening – Five respondents agreed that blood pressure is important. Four of the
interviewees agreed on motion and brain activity should be monitored for diagnostic purposes.
Three interviewees highlighted that heart rate, breathing rate, activity, blood sugar levels, heart
electrical activity and blood volume pulse. Then one interviewee identified temperature, sleep
quality, urine composition, picture monitoring and body water levels.
• Treatment of diseases – Two respondents identified heart rate, motion, breathing rate, activity,
blood pressure, blood sugar levels, heart electrical activity and brain activity. Then only one
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interviewee identified temperature, sleep activity, urine composition, blood volume pulse and
body water levels.
• Rehabilitation – Three of the interviewees suggested that monitoring motion, activity, blood
pressure and brain activity would be essential for monitoring a patient after a stroke. Two
interviewees agreed that breathing rate, blood sugar levels, heart electrical activity and blood
volume pulse. Only one interviewee identified heart rate, sleep activity, urine composition, body
water levels and pressure levels (gait analysis).
C.1.9 Ischaemic heart disease
Choose the physiological signs and their respective stage of care:
• Preventative care – All the interviewees highlighted the importance of monitoring the heart rate
for at risk users. Four of the interviewees agreed that blood pressure will be essential as well
to monitor. Three interviewees agreed that motion, breathing rate, activity, oxygen saturation,
blood sugar levels(in certain cases where the patient is diabetic) and heart electrical activity.
Two interviewees identified the following physiological signs are temperature, sleeping activity,
urine composition (for diabetic patients) and blood volume pulse. One of the interviewees
mentioned body water levels 1.
• Wellness care – Four of the interviewees said that monitoring the heart rate can be used for
wellness purposes. Three of the interviewees agreed that blood pressure monitoring can be used
for wellness care and motivate a healthy lifestyle. Two interviewees suggested the following phys-
iological signs motion, activity,breathing rate, oxygen saturation, blood sugar levels and heart
electrical activity. Then one interviewee identified temperature, sleep activity, urine composition
and blood volume pulse for wellness purposes.
• Diagnosis and screening – Five respondents agreed that heart rate and blood pressure is im-
portant. Four of the interviewees agreed on heart electrical activity should be monitored for
diagnostic purposes. Three interviewees indicated motion, oxygen saturation and blood sugar
levels can be used for diagnosis. Then two interviewee identified temperature, breathing rate,
activity, sleep activity, urine composition and blood volume pulse. One of the interviewee sug-
gested monitoring body water levels.
• Treatment of diseases – Four respondents identified heart rate, blood pressure and heart elec-
trical activity. Three interviewees suggested using oxygen saturation and blood sugar levels for
monitoring ischaemic heart disease. Two interviewees identified temperature, motion, breathing
rate, activity, sleep activity, urine composition and blood volume pulse. One of the interviewees
suggested monitoring body water levels.
• Rehabilitation – Four of the interviewees suggested that monitoring heart rate and blood pressure
when recovering from heart attack. Three interviewees agreed that motion, breathing rate, ac-
tivity, oxygen saturation, blood sugar levels and heart electrical activity can be monitored during
rehabilitation. Then two interviewees indicated temperature, sleep activity, urine composition
and blood volume pulse. Only one interviewee identified body water levels for monitoring a
patient in recovery.
1Water intake can reduce the risk of getting heart diseases (Jang et al., 2016)
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Table C.1: Illustration of the feedback from the interviewees
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Preventive care 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wellness care 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Diagnosis and screening 3 4 0 4 0 4 2 2 1 1 1 2 1 1 0 0 1 0 0 0
Treatment of diseases 4 5 0 5 0 5 2 2 0 1 1 2 1 0 0 0 1 0 0 0
Rehabilitation 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
H
I
V
/
A
I
D
S
Preventive care 2 2 0 2 1 2 1 1 0 1 1 1 0 0 0 0 0 0 0 0
Wellness care 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Diagnosis and screening 3 3 1 3 2 3 2 2 0 1 3 2 1 1 0 0 0 0 0 0
Treatment of diseases 4 4 1 4 2 3 2 2 0 1 3 2 1 1 0 0 0 0 0 0
Rehabilitation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
D
i
a
r
r
h
o
e
a
l
d
i
s
e
a
s
e
s
Preventive care 1 1 0 0 0 1 1 1 0 0 0 1 0 1 0 0 0 0 0 0
Wellness care 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Diagnosis and screening 3 3 1 4 1 3 3 3 0 1 0 4 1 4 1 1 0 0 0 0
Treatment of diseases 3 3 1 4 1 3 3 3 0 1 0 4 1 4 1 1 0 0 0 0
Rehabilitation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
M
a
l
a
r
i
a
Preventive care 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wellness care 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Diagnosis and screening 3 3 1 2 1 3 3 3 1 0 1 2 1 1 0 0 0 1 0 0
Treatment of diseases 5 5 2 2 2 3 3 3 1 0 1 2 1 1 0 0 0 1 0 0
Rehabilitation 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
P
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t
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B
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C
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Preventive care 1 1 1 0 1 0 1 1 1 0 0 1 0 0 0 0 0 0 0 0
Wellness care 1 1 1 0 1 0 1 1 1 0 0 1 0 0 0 0 0 0 0 0
Diagnosis and screening 4 4 3 3 3 4 4 4 3 1 2 4 1 1 1 0 0 0 0 0
Treatment of diseases 4 4 3 3 3 3 3 4 3 1 2 3 1 1 1 0 0 0 0 0
Continued on next page
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Wellness care 1 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0
Diagnosis and screening 4 3 1 4 1 3 1 1 0 1 1 1 0 1 0 0 0 0 0 1
Treatment of diseases 4 3 1 4 1 3 1 1 0 1 1 1 0 1 0 0 0 0 0 1
Rehabilitation 1 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0
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Treatment of diseases 4 4 3 4 2 3 3 3 3 1 1 2 1 1 0 0 0 0 0 0
Rehabilitation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
S
t
r
o
k
e
Preventive care 2 1 3 3 3 0 5 2 3 1 4 1 2 1 0 0 0 0 1 0
Wellness care 1 1 1 2 1 0 3 2 2 0 2 1 1 1 0 0 0 0 0 0
Diagnosis and screening 3 1 4 3 3 0 5 3 3 1 4 1 3 1 1 0 0 0 1 0
Treatment of diseases 2 1 2 2 2 0 2 2 2 1 2 1 1 1 1 0 0 0 1 0
Rehabilitation 1 0 3 2 3 0 3 2 2 1 3 1 2 1 1 0 0 0 1 0
I
s
c
h
a
e
m
i
c
h
e
a
r
t
d
i
s
e
a
s
e
s Preventive care 5 2 3 3 3 3 4 3 3 2 0 2 2 1 0 0 0 0 0 0
Wellness care 4 1 2 2 2 2 3 2 2 1 0 1 1 0 0 0 0 0 0 0
Diagnosis and screening 5 2 3 2 2 3 5 3 4 2 0 2 2 1 0 0 0 0 0 0
Treatment of diseases 4 2 2 2 2 3 4 3 4 2 0 2 2 1 0 0 0 0 0 0
Rehabilitation 4 2 3 3 3 3 4 3 3 2 0 2 2 1 0 0 0 0 0 0
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APPENDIX D
CRITERIA SELECTION
The appendix contain mainly data on the number of criteria that were identified from previous studies.
The studies reviewed are illustrated in Table 5.1.
D.1 The criteria identified from previous studies
The data collected from the literature review is provided in Table D.1. The table provides the total
number of criteria identified.
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Table D.1: The criteria that have been identified in previous studies for priority setting.
Number Criteria [1] [2] [3] [4] [5] [6] [7] [8] [9] Total
1 Cost-effectiveness 1 1 1 1 1 1 6
2 Expected outcome of treatment 1 1 1 1 4
3 Costs of treatment 1 1 1 1 1 5
4 Safety 1 1 1 3
5 Alternatives 1 1 1 1 1 5
6 Potential clinical benefit over existing treatment 1 1
7 Improvement of patient-reported outcomes 1 1 1 1 4
8 Size of population affected by disease (Target group) 1 1 1 1 1 5
9 Potential to detect a condition which, if treated early,
averts costs in the future
1 1
10 Public health interest 1 1 2
11 Integration into health system 1 1 2
12 Type of medical service 1 1 2
13 Rare diseases 1 1
14 Long term impact 1 1
15 Clinical guidelines 1 1
16 Sustainable 1 1 2
17 Burden of disease 1 1 1 1 1 5
18 Effectiveness of treatment 1 1 1 1 1 5
19 Severity of the condition 1 1 1 1 1 1 6
20 Quality of evidence on effectiveness 1 1 1 3
21 Urgency of need of care 1 1 1 1 4
22 Age 1 1 1 1 1 5
23 Gender 1 1 2
24 Race 1 1 2
25 Technology requirements 1 1
26 Religion 1 1
27 Social status 1 1 1 3
28 Health expenditure 1 1
29 Budget impact 1 1 1 1 1 1 6
30 Responsibilities 1 1
31 Mental (or) capabilities 1 1 2
Continued on next page
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Table D.1 – Continued from previous page
Number Criteria [1] [2] [3] [4] [5] [6] [7] [8] [9] Total
32 Physical Capabilities 1 1 2
33 Area of residence 1 1 2
34 Time on waiting lists 1 1
35 Political views 1 1 2
36 Community’s views 1 1
37 Timeless of the technology or Novelty 1 1 1 3
38 Expected level of interest 1 1
39 Cultural views 1 1
40 Number of people benefiting 1 1 1 1 4
41 Ethical and legal issues 1 1 1 3
42 Genetic background and sexual orientation 1 1
43 Patient’s lifestyle responsible for cause of disease 1 1
TOTAL 22 26 9 12 7 17 7 8 6
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APPENDIX E
MORE RESULTS FOR
PRIORITISATION
This appendix provides the detailed description of the wearable sensors efficacy. The efficacy assessment
is based on the accuracy, specificity and sensitivity of the wearable sensors as shown in Table E.1.
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Table E.1: Brief description of the wearable sensors for each of the set of criteria
Wearable sensor Accuracy Sensitivity Specificity
Accelerometer The accuracy of accelerometers is 97 percent and
can be applied for medical applications (Yang
et al., 2015). In previous studies the accuracy
of accelerometers was improved through coupling
them with pressure sensors or gyroscopes for a full
range of motion.
The sensitivity ranges from 83 to 98.75
percent because there are certain mo-
tions that can not be accurately de-
tected by the sensors such as falling.
The specificity is 92 percent
which is good and can be
utilised with a low chance of
recording false positives.
Gyroscope A gyroscope has an accuracy that ranges between
76 to 79 percent.Coupling with an accelerometer
gyroscope increases the accuracy to as high as 95
percent.
The sensitivity of a gyroscope is 91 per-
cent however studies shows that when
an accelerometer is coupled with it the
sensitivity will reduce to below 80 per-
cent making it difficult to detect falls.
The specificity is 92 percent
which can be improved by cou-
pling with an accelerometers to
approximately 99,38 percent.
Pedometer The accuracy of the pedometers is affected by the
positioning of the sensors. The pedometers worn
around the waist provide more accurate results
as the wrist ones can fail to detect small steps
(Husted and Llewellyn, 2017). The accuracy is
between 56 and 80 percent.
No studies have been conducted yet to
determine the sensitivity
No studies have been performed
on the specificity
Magnetic sensors The accuracy is 48 - 71% relative to the position-
ing of the wearable sensor. The readings are more
accurate around the leg (Kunze et al., 2010).
ECG electrodes The accuracy ranges from 97% to 98 %. Accuracy
is dependent on the type of electrodes whether
metal or adhesive the latter being more accurate
(Guo et al., 2016).
The sensitivity ranges from 87.5% to
99.34% detects significant diseases us-
ing algorithms.
The specificity ranges from
91.67% to 99.37%.
PhotoplesthmographyThe accuracy of the PPG is 89 %. Challenges with
PPG include cancelling the effects of ambient light
and accommodating differences in skin colour and
condition. Tattoos reduce the accuracy of PPGs
and people of colour usually record less accurate
results.
The sensitivity is approximated at
91%.
The specificity is approximated
at 88%.
Continued on next page
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Table E.1 – Continued from previous page
Wearable sensor Accuracy Sensitivity Specificity
Blood pressure
meter
The accuracy of blood pressure meters is low at
44 % and unreliable results will be produced.
The sensitivity is 80 %. The specificity is 68%. This
highlights that the sensor is
not highly specific to the blood
pressure and can read false
positives.
Respiratory me-
ter, force sensors,
nasal pressure
transducer
The accuracy of the pressure sensors range from
62 % to 88 % when measuring respiratory activi-
ties.
These sensors have a high sensitivity of
92 % therefore the signal output has
less error.
The specificity is low at 72
% therefore it will be difficult
to detect respiratory conditions
and unusual breathing patterns.
Thermistor- neg-
ative temperature
coefficient (NTC)
sensor
These are deemed the most accurate temperature
sensors that are commercially available with an
accuracy of ±0.2 ◦C
Infrared ther-
mopile
The accuracy of the thermopile is low at ±9.5 ◦C
but has a long temperature range.
Pulse Oximeter The level of accuracy is high at 99.47 % measuring
oxygen saturation efficiently.
The sensitivity is at a 100 % The specificity is at 100 % show-
ing that it can measure hypoxia
effectively.
EEG electrodes The accuracy of EEGs to measure brain activity
is approximately 63 %.
The sensitivity of the EEGs is the 62
to 70 %. Although it was slightly more
sensitive for focal seizures compared to
generalized patterns, our reduced ar-
ray has an unacceptably poor sensitiv-
ity for seizure detection.
The specificity of EEGs is 86 to
90 % which is high and can eas-
ily detect seizure and abnormal
brain activities.
Biosensors or
chemical sensor
The accuracy of the bio-sensors is 89 %.
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